FINAL DRAFT
       United States                                     ECAO-CIN-G070
       Env^ronmema. Protecnon                               February, 1990
       Research  and
       Development
       HEALTH AND ENVIRONMENTAL  EFFECTS DOCUMENT FOR
       MOLYBDENUM AND SELECTED MOLYBDENUM COMPOUNDS
      Prepared for
       OFFICE OF SOLID WASTE AND
       EMERGENCY RESPONSE
      Prepared  by
      Environmental Criteria  and Assessment Office
      Office of Health  and Environmental  Assessment
      U.S. Environmental  Protection Agency
      Cincinnati,  OH 45268
                   DRAFT: DO NOT CITE OR QUOTE
                          NOTICE

   This document 1s a preliminary draft.  It has not been formally released
by the  U.S. Environmental Protection  Agency and should not at  this stage be
construed to represent Agency policy.  It 1s being circulated for comments
on Its technical accuracy and policy Implications.

-------
                                  DISCLAIMER

    This report  1s  an external draft  for  review purposes only  and  does not
constitute  Agency  policy.   Mention  of  trade names  or  commercial  products
does not constitute endorsement or recommendation for use.
                                      11

-------
                                   PREFACE
    Health and  Environmental  Effects  Documents  (HEEDs) are prepared  for  the
Office of Solid Waste  and  Emergency Response (OSWER).  This  document  series
Is Intended to support listings under the Resource  Conservation  and  Recovery
Act  (RCRA) as  well  as to  provide  health-related  limits and  goals for  emer-
gency  and  remedial  actions under  the Comprehensive  Environmental Response,
Compensation   and  Liability  Act  (CERCLA).    Both   published  literature  and
Information obtained  for Agency  Program Office files  are evaluated  as  they
pertain to potential human health, aquatic life and environmental  effects  of
hazardous waste constituents.  The  literature searched for In this  document
and  the  dates  searched  are  Included 1n  "Appendix:  Literature  Searched."
Literature search material  Is  current up to  8  months previous  to the  final
draft  date  listed  on  the  front  cover.   Final  draft  document  dates  (front
cover) reflect the date the document 1s  sent  to  the  Program Officer (OSWER).

    Several quantitative  estimates are  presented  provided  sufficient  data
are available.  For systemic toxicants, these Include  Reference  doses  (RfDs)
for  chronic   and  subchronlc  exposures   for   both   the  Inhalation and  oral
exposures.  The  subchronlc or  partial  lifetime  RfO  1s  an  estimate  of  an
exposure  level  that  would not  be expected  to cause  adverse effects  when
exposure  occurs during a  limited  time  Interval I.e.,  for an Interval  that
does  not  constitute a  significant portion  of  the  Hfespan.   This  type  of
exposure  estimate  has  not  been  extensively  used,   or  rigorously  defined  as
previous risk assessment efforts have Focused primarily on  lifetime  exposure
scenarios.  Animal  data   used  for  subchronlc  estimates  generally   reflect
exposure  durations  of 30-90  days.   The general  methodology   for  estimating
subchronlc RfDs Is  the same as traditionally  employed  for  chronic  estimates,
except that subchronlc data are utilized  when  available.

    In the case of  suspected  carcinogens,  a  carcinogenic potency  factor,  or
q-j*  (U.S.  EPA, 1980),  1s  provided.   These  potency  estimates  are   derived
for  both  oral  and  Inhalation  exposures  where  possible.   In  addition,  unit
risk estimates for  air and drinking water  are presented  based on  Inhalation
and  oral  data,  respectively.    An   RfD  may   also  be   derived  for   the
noncardnogenlc health effects  of  compounds which are also carcinogenic.

    Reportable quantities  (RQs) based on  both chronic toxlclty  and  carclno-
genldty are  derived.   The RQ 1s used to determine  the quantity  of a  hazard-
ous  substance  for  which  notification Is required  In the event of a  release
as  specified  under the  Comprehensive  Environmental  Response,  Compensation
and  Liability  Act   (CERCLA).  These  two  RQs   (chronic  toxldty and  carclno-
genldty) represent two of six  scores developed (the remaining  four  reflect
IgnltabUHy,   reactivity,  aquatic  toxlclty,   and  acute mammalian  toxlclty).
Chemical-specific  RQs-Teflect  the lowest of these six  primary criteria.   The
methodology for chronic  toxlclty and  cancer  based  RQs  are defined  In  U.S.
EPA, 1984 and  1986a, respectively.
                                     111

-------
                              EXECUTIVE SUMMARY
                *
    Molybdenum  Is  a  silvery-gray  metal  that belongs  to group  VIB of  the
periodic table  of  elements.   It can have  valence  states of +6,  *5,  +4,  f3,
+2 and 0, although valence state +6  Is  the most  stable.   Host  of the world's
molybdenum  comes   from mined  ores,  although  It   Is  also  recovered  as  a
by-product  of  copper  mining.   The  only  commercially   Important  molybdenum
mineral   1s   molybdenite   (molybdenum   dlsulflde).   Molybdenum   producers
concentrate  the molybdenite  ore  by crushing, grinding  and using  flotation
processes  to  yield  a  molybdenite  concentrate  which   1s  then  roasted  to
convert  the  sulflde  to the oxide.   The  converted   oxide, known  as  technical
molybdlc oxide  (chemically, molybdenum trloxlde),   can be added to  steel  In
this  form  (Barr,  1981)  and  Is  the  primary  end-use  commercial  molybdenum
material.  In 1987, U.S. molybdenum producers  produced -75 million  pounds  of
contained molybdenum  In molybdenite concentrate.   United States  consumption
of molybdenum  In  1987  was -33 million  pounds of contained molybdenum.   The
end-use  pattern  for  molybdenum In  1987  was  as  follows:  steel  (56%),  cast
Iron  (4%),   superalloys  (8.8%),  alloys  (excluding steel  and  superalloys)
(2%), mill  products  made  from metal powder  (11.5%), chemicals  and  ceramics
(8.9%) and miscellaneous (8.8%)  (USDI,  1988).
    Molybdenum  Is a natural element  that cannot  be  degraded by environmental
processes.   Although  environmental  processes  may  transform   one  molybdenum
compound Into another, the molybdenum Is still present.   The major  source of
molybdenum  release  to  the  atmosphere  Is  the  combustion  of  coal,  which
releases participate ash  containing molybdenum  Into the atmosphere  (Section,
3.3.).  The primary processes  that remove  atmospheric molybdenum are wet  and
dry  deposition.  One  of   the  most "Important  factors   that  determines  the
                                      1v

-------
degree  of  molybdenum  transport   In  water  and  soil   1s  pH.   In  general,
Increases  1n  solubility  enhance  molybdenum  availability  to  plants  and
transport  1n  water  and soil.  As  the pH of  the  media  Increases,  molybdenum
mobility  in  soil and  water and  uptake  In  plants  Increase  (Lindsay,  1979;
Bohn  et  al., 1985;  Davles,  1980).   Dissolved  molybdenum In soil  and  water
usually occurs as the molybdate Ion.  The mobility  of  molybdenum In soil  and
water  may decrease  by  sorptlon   onto  Fe_0. and humlc  materials   In  these
                                          & 0
media.   Molybdenum  leaching  from  fly   ash   Increases  as  pH  Increases  and
because the  leaching  molybdenum  Is In the form of  the  molybdate Ion (Goetz,
1983).  Therefore,  fly  ash  deposited  on alkaline soils  1s more  likely  to
leach  molybdenum  Into  the  underlying   soil  than  Is  fly  ash   deposited  on
acidic soils.
    Molybdenum occurs  naturally  In soils at  levels that  commonly  range from
0.2-5  ppm,  although  an accepted  average soil  content  1s  2 ppm  (Lindsay,
1979).  Molybdenum does  not occur  naturally  In  elemental  form,  but  primarily
as sulfldes  or oxides.   The concentration of molybdenum In surface  waters Is
generally  <5   yg/l,  although   concentrations   <500  yg/l  were   reported
In  some  drinking  waters.   Concentrations  >20 yg/l  In  water   are  probably
due  to an  anthropogenic  Influence   (Chappell  et al.,  1979).   The  average
human  dally   Intake  of  molybdenum In  drinking  water  1s  reportedly <5  vg,
which  represents only  1.5%  of  the  total  dally Intake  (Wlersema  et al.,  1984;
Chappell  et  al., 1979).   The  average amount of  molybdenum  In  the American
diet  Is 288  ng/g of  food (M1ller-Ihl1 and Wolf,  1986).   Assuming the average
American  adult  consumes  1600  g  of   food/day,  the  average  dally  Intake  of
molybdenum  Is  460  yg.   A  similar food  Intake  of 335  yg/day   was  reported
and  thought  to  represent 98.5% of the  total dally Intake  (Wlersema  et al.,
1984).   Available  ambient  air  monitoring data  for molybdenum  (Wlersema  et

-------
a!., 1984;  Evans  et al.,  1984} Indicate  that  dally Intake  from  Inhalation.
represents only <0.1154 of  total  dally Intake.  The major source of  molyb-
denum  emissions  to  the  atmosphere  Is the  combustion  of  coal  by  electric
power  generation stations  and   Industry (U.S.  EPA,  1973;  Nrlagu and  Pacyna,
1988).    The  molybdenum  Is  emitted  In the  coal  fly ash, which  eventually
settles to terrestrial  surfaces and surface waters.
    Data  currently  available  Indicate that  molybdenum  can be acutely  toxic
to  freshwater vertebrates at concentrations >0.73 ppm (B1rge,  1978;  B1rgo et
al., 1979).   Molybdenum  can be acutely toxic  to saltwater fauna  at  concen-
trations >147 mg/t  (Morgan et  al.,  1986).
    BCF  values for  molybdenum  In  aquatic  fauna did  not exceed 100,  although
values   In algae could be >2000 and  <10,000 In aquatic  plants (Brooks  and
Rumsby,  1965; Suloway  et al..  1983;  Sakaguchl  et  al.,  1981;  Kovacs  et  al.,
1984).   The highest concentrations of  molybdenum In  aquatic macrophytes  were
from samples  collected from the  Tejo River,  Portugal  (8.2 ppm dry  weight)
(Freltas  et  al.,   1988).   The  highest levels  of  molybdenum  In  tissues  of
Invertebrates were  reported for  Molna rectlrostrls  (605  mg/kg dry  weight)
and  ollgocheates  (60.3 mg/kg  dry  weight)  from a  sewage  treatment basin  In
          ••          • '
Hungary  (Czegeny and  Deval, 1985).   No  single  sample  of  fish  exceeded  3.6
yg/g dry weight (carp;  Sa1k1  and May,  1988).   Levels In  wildlife were  <0
to -58 wg/g wet  weight  (Wren et al.,  1983).
    Excretion studies  using pigs  suggest  that ~80-86% of  an orally  admin-
istered  dose  of Mo  was   fairly rapidly  absorbed  from  the  gastrointestinal
tract  (Bell  et  al., 1964).  In 6- to 10-year-old  girls,  a positive  balance
was  observed  when  the diet  provided  40-80  jig  Mo/day  (Engel  et al.,  1967).
Molybdenum appears  to be rapidly absorbed  from  the  gastrointestinal  tract of
guinea  pigs.  Studies  using  rats  suggest  that absorption  of  molybdenum  from
                                      vl

-------
molybdenum trloxlde  Is  more  rapid than from molybdenite,  because  the former
1s more soluble In digestive juices  (Falrhall  et  al.,  1945).   Molybdenum was
widely distributed throughout the body after oral  dosing  of  steers (Comar et
al., 1949) and  guinea pigs  (Falrhall  et  al.,  1945).   Qualitatively  similar
results were obtained In mice after  Intravenous  Injections and  In  rats after
oral  administration  of  radlolabeled  molybdenum   (Nellands  et  al.,  1948;
Rosoff  and  Spencer,  1973).   In  mice, rats and  steers,  liver and  kidneys
accumulated a considerable  percentage  of  the administered dose.   In  humans,
molybdenum 1s  found  mainly  1n  the liver,  kidneys,  fat  and  blood  (Goyer,
1986).                            	
    Molybdenum 1s  apparently eliminated primarily  by  excretion.  There  was
no  evidence   found  for metabolism  of  Mo.   In  swine,   urinary   excretion
accounted  for  80-86%  of  an oral  dose and  fecal excretion  accounted  for
8.6-14.6%  (Bell  et  al.,  1964).   In  humans treated  Intravenously,  urinary
excretion  accounted  for  16.6-27.2% of  the  dose  and  fecal   excretion  for
1.0-6.8%.  Substantial  amounts  of Mo  may  be  lost through profuse  sweating
(Consolazlo et al.,  1964).  Following Intravenous treatment,  mice  excreted
35.6% of the dose  1n the urine and  2.6% In  the  feces  over a 24-hour period
(Rosoff   and   Spencer,   1973).    Lener    and  B1br   (1979)   demonstrated
qualitatively  that biliary excretion 1s  Involved 1n Mo elimination,  but  the
extent of excretion by this route was not determined.
    Reported  oral  LD^.s for  Mo  In  rats  exposed  through diet  for   40  days
were 101 mg/kg for  calcium molybdate,  125  mg/kg for molybdenum trloxlde  and
333 mg/kg  for  ammonium  molybdate (Falrhall et  al.,  1945).   L0,_ data  for
                                                                 DU
other   species  were  not available.    Short-term  oral   studies  with  various
species Indicate that molybdenum  depresses  body  weight  gain and affects  the
gastrointestinal  tract,  the  liver  and kidneys.    The  doses  associated with

-------
these,  effects  vary  with  different  molybdenum compounds.   In rats,,  sodium
molybdate caused  death  1n <2  weeks at  doses  of 250  mg  Ho/kg (Ne1lands  et
al., 1948), whereas  571 mg  Ho/kg/day from ammonium molybdate  was  not  lethal
(Rana et al.,  1980).  Ammonium  tetrathlomolybdate 1s apparently considerably
more toxic  than  other molybdenum  compounds,  since dietary  doses  of  0.3  mg
Ho/kg for 21 days had gastrointestinal and skeletal effects  In rats  (Fell  et
al., 1979; Spence et al., 1980).   Inhalation of  dusts  of  molybdenum  trloxlde
and  calcium  molybdate  killed guinea pigs  In  <5 weeks at  levels  of 200  and
155  mg  Ho/m3,  respectively;   however,   these  experiments   were  not  well
designed and the  results  not clearly reported  (Falrhall et  al., 1945).
    Molybdenum added to  the  diet of  male  rats -as   the  trloxlde,   calcium
molybdate, or  as  ammonium molybdate  In  doses  between 85  and 6757  mg Ho/kg
for 8-232 days caused weight loss and mortality (Falrhall  et  al.,  1945).
    In  rabbits,  dietary  doses  of  >91 mg  Ho/kg as sodium molybdate  In  the
diet caused  anemia  and,  eventually, death In  "40 days,  but  doses of  <25  mg
Mo/kg had no noticeable adverse  effects  (ArMngton and Davis,  1953;  Robinson
et  al.,  1969).  In  rats,  doses of -20  mg  Ho/kg/day   from sodium  molybdenum
for  42  days   1n   the diet  or   drinking  water   significantly  decreased  body
weight gain (Lallch et al.,  1965; Nellands  et al., 1948).
    In  rats,  sodium molybdate  added to  the  drinking water  at levels  that
provided doses of 0.28-2.8  6 mg Mo/kg/day decreased the  Incidence of  tumors
Induced by known carcinogens (Luo  et al., 1983;  Wei et al.,  1985).   However,
Intraperltoneal Injections of  molybdenum trloxlde In  mice for a  total  dose
of  31(>7 mg Mo/kg over a 30-day  period  Increased  the  Incidence of  lung  tumors
(not statistically  significant) and  significantly  Increased  the  number  of
lung  tumors/mouse  (Stoner  et   al.,  1976).   The  overall   evidence  Indicates
that  some  molybdenum  compounds  are  weak  mutagens   In  bacterial  assays

-------
 (Kanematsu  et al.,  1980;  Rosmann et  al.,  1984).   In  the only  assay using
 mammalian   cells,   molybdate   anlons   gave   a 'positive  mutagenlc  response
 (Zellkoff  et al.,  1986).   Sodium  molybdate  did  not  produce  developmental
 toxldty when Injected Intravenously to pregnant hamsters (Perm, 1972).
     In a 3-generat1on  study by Schroeder  and  MHchener  (1971),  a dose of 1.9
 mg  Ho/kg In  drinking  water  was  associated  with  early death  In  offspring,
 Increased number of dead Utters, maternal mortality and the birth of runts.
     In rats,  20  ppm Mo In  the diet  (1  mg/kg/day)  was associated with reduced
 body weight  gain  In male rats and reduced lactation Index In female rats; 80
-ppm  (4 mg/kg/day)  was associated with  male  Infertility  (Jeter  and  Davis,
 1954).
    An  RfD  of  1  yg Mo/kg/day  was  derived for  subchronlc  oral  exposure to
 sodium  molybdate  based  on  the  LOAEL  of  1   mg  Mo/kg/day  In  rats   In  the
 reproductive  study  by  Jeter and Davis  (1954).   Because  Mo Is  a nutritionally
 essential element,  and because the  subchronlc oral  RfD  Is  somehow below the
 recommended dally allowance for Mo, the  subchronlc  oral  RfD was also adopted
 as the RfD  for  chronic exposure.  The  RfD values  are well below the line for
 adverse effects  1n  a dose/duration-response plot  of the  oral  toxlclty data.
 An RQ  of 100 pounds was derived  based  on reproductive  effects  In  mice  1n  a
 3-generat1on  study  (Schroeder  and MUchener,  1971).   Molybdenum was assigned
 to  EPA Group D:  not  classifiable  as  to  human cardnogenlclty.   A  cancer-
 based RQ was not derived.
                                      1x

-------
                             TABLE  OF  CONTENTS

                                                                       Page
1.  INTRODUCTION	    1

    1.1.   STRUCTURE AND CAS NUMBER	    1
    1.2.   PHYSICAL AND CHEMICAL PROPERTIES 	    1
    1.3.   PRODUCTION DATA	    1
    1.4.   USE DATA	    4
    1.5.   SUMMARY	    8

2.  ENVIRONMENTAL FATE AND TRANSPORT	    9

    2.1.   AIR	    9
    2.2.   WATER	   10
    2.3.   SOIL	   10
    2.4.   SUMMARY	   11

3.  EXPOSURE	   13

    3.1.   WATER	   13
    3.2.   FOOD	   14
    3.3.   INHALATION	   14
    3.4.   DERMAL	'. .   15
    3.5.   SUMMARY	   16

4.  ENVIRONMENTAL TOXICOLOGY	   17

    4.1.   AQUATIC TOXICOLOGY 	   17

           4.1.1.   Acute Toxic Effects on Fauna	   17
           4.1.2.   Chronic Effects on Fauna	 .   18
           4.1.3.   Effects on Flora	   19
           4.1.4.   Effects on Bacteria	"...	   20

    4.2.   TERRESTRIAL TOXICOLOGY 	   20

           4.2.1.   Effects on Fauna	   20
           4.2.2.   Effects on Flora	   20

    4.3.   FIELD STUDIES	   20
    4.4.   AQUATIC RISK ASSESSMENT	   27
    4.5.   SUMMARY	   30
                                                   !• '     f
5.  PHARMACOK1NETCS ,-	   31

    5.1.   ABSORPTION	   31
    5.2.   DISTRIBUTION	   32
    5.3.   METABOLISM	   35
    5.4.   EXCRE1ION	   35
    5.5.   SUMMARY	   36

-------
                           TABLE OF CONTENTS (cent.)

                                                                         Page
 6.  EFFECTS	    38

     6.1.   SYSTEMIC TOXICITY	    38

            6.1.1.   Inhalation Exposure  	    38
            6.1.2.   Oral Exposure	    40
            6.1.3.   Other Relevant Information	    47

     6.2.   CARCINOGENICITY	    50

            6.2.1.   Inhalation	    50
            6.2.2.   Oral	    50
            6.2.3.   Other Relevant Information	    50

     6.3.   MUTAGENICITY	    52
     6.4.   DEVELOPMENTAL TOXICITY  	    54
     6.5.   OTHER REPRODUCTIVE EFFECTS 	    54
     6.6.   SUMMARY	    56

 7.  EXISTING GUIDELINES AND STANDARDS 	    58

     7.1.   HUMAN	:	    58
     7.2.   AQUATIC	    58

 8.  RISK ASSESSMENT	    59

     .8.1.   CARCINOGENICITY	    59

            8.1.1.   Inhalation	    59
            8.1.2.   Oral	    59
            8.1.3.   Other Routes'.	    59
            8.1.4.   Weight of Evidence	    59
            8.1.5.   Quantitative Risk Estimates 	    60

     8.2.   SYSTEMIC TOXICITY. .  .	    60

            8.2.1.   Inhalation Exposure  	    60
            8.2.2.   Oral Exposure	    60

 9.  REPORTABLE QUANTITIES 	    65

     9.1.   BASED ON SYSTEMIC 10XICITY 	    65
     9.2.   BASED ON CARCINOGENICI1Y	    69

10.  REFERENCES. . .	    72
    i *.             —
APPENDIX A: LITERATURE SEARCHED	    88
APPENDIX B: SUMMARY TABLE FOR MOLYBDENUM  	    91
APPENDIX C: DOSE/DURATION RESPONSE GRAPH(S) FOR EXPOSURE TO
            MOLYBDENUM	"	    92
                                      x1

-------
                               LIST OF TABLES
No.                               Title                                Page
1-1     Synonyms, CAS Numbers, Molecular Weights,  Empirical
        Formulas and Structures of Molybdenum and  Compounds 	    2
1-2     Physical Properties of Molybdenum and Compounds 	    3
1-3     U.S. Manufacturers of Selected Molybdenum  Compounds 	    5
1-4     Salient Molybdenum Statistics 	    7
4-1     Molybdenum Concentrations 1n Field Collected Flora and
        Fauna	   22
5-1     The Distribution of Molybdenum Following Oral Adminis-
        tration of.Molybdenum Tr1ox1de to Guinea P1gs	   33
6-1     Ingestlon of Molybdenum by Groups of Male  White Rats Fed
        Diets Containing Various Molybdenum Compounds 	   41
6-2     Mutagenldty Testing of Molybdenum	   53
9-1     Toxldty Summary for Molybdenum Compounds	   66
9-2     Composite Scores for Molybdenum Compounds  	   68
9-3     Molybdenum:  Minimum Effective Dose (MED) and Reportable
        Quantity (RQ)	   70

-------
                             LIST  OF ABBREVIATIONS

ADI                     Acceptable dally intake
BCF                     Bloconcentratlon factor
CAS                     Chemical Abstract Service
CS                      Composite score
OFF                     011sopropy1 phosphorofluorldate
ECso                    Concentration  effective to 50% of recipients
                        (and all other subscripted dose levels)
GMAV                    Genus mean acute values
GMCV    ~               Genus mean chronic values
LC5Q                    Concentration  lethal to 50% of recipients
                        (and all other subscripted dose levels)
1050                    Dose lethal to 50% of recipients
MBN                   •  Methylbenzyln1trosam1ne
MED                     Minimum effective dose
NMU                     N-N1troso-n-methylurea
NOAEL                   No-observed-adverse-effect level
NOEL                    No-observed-effect level
NSEE                    N-NHrososarcos1ne
PEL                     Permissible exposure limit
ppm                     Parts per million
RQ                      Reportable quantity
RVd                     Dose-rating value
RVe                     Effect-rating  value
TLm                    -Median tolerance unit
TLV                     Threshold limit value
TWA                     Time-weighted  average

-------
                               1.  INTRODUCTION
1.1.   STRUCTURE AND CAS NUMBER
    The  structure,  CAS  registry  numbers,  molecular  weights and  empirical
formulas  of  molybdenum  and  selected molybdenum  compounds  are  presented  In
Table  1-1.   The selection of molybdenum  compounds  for discussion  was  based
upon  the ability of  the molybdenum  Ion to  dissociate  under  physiological
conditions,  the presumption  that  the  molybdenum 1on would  be the most  toxic
moiety and the availability of toxlcologlcal  and physlcochemlcal  data.
1.2.   PHYSICAL AND CHEMICAL PROPERTIES
    Molybdenum  1s  a  silvery-gray metal  that  belongs  to  group  VIB of  the
periodic  table  of elements  (Barr, 1981).  -It can have  valence  states of *6,
+5,  -t-4,  +3,  +2  and  0,  although valence   state  +6  1s  the  most  stable.
Physical  properties  of  molybdenum  and  selected molybdenum compounds  are
listed In Table 1-2.
    Molybdenum  metal   has  an  extremely  high  melting  point (2626°C)  that
permits  high-temperature applications such as  furnace  parts,  rocket nozzles,
welding  tips,  thermocouples, glass-melting electrodes,  dies and  molds (Barr,
1981).   It resists corrosion by mineral  acids and some liquid  metals.
1.3.   PRODUCTION DATA
    Most  of  the world's  molybdenum supply comes from mined molybdenum  ores,
although  H  Is also  recovered  as a by-product  of  copper  mining.   The  only
commercially   Important   molybdenum  mineral   Is  molybdenite   (molybdenum
dlsulflde).  Primary  ore bodies  In the Western Hemisphere  contain  -0.2-0.4%
molybdenum and give a recovery of 2-4 kg/metric ton  of ore (Barr, 1981).
    Molybdenite ore  Is  concentrated  by crushing and  grinding  the  ore  and
then subjecting H  to a  series of flotation  operations.  Molybdenite concen-
trate  contains -90X molybdenum dlsulflde; the  remainder 1s  primarily silica.


0186d                               -1-                              02/05/90

-------
                                                           TABLE  1-1
2 Synonyms.
a.
Compound (Synonyms)
Molybdenum
Ammonium molybdate
(ammonium orthomolybdate)
(ammonium normal molybdate)
Amonlum dlmolybdate .-;
iv> Ammonium hep tamo Tybdate
(ammonium paramolybdate)
Molybdenum dlsulflde
(molybdenum sulflde)
(molybdenite)
Molybdenum trloxlde
(molybdenum anhydride)
(molybdlc acid anhydride)
(molybdlc oxide)
Sodium molybdate
CAS Numbers, Molecular Heights, Empirical Formulas and
Structures of Molybdenum and Compounds
CAS Number
7439-98-7
13106-76-8
27546-07-2
i
12027-67-7
1317-33-5
1313-27-5
7631-965-0
10102-40-6
(dlhydrate)
Molecular Empirical
Weight Formula
95.94 Mo
196.01 H6MoN204
339.96 HeMo2N207
11,163.89 H24Mo7Ne024
160.06 HoS2
143.94 Mo03
205.92 MoNa204
Structure
Mo
(NH4)?Mo04
(NH4)2Mo207
(NH4)6Mo7024
MoS2
Mo03
Na2Mo04
o
in
oo
us

-------
00
en
Q.
TABU 1-2


Physical Properties of Molybdenum and Compounds
Chemical
Molybdenum
Ammonium
molybdate
Ammonium
heptamolybdate
(tetrahydrate)
i Molybdenum
dtsulftde
Molybdenum
trloxlde
Sodium molybdate
aBarr, 1981
°Weast, 1985
NO . No data
Description Melting Point Boiling Point
CC) CC)
silver -gray metal3 2626a 5560*
r
colorless solid0 decomposes0 decomposes0
colorless to yellowish -^0 at 90° decomposes 190°
solid0
black luster solid0 1185° ND
colorless or white- 795° sublimes 1155°
yellow solid0
white solid0 687° NO



Density
(g/cm»)
10.223
(20*C)
2.276b
(25'C)
2.498°
4.80°
(14-C)
4.692°
(21'C)
3.2Bb



Vapor
Water Solubility Pressure
(mm Hg|
Insoluble6 2.96xlO"«a
(1725*C)
soluble with NO
decomposition0
43 g/100 ccb ND
(cold water)
Insoluble0 ND
0.1066 g/100 cc 1.0
(18*C)° (734-C)0
44.3 g/100 cc NO
(cold water)0



in
CO

-------
The  concentrate 1s  then  roasted to  convert  the sulflde  to  the oxide.  The
converted  oxide,  known as  technical molybdlc  oxide (chemically, molybdenum
trloxlde),  can  be  added  to  steel  1n  this  form  (Barr,  1981)  and  Is  the
primary end-use commercial molybdenum material  (USDI, 1988).
    Aqueous  solutions  of  purified  molybdlc  oxide  can  be  converted  to
ammonium  molybdate  or  sodium  molybdate by  reaction with  ammonia  or sodium
hydroxide, respectively (Barry, 1981).
    U.S.  manufacturers of  ammonium  molybdate,  molybdenum  trloxlde, molyb-
denum  dlsulflde  and  sodium  molybdate  are  given  In   Table  1-3.   Salient
statistics  for molybdenum  for 1983-1987  are presented  1n Table  1-4.   The
decreased  production  of molybdenite  concentrate In  1987  was due to a cutback
by domestic  producers to  correct an  over-supply  situation.   The two largest
U.S. producers  of  molybdenum  are AH AX  Inc.,  and Cyprus  Minerals  Co. (USDI,
1988).
1.4.   USE DATA
    The apparent  U.S. consumption  of contained  molybdenum 1n 1987  was  -33
million  pounds.   Apparent  consumption  1s   defined as  U.S.  primary  plus
secondary  production,  plus  Imports,  minus  exports, plus adjustments  for
government and  Industry stock  changes.   The  end-use pattern  for  molybdenum
In 1987  was  as  follows:   steel  (56%),  cast  Iron  (4%),  superalloys  (8.8%),
alloys (excluding steel and  superalloys)  (2%),  mill  products  made  from metal
powder  (11.5%), chemicals  and  ceramics  (8.9%)  and  miscellaneous  (8.8%).
Based  upon  the various   commercial  molybdenum  chemicals,  consumption  of
molybdenum  In  1987 was  as follows:  molybdlc  oxide (58%),  ferromolybdenum
(15.5%),   ammonium   and sodium molybdate  (5.0%),   other  materials  (21.4%)
(USDI,   1988).   Ferromolybdenum   Is  formed  by  reducing  technical  molybdlc
oxide with Iron oxide (Barr,  1981).

0186d                               -4-                               02/05/90

-------
                                  TABLE 1-3

             U.S.  Manufacturers of Selected Molybdenum Compounds*
               Manufacturer
                        Location
Ammonium molybdate (basic molybdate)

Gulf Chemical & Metallurgical  Co.

The Procter & Gamble Co.
  R1chardson-V1cks, Inc., subsidiary
  J.T. Baker Inc., subsidiary

Molybdenum trloxlde (molybdenum anhydride,
  molybdlc acid anhydride, molybdlc oxide)

AMAX Inc.
  AMAX Metal Products division
BP America, Inc.
  BP Minerals America
  Kennecott division
  Utah Copper division

Cyprus Minerals Co.
  Cyprus Metec Corp.
                Freeport,  Texas
                PhllUpsburg,  New Jersey
                Fort Madison, Iowa
                Langeloth, Pennsylvania
                Salt Lake City, Utah
                Wlnslow, New Jersey
Molybdenum dlsulflde (molybdenum sulflde)

AMAX Inc.
  AMAX Metal Products division

BP America, Inc.
  BP Minerals America
  Kennecott division
  Utah Copper division

Cyprus Minerals Co.
  Cyprus Metals Co. division

Dow Corning Corp.

Phelps Dodge Corp.
  Chlno Mines Co., subsidiary

Unocol Corp.
  Molycorp, Inc., subsidiary
                Langeloth, Pennsylvania
                Salt Lake City, Utah


                Chains, Idaho

                Trumbull, Connecticut


                Hurley, New Mexico


                Questa, New Mexico
0186d
-5-
05/31/89

-------
                               TABLE  1-3  (cont.)
               Manufacturer                                 Location
Sodium molybdate

AMAX, Inc.
  AMAX Metal Products division                      Fort Madison,  Iowa

Cyprus Minerals Co.
  Cyprus Metec Corp.                                Wlnslow,  New Jersey

North Metal and Chemical Co.                        York,  Pennsylvania

The Procter & Gamble Co.
  R1chardson-V1cks, Inc., subsidiary
  J.T. Baker Inc., subsidiary                       PhllUpsburg,  New Jersey


*Source:  SRI, 1988
0186d                               -6-                             05/31/89

-------
o
CO
o.
                                                      T/toefi-4
                                           Salient Molybdenum Statistics3
                      (In thousands of pounds of contained molybdenum and thousands  of  dollars)
'
United States:
Concentrate:
' i
Production '
Shipments
Value
Reported consumption
Imports for consumption
Stocks, Dec. 31: mine and plant
Primary products:
Production
Shipments
Reported consumption
Stocks, Dec. 31: producers'
World: Mine production
1983

i

33,593
48.805
$166,612
27,014
1.673
11.637

37,533
50,562
27,225
28,352
. 140,616°
1984



103,664
102,405
$326.780
54,843
28
12,450

79.689
65,527
34,792
22,155
214,275°
1985



108,409
111,936
$347,812
Confidential
112
9,332

87,436
73,861
33,451
21,014
216,364
1986



93,976
95,006
$240,484
53,061
1.120
8,715

41,490
57.855
31,898
20,699
203,466°
1987



75,117
69.868
$179,286
37,442
1.264
15,082

34,659
40.668
32,629
22.168
186,405d
    aSource:  USOI, 1988
    °Rev1sed
    cPre!1m1nary
    ^Estimated
CO
CO

-------
    The   ammonium  molybdates  are  used  as   specialty   catalysts  and  as
h1gh-pur1ty  sources for  producing molybdenum  metal  (Barry,  1981).   Sodium
molybdate  1s  used  In  the  pigment  and metal-f 1n1sh1ng  Industries,  as a soil
additive and  for  aqueous corrosion-Inhibition applications (Barry,  1981).
1.5.   SUMMARY
    Molybdenum  1s  a  silvery-gray  metal  that  belongs  to group VIB  of the
periodic  table  of elements.  It can  have valence states of  +6,  *5,  +4, +3,
4-2 and 0,  although  valence state  +6 1s the most stable.  Most of the world's
molybdenum  comes  from  mined  ores,  although  1t  1s  also   recovered   as  a
by-product  of  copper  mining.  The only  commercially  Important  molybdenum
mineral   1s   molybdenite   (molybdenum  dlsulflde).    Molybdenum   producers
concentrate  the molybdenite  ore  by crushing,  grinding and  using  flotation
processes  to yield a  molybdenite concentrate,  which  1s  then roasted  to
convert  the  sulflde to the  oxide.   The converted  oxide,  known  as  technical
molybdlc  oxide  (chemically,  molybdenum trloxlde),  can  be added to steel  1n
this  form (Barr,  1981) and  Is the  primary  end-use  commercial  molybdenum
material.  In 1987, U.S. molybdenum producers produced  -75 million  pounds  of
contained molybdenum 1n molybdenite concentrate.   U.S.  consumption  of molyb-
denum In  1987 was -33  million  pounds  of contained molybdenum.  The  end-use
pattern for molybdenum  In  1987  was  as  follows:   steel (56%), cast  Iron (4%),
superalloys  (8.8%), alloys   (excluding  steel  and superalloys)  (2%),  mill
products made from  metal  powder (11.5%),  chemicals and ceramics  (8.9%) and
miscellaneous (8.8%) (USDI, 1988).
0186d                               -8-                              02/05/90

-------
                     2.  ENVIRONMENTAL  FATE  AND  TRANSPORT

    Molybdenum 1s a natural element that cannot be degraded  by  environmental
processes.   Although  environmental processes  may  transform one  molybdenum
compound Into another, the molybdenum will  still be present.  Therefore,  the
environmental fate and transport of molybdenum  Involves  Us  transport  In  and
between environmental  media  (air, water  and  soil) and  conversion from  one
compound  Into  another.  Molybdenum reactions are  described as  some of  the
most complex of any chemical element (Lindsay,  1979), and  a  detailed  discus-
sion of  chemical  equilibria  1n  soil and  water  Is beyond  the  scope of  this
document.  Therefore,   this  section  will   discuss  only  the  more  Important.
aspects that Influence the fate and transport  of molybdenum.
2.1.   AIR
    The major source  of  molybdenum release  to the atmosphere 1s  the  combus-
tion of  coal,  which   releases  partlculates containing  molybdenum Into  the
atmosphere  (Section  3.3.).    Molybdenum  released  to  the  atmosphere  from
combustion  processes   will  probably exist  as  an oxide  (U.S.  EPA,   1973).
Molybdenum  partlculates   released  from mining  operations,  which  generally
Involve molybdenum  sulflde ores,  will  contain molybdenum  In a  sulflde  form.
It  Is  unlikely  that molybdenum 1n these partlculates undergoes any  chemical
transformation  In  air.    Molybdenum  partlculates  In  air  will   eventually
settle to  the  earth's surface  by dry and wet deposition.  The  rate of  depo-
sition depends  on the size,  density and  water  solubility of the  particles.
The  residence  time  of  the  particles   ranges  from  a  few days  to  60  days
(Lantzy and MacKenzle. 1979).
0186d                               -9-                              05/31/89

-------
2.2.   WATER
    The  fate  of molybdenum  1n  aquatic  systems Is  expected  to depend partly
on  the pH of  the media  (Section  2.3.)-  In  general,  molybdenum solubility
Increases as pH  Increases  In the  environmental  range (Lindsay, 1979; Bohn et
a!.,  1985;  Davles, 1980),  suggesting  that the dissolved  molybdenum content
In  water  will  Increase  as  the  water  becomes  more  alkaline.   In  acidic
waters,  the molybdenum  content  In  sediments and  suspended  material 1s likely
to  be  higher  (In general) than In alkaline waters  because  of precipitation
from  solution.   Dissolved molybdenum  1n environmental  waters exists  as  the
molybdate  1on.   This  1on can  react  with cations In water  to form Insoluble
compounds, or  the soluble  compounds  may  be  readily bloavallable  to plants
and  animals •  for uptake.   Soluble molybdenum compounds  may be sorbed  by
Fe.O. and humlc materials 1n water (Bysshe, 1988).
    Molybdenum 1n aquatic systems  Is unlikely  to  be transported  by volatili-
zation.  Pertinent data regarding  blodegradatlon  of molybdenum In water  were
not located In the available literature dted  1n Appendix A.
2.3.   SOIL
    Molybdenum occurs  1n  soil  naturally or  from anthropogenic  sources  such
                            •'•'          f t  *   '         ^ _         '„         _  .
as  atmospheric  fallout  of partlculate matter  from  coal combustion  or  land-
filling  of  coal  combustion  ash (Section  3.1.).  One  of the  most Important
factors  that  determines  the degree  of molybdenum transport or  conversion
from  one form to another  Is pH (Lindsay, 1979;  Bohn  et a!., 1985;  Davles,
1980).   In general,  solubility  and  molybdenum  availability to plants  or
leaching  Increases  as- pH  Increases  1n  the   environmental  range  (Lindsay,
1979; Bohn et  al..  1985;  Davles, 1980).   Soil may  be  limed to raise  Us  pH
and Increase molybdenum availability to  plants  In molybdenum-deficient  areas
0186d                               -10-                             01/30/90

-------
(Davles,  1980),   Intentional  soil  applications  of   soluble   sodium  and
ammonium  molybdates   Is   used  to   Increase  molybdenum  availability   1n
molybdenum-deficient soils (Barry,  1981).
    Partlculate and  ash material  from  coal  combustion contains  molybdenum
mostly  1n the  form  of molybdenum oxides (U.S. EPA, 1973).  The  fate  of this
material  1s  of prime  Importance,  since 1t occurs  In  soil  from  human  Input
rather  than  naturally.   Goetz  (1983)  examined  the  leaching of  molybdenum
from coal fly ash and  found a strong  dependence  on  pH.   Adsorption of molyb-
denum to  the fly ash  decreased with Increases  1n  pH,  thereby  permitting more
leaching  from  the fly ash as  pH Increased.  The form of the  leaching molyb-
denum was the  molybdate 1on.   Molybdenum  oxide  (HoO«)  Is  an add  oxide  and
can combine with cations  In  soil  to form molybdates  (Davles,  1980).   There-
fore, fly ash deposited on alkaline soils  Is  more  likely to leach molybdenum
Into the  underlying soil than Is fly  ash deposited  on  acidic  soils.  Soluble
molybdenum 1n  soil  usually occurs  as  the molybdate Ion  (Lindsay,  1979; Bonn
et al.,  1985;  Davles, 1980).   This 1on  Is  affected by Iron oxides  1n  soil,
which  can adsorb  or  react   with   the  molybdate  1on,  thereby  controlling
transport (Davles,  1980).  Molybdenum  may also  form  chelates with  organic
matter  In soil.   Mlcroblal  breakdown  would keep  the  element  In  a  continual
state of circulation and Increase Us  availability  to  plants (Davles,  1980).
2.4.   SUMMARY
    Molybdenum 1s a natural element that cannot be  degraded by  environmental
processes.   Although  environmental processes  may  transform  one  molybdenum
compound  Into another, the molybdenum 1s still present.  The  major  source of
molybdenum  release  to the  atmosphere   Is the  combustion  of  coal,  which
releases  partlculate  ash  containing molybdenum Into the atmosphere (Section
                                    i*
3.3.).  The primary processes that remove atmospheric molybdenum  are  wet  and


0186d                               -11-                             01/30/90

-------
dry  deposition.   One  of  the  most   Important  factors  that  determines  the
degree  of  molybdenum  transport  In  water  and  soil  1s  pH.   In  general,
Increases   In   solubility  enhance  molybdenum  availability  to  plants  and
transport  In  water and soil.   As  the pH of  the  media Increases,  molybdenum
mobility  In soil  and  water  and uptake  1n plants  Increases  (Lindsay,  1979;
Bohn  et al., 1985;  Davles,  1980).   Dissolved  molybdenum  1n  soil  and  water
usually occurs  as  the  molybdate 1on.  The  mobility of molybdenum In soil and
water  may  decrease  by  sorptlon  onto  Fe n  and humlc  materials   1n  these
media.   Molybdenum leaching  from fly  ash  Increases as  pH  Increases;  the
leaching  molybdenum  1s  In  the form of  the molybdate  Ion  (Goetz,  1983).
Therefore,  fly  ash  deposited  on  alkaline  soils  Is more  likely   to  leach
molybdenum  Into the  underlying soil  than  1s  fly  ash  deposited  on  addle
soils.   Since  natural  soil  1s likely  to  contain  predominantly   the  same
chemical  forms  of  molybdenum  as fly ash,  leaching  characteristics  1n  soil
will be similar.
0186d                               -12-                             01/30/90

-------
                                 3.   EXPOSURE

    Molybdenum  occurs  naturally  In  soils  at levels  commonly ranging  from
0.2-5  ppm,  although  an  accepted  average  soil  content  Is  2 ppm  (Lindsay,
1979).  Molybdenum does not occur naturally  1n elemental  form,  but  primarily
as sulfldes or oxides.
3.1.   WATER
    The  presence  of molybdenum  1n  surface,  ground and  drinking waters  Is
expected,  since  molybdenum occurs naturally  In  soil.   The  concentration  of
molybdenum  In  surface  waters  1s  generally~<5  vg/l,  although  concentra-
tions  <500 vg/s,  were  reported   for  some  drinking waters.   Concentrations
>20   pg/l   1n  water  are  probably   due  to  an   anthropogenic   Influence
(Chappell et a!., 1979).
    The  average  human  dally  Intake  of  molybdenum  In  drinking  water  Is
reportedly  <5 vg (VHersema et  al.,  1984;  Chappell et a!.,  1979).   Accord-
Ing to Wlersema et al. (1984), Intake  of molybdenum In drinking water repre-
sents  only  1.554  of  the total  dally  Intake.   Intake  of  food  Is the  major
route of molybdenum exposure (Section 3.2.).
    Anthropogenic  Inputs  of molybdenum  Into aquatic  ecosystems  can  result
from  a  variety  of  wastewater  sources  Including  domestic,  electric  power
generation, mining,  smelting and  refining  wastewaters  as  well as  wastewaters
from manufacturing processes such as those  of metals and  chemicals.   A major
source of  molybdenum release  to  soil  and water   Is  atmospheric  fallout  from
coal  fly ash  and  landfllllng of bottom ash from  coal combustion.   Dumping  of
sewage sludge  Is  a  major  source  of molybdenum release to aquatic ecosystems
(Nrlagu and Pacyna, 1988).
0186d                               -13-                             07/26/89

-------
3.2.   FOOD
    Molybdenum 1s common  In  foods.  The average amount  of  molybdenum In the
American  diet 1s  288 ng/g  of  food.   This  was determined  by  selecting  a
variety  of  commonly  consumed,  everyday  foods  and  blending   them  Into  a
homogeneous  reference material;  this  was  followed  by elemental  analysis.
The diet material used for this  analysis  was  accepted by the National Bureau
of Standards  as a Reference  Material  (M1ller-Ihl1 and Wolf, 1986).   Assuming
the  average  American  adult  consumes   1600  g  of   food/day,   the  AOI  of
molybdenum  Is 460  yg.   This  value  1s reasonably  close to  a  value of 335
yg/day  reported  by Wlersema et ^V.  (1984).    According  to Wlersema et al.
(1984),  Intake  of  molybdenum through  food  represents  98.5%  of  the  total
dally Intake of molybdenum.
3.3.   INHALATION
    The  major source of  molybdenum  emissions  to   the  atmosphere  Is  the
combustion of coal  by electric power generation stations and  Industry  (U.S.
EPA, 1973; Nrlagu and Pacyna,  1988).   Worldwide emissions of  molybdenum from
coal combustion  In  1983 were  estimated  to range from 628-4800  thousand  kg
(Nrlagu and Pacyna, 1988).   The  vehicle by  which molybdenum Is  released from
coal  combustion  1s  fly  ash,  which reportedly contains average  molybdenum
concentrations ranging  from 12-100  mg/kg  (U.S.  EPA, 1973; Hjelmar,  1983).
The amount  of molybdenum  In  fly  ash depends  on the  amount  In the  source
coal.   Molybdenum 1s  also  released 1n oil ash  partlculates  from oil  combus-
tion  (U.S.  EPA,   1973;  Nrlagu  and  Pacyna,  1988).    Worldwide  emissions  of
                                           1        •     •     "            r<  ".'
molybdenum from oil combustion 1n  1983 were -165-943 thousand  kg (Nrlagu and
                      '»
Pacyna, 1988).  Molybdenum  Is  also  released  to air   from open-pit  mining  of
molybdenum  and   copper  ore,  ferromolybdenum   production,  steel  production
0186d                               -14-                             07/26/89

-------
using molybdenum and roasting  of  molybdenum ore (U.S. EPA,  1973).   A molyb-
denum concentration of 160 ppm was detected  1n  partlculate  material  released
from  a  Philadelphia  municipal   Incinerator  (Olmez   et   a!.,   1988).    The
chemical forms of  molybdenum released to  the  atmosphere  are believed  to be
primarily oxides  and sulfldes (U.S.  EPA,  1973).
    A1r-mon1tor1ng  data  for  molybdenum  from the  National  A1r  Surveillance
Network and  various EPA regional offices  were  compiled  for  1977-1979.   The
compilation  Is divided  Into  urban and nonurban  frequency  distributions.   In
urban  atmospheres,  70%  of  the   10,769  air  samples  were  below  molybdenum
detection  limits  (analytic detection  limit not  reported).  The  maximum con-
centration  1n  a  single  sample  for  each  of the 3  years  was 120-275 ng/m3,
while the  arithmetic mean  concentration  for each of  the 3  years was 2.2-1.5
ng/m3  In  urban  air.   In  nonurban  air,   90%  of  1402  samples  were  below
detection  limits.   The maximum concentration In a single sample  for each of
the  3 years  was 16-4  ng/ma,  while  the  arithmetic  mean   concentration  for
each  of the  3  years  was  1.1-0.8  ng/m3   In  nonurban  air  (Evans   et  a!.,
1984).   W1tz  et  al.  (1986)  found  molybdenum levels  of  20.6-61.2" ng/m3  In
Indoor air of cars traveling  on Los  Angeles freeways.
    Wlersema  et  al. (1984)  monitored  ambient air  for  molybdenum and  other
compounds  at  various  locations  1n Texas  between 1978 and  1982  and  found the
highest  annual  molybdenum  concentration   to  be  19  ng/m3  In  Fort  Worth.
Based  upon this  value, Wlersema  et  al.  (1984)  estimated that  only  0.11% of
the total  dally human Intake  of molybdenum results  from Inhalation.
3.4.   DERMAL
    Pertinent  monitoring  data  regarding  the dermal  exposure  of  molybdenum
were not located  1n the available literature cited  In  Appendix A.
0186d                               -15-                             05/31/89

-------
3.5.   SUMMARY
    Molybdenum occurs naturally  In  soils at levels that  commonly  range  from
0.2-5  ppm,  although  an accepted  average  soil  content  Is  2 ppm  (Lindsay,
1979).  Molybdenum does not occur naturally In  elemental  form,  but  primarily
as sulfldes or oxides.  The concentration  of molybdenum In  surface  waters Is
generally  <5   yg/l,   although   concentrations   <500  yg/l  were   reported
In  some  drinking  waters.   Concentrations  >20 yg/l  In  water  are  probably
due  to an  anthropogenic   Influence  (Chappell   et  al.,  1979).   The  average
human  dally  Intake  of  molybdenum  In drinking  water  Is  reportedly <5  vg,
which represents only 1.5% of  the total  dally  Intake  (Wlersema  et  al.,  1984;
Chappell  et  al.,  1979).   The  average amount  of  molybdenum In the  American
diet Is 288 ng/g of food (MUler-IhH  and  Wolf,  1986).   Assuming  the average
American adult  consumes 1600  g  of  food/day,   the  average  dally  Intake  of
molybdenum 1s  460 v9-   A  similar  food  Intake  of  335  yg/day  was  reported
and thought  to  represent  98.5%  of  the total  dally Intake  (Wlersema  et  al..
1984).  Available  ambient  air-monitoring  data for molybdenum  (Wlersema  et
al.,  1984;  Evans  et  al.,  1984) Indicate  that dally  Intake by  Inhalation
represents  only  <0.11%  of  total  dally  Intake.  The  major  source of molyb-
denum  emissions  to  the atmosphere  1s  the  combustion of  coal  by  electric
power generation  stations  and  Industry  (U.S.  EPA,  1973;  Nrlagu and  Pacyna,
1988).  Molybdenum 1s emitted  In the coal   fly ash, which eventually  settles
to terrestrial  surfaces  and surface  waters.
0186d                               -16-                            07/26/89

-------
                         4..  ENVIRONMENTAL TOXICOLOGY
4.1.   AQUATIC TOXICOLOGY
4.1.1.   Acute Toxic  Effects on  Fauna.   Abbott  (1977) assessed  the  acute
toxlclty  of  molybdenum  (as  ammonium  molybdate)  to  hermit crab,  Eupagurus
bernhardus. shore crab,  Cardnus  maenas. pullet-shell,  Venerupls  pullastra.
and  starfish,  Asterlas  rubens.   Specimens  of each  species were exposed  to
molybdenum for <48  hours and  monitored  over  a  5-day recovery  period.   The
48-hour  TL   values  for  shore  and  hermit  crab  were  1108 and  >191  <254
           m
mg/l,  respectively.    The  24-hour  TL   values   for  starfish   and  pullet-
shell were >127 <254  and >254 <509 mg/l,  respectively.
    Dorfman (1977) assessed  the acute toxlclty of molybdenum  (as  molybdenum
oxide)  to the mummlchog,  Fundulus heteroclltus.   Fish were collected  from
marine waters  with a salinity  >17  o/oo  and  acclimated  to  laboratory condi-
tions for 3 days before  the  test.   Tests  were conducted at  salinities of 7.9
and  18.8  o/oo  and at 20°C.   Nine  fish were  exposed  to  each concentration of
molybdenum 1n  groups  of three.   The  96-hour TL   values for fish  exposed to
molybdenum In  the low-  and  h1gh-sal1n1ty  test  solutions   were  230  and  315 .
mg/l, respectively.
    B1rge  (1978)  and  Blrge  et  al.  (1979)  assessed the acute toxlclty  of
molybdenum to  rainbow  trout.  Salmo galrdnerl. goldfish, Carraslus  auratus.
and  the  narrow-mouthed  toad,  Gastrophryne  carollnensls.  In  semi-static
embryolarval   assays.   Fertilized  eggs   of   each  species  were  exposed  to
molybdenum from fertilization to 4  days posthatch.   Total exposure  times for
goldfish  and  toad were 7 days  but 28 days  for  trout.   Test solutions  were
renewed  twice  dally.   Test  temperatures were 13°C  for   trout and  22.0°C for
the  other two species.   The LCrQ  values obtained  for trout,   goldfish  and
toad were 0.73, 60.0  and 0.96 ppm, respectively.
0186d                               -17-                             07/26/89

-------
    Horgan  et  al.  (1986)  assessed  the acute  toxIcHy  of molybdenum  (as
ammonium molybdate)  to larvae of  the mussel, MytHus  edulls.   Gametes were
obtained from mussels chilled to  4°C for 22  hours  before being transferred
to  22°C  water.   Gametes released  from  Isolated male  and female mussels over
a  1-hour period  were  combined  In  a 1 JL beaker  to achieve  fertilization.
Exposure  to  molybdenum was  begun within 2  hours  of   fertilization.   Test
solutions were  maintained at the  fertilization temperature  of  19°C.   Molyb-
denum  concentrations   were  analytically  verified.  Investigators reported  a
48-hour ECgg  of 147 mg/i based on mortality and abnormal development.
4.1.2.   Chronic Effects on Fauna.
    4.1.2.1.   TOXICITY — Abbott  (1977) reported  that exposure  of   hermit
crab,  Eupaqarus  bernhardus.  to  100  mg/i  molybdenum (as  ammonium  moybdate)
for 50 days resulted 1n no mortalities among  test  animals.
    4.1.2.2.   BIOACCUNULATION/BIOCONCENTRATION — Brooks  and  Rumsby  (1965)
determined  the  level  of molybdenum In three  species  of New Zealand bivalves
from Tasman Bay.   They reported enrichment  factors  for the  scallop,  Pecten
novaezelandlae. oyster,  Ostrea slnuata.  and  mussel,  Hytllus edulls.  of  ^0,
30 and 60,   respectively.
    Suloway  et  al.  (1983)  assessed  the uptake of  molybdenum  from fly  ash
extracts by fathead minnows,  Plmephales  promelas.  and green sunflsh,  Lepomls
cyanellus.    Tests  were  conducted  In   60   8.  aquaria  containing  40  I  of
diluted extract at  23°C.   Fish were  fed frozen brine  shrimp dally over  the
30-day  exposure  period.    F1sh  were  freeze-drled  whole,  homogenized  and
    *                                                       (     — .     —
digested to provide  samples for  analysis of  molybdenum.   Molybdenum  concen-
                       >                                             *'.
tratlons In minnows  exposed  to  extracts  of  five separate fly ash  samples
ranged  from  0.062-1.06  mg/kg  compared  with <0.05  mg/kg  1n  controls.
0186d                               -18-                             07/26/89

-------
Molybdenum concentrations 1n sunfIsh exposed to extracts of  the  same  fly ash
samples ranged from 0.08-2.38  mg/kg  compared  with <0.064 mg/kg  1n -controls.
The BCFs for molybdenum In both species  ranged  from -1-100.
4.1.3.   Effects  on Flora.
    4.1.3.1.   TOXICITY — Colmano  (1973)  assessed  the  effects  of   molyb-
denum on cultures  of  Euglena  gradlls.   Cells  were grown normally  under 300
foot-candles of fluorescent light at 24-26°C 1n a  medium containing 5.44 ppm
molybdenum.   No   abnormal  cells  were  observed  In cultures  grown  1n  the
presence of 96 ppm  molybdenum.  At  concentrations between  96  and  960 ppm
molybdenum,  the   Euqlena  cells  clustered  In  groups  of  three  to  nine  and
divided abnormally.  Cultures  exposed to >960  ppm molybdenum did  not grow.
    4.1.3.2.   BIOCONCENTRATION — Sakaguchl   et  al.   (1981)  assessed  the
accumulation  of  molybdenum (as  ammonium molybdate) from  test  solutions  by
green  mlcroalgae, Chlorella   regularls.  two  species   of  Chlamydomonas  and
three  species  of  Scenedesmus.   Tests  were  conducted   1n  500 mj.  Erlenmeyer
flasks for  20 hours at a  pH of 5.0  and  a temperature of 30°C. Cell cultures
were  constantly   stirred  while  being  exposed   to   10   mg/s.   molybdenum.
Preliminary  studies   demonstrated  that  growth  of C_. regulaMs   was  not
affected  at  20   mg/a  molybdenum  but  was  markedly Inhibited  at  50  mg/a.
C_.  regulaMs.  Chlamydomonas   spp.   and  Scenedesmus  spp.   absorbed  13,200,
9445-21,167  and   7567-23,214  yg/g molybdenum  for  dry  cells, respectively,
to produce BCFs of 1320,  944-2116 and 756-2321, respectively.
    Kovacs  et  al. (1984)  measured  molybdenum 1n  water and  aquatic  plants
from  Lake   Balaton,   Hungary.    They   reported   concentration  factors  for
Ceratophyllum  submersum.  HydrochaMs  morsus.. Lemna  trlscula.  Hyrlophyllum
sj) lea turn.  Potamogeton sp.  and  Stralotes  aloldes  ranging   from  100-10,000.'"
They also reported a  concentration fa'ctor of 100 for Cladophora glomerata.


0186d                               -19-                             05/31/89

-------
 4.1.4.   Effects  on  Bacteria.    Pertinent  data  regarding  the  effects  of
 exposure of  aquatic  bacteria  to molybdenum  were  not  located 1n the available
                                                       •
 literature dted 1n Appendix A.
 4.2.   TERRESTRIAL TOXICOLOGY
 4.2.1.   Effects on  Fauna.  Pertinent  data regarding the  effects of  expo-
 sure  of  terrestrial   fauna  to  molybdenum were not  located In  the available
 literature dted 1n Appendix A.
 4.2.2.   Effects on  Flora.  Molybdenum 1s  an  essential  plant  mlcronutrlent
 believed  to  be  Important  In  nitrogen  fixation   and   protein  synthesis.
 Molybdenum has been  applied as  a fertilizer to crops  such as  clover,  lettuce
 and  spinach  1n molybdenum-deficient  soils.   Liming  of  add  soils has  been
 necessary In many cases  to release  tightly  bound molybdenum and Increase Us
 b1oava1labH1ty (Davles,  1980).  Dreesen  and Cokal  (1984)  assessed the  b1o-
 avallabllUy of  molybdenum to  alfalfa,  clover,  barley,  saltbush  and  summer
 cypress  grown  on  soils  covering  uranium  mine tailings.    Species   were
 selected on  the  basis  of  their use  In reclamation  efforts.   Plants  were
 grown  from  seeds  1n  a media without  soil  until a  root mass  developed (-4
 weeks).  The plants  were then  grown  on the test material  for  an  additional
 4-6 weeks before  harvesting.   Concentrations  of  molybdenum 1n  the harvested
 plant  materials   did  not  exceed  5.4  yg/g  but since  these  species - were
 selected because of their  use 1n reclamation  efforts,  they  might  be expected
 to tolerate higher  molybdenum levels than  other plants.
 4.3.   FIELD STUDIES
    Colborn   (1982a,b)  assessed   the ability  of  aquatic  Insects  to serve  as
 biological  monitors  for  molybdenum'.  Aquatic  Insects, Prunella sp., Clnyq-
mula  sp. and Brachycentrus brachycentrus were collected from an  unpolluted
 stream (Coal Creek)  and  transplanted to  sites on the Slate River receiving


0186d                               -20-                            02/05/90

-------
discharges  from  a  mining operation.  Despite  the  lack of measurable  levels
of  molybdenum In  water from  either the  control  or  transplant site,  body
burden levels of molybdenum  In  caddlsfHes  Increased  (0.86-2.3  and  1.25-1.55
ppm)  after  65-70 hours  1n  separate trials.   Molybdenum  levels  In  mayflies
rose  from  1.75-2.93  ppm after  65  hours  1n one experiment but  declined  from
2.75-1.57  ppm after  70.5 hours  1n a second  trial.   Fluctuations  1n  molyb-
denum  levels  were  negatively  associated  with changes  In  the body  burden
level of cadmium.
    Levels  of molybdenum In tissues  of  flora and fauna  from  the  field  are
presented  1n  Table 4-1.  The highest concentrations of molybdenum In aquatic
macrophytes were  reported for  samples  collected  from Kesterson  Reservoir,
California  (5.25 ppm dry weight),  hydroelectric storage lakes In New Zealand
(<5.6 yg/g  dry weight). Lake  Balaton,  Hungary  (<6.88  ppm dry  weight),  and
the Tejo  River,  Portugal (8.2  ppm dry  weight) (Rawlence and UhUton,  1976;
Ohlendorf  et  a!.,  1985; Frletas  et a!.,  1988).   Levels of  molybdenum  In
grasses exceeded  that  reported  for aquatic macrophytes.  Cherry  and Guthrle
(1979)  reported  levels  of   6.2 and  10.7   ppm  In  nutgrass  and  sedgegrass,
respectively.
    The  highest   levels of  molybdenum  In  tissues   of  Invertebrates  were
reported  for  Holna  rectlrostrls (605 mg/kg dry  weight),  ollgocheates  (60.3
mg/kg dry  weight),  Slqara  lateralls (30.9  mg/kg dry  weight) and Chlronomus
annularls  (17 mg/kg  dry weight)  collected from  a   sewage  treatment  basin
(Czegeny and  Deval, 1985).  Generally, however, molybdenum levels In aquatic
Invertebrates  were <5'ppm.   No single sample  of carp exceeded   3.6  ^g/g  dry
weight  (Salkl and  Hay,  1988).   Levels  In  wildlife were  <0.58  vg/g  wet
weight (Wren et al.,  1983).
0186d                               -21-          -                   02/05/90

-------
o

CD

O.
                                                                             TABIE  4-1

                                                   Molybdenum Concentrations In Field-Collected flora and fauna
                   Species
                                 Tissue
                      Molybdenum Concentration
                                         Sampling Site
                                              Reference
 i
 ro
 o
 in
Plankton

Freshwater anglosperms

Plants

Aquatic plant
  Caulerpa sp.
                 .     *•  i
                      •  ;
Duckweed
  Lcmna pcrpusllla

Aquatic vascular plants
  Nophar advena
  Pontederla cordata
  Hymphaea odorata
  Oecodon vertlclllatus

Aquatic macrophytes
  Ceratophyllum
  Elodea
  Lagaroslphon
  Potamoqeton
  tgurla
  Hymphaea

Plants
  duckweed, Lemna
  cattail, Typha
  algae. Osclllatorla
  hydrodlctyon

Aquatic plants
  Ceratophyllum submersum
  Hydrocharlj morsus
  Lemna trlscula
  Hyrlophyllum splcatum
  Potamogeton pectlnatus
  Potamoqeton perflolatus
  Stratlotes aloldes
  Cladophora glomerata
.whole samples

 whole body

•whole body

 whole body


 whole body


 whole body





 whole body
                                      whole body
                                     .whole body
 leaf and stem
 whole body
                                                          0.13-1.5 |ig/g dry weight

                                                          0.26-4.6 mg/kg dry weight

                                                          5.25 ppm dry weight

                                                          0.27-0.46  ppm dry weight


                                                          0.34 ppm


                                                          0.01-1.8 ppm
0.4-5.6 yg/g dry weight
                      0.5 ppm
5.15. 5.23 ppm dry weight
5.35. 5.62 ppm dry weight
2.22 ppm dry weight
2.18, 6.88 ppn dry weight
1.60. 3.73 ppn dry weight
0.73-31.21 ppm dry weight
2.33-6.05 ppra dry weight
0.6-2.86 ppm dry weight
                              series of lakes In New Zealand

                              Japan

                              Kesterson Reservoir, California

                              Red Sea Coast. Saudi Arabia


                              damp ash sediment
                              Llnsley Pond, Cedar Lake.
                              North Branford. CT
hydroelectric strorage lakes.
New Zealand
                              fly ash basin drainage system.
                              Savannah River Project
                                                    Lake Balaton,  Hungary
                                      Rawlence and Whttlon,  1976

                                      Yamamoto et at..  1985

                                      Ohlendorf et al..  1986

                                      Al-Amoudl and  EI-Naggar.
                                      1987

                                      Cherry and Guthrle.  1979


                                      Cowglll. 1974
Rawlence and Whltton. 1979
                                      Cherry  and  Guthrle,  1978
                                                                    Kovacs et at..  1984
 CO

-------
                                                                                   (cont.)
GO
sr
a.
                  Species
                                 Tissue
                      Molybdenum Concentration
                                         Sampling Site
                             Reference
ro
co
 i
Aquatic macrophytes
  Hyrlophyllum
  Vertlcllatum
  Potacnogetum crlspus
  Ranunculus sp.
  Potamoqetum sp.

Japanese seaweeds

Nut grass
  Cyperus retrofractus

Sedge grass
  Andropoqon vlrqlnkus

Invertebrates
  midges, Chlronorolnal
  adonates Llbellula
  Hacromla
  Ischnura;
  crayfish, Cambarus
  snails, Physa

Invertebrates
  Holna rectlrostrls
  Daphnla maqna
  Slqara latelalls
  Chlronomus annularlus
  ollgochaetes

Crayfish
  Procambarus clarkll
         Golden King Crab

           Uthodes aequlsplna
                                     whole body
                                     whole body
                                     whole body
                                     whole body

                                     whole body
                                    ' whole body


                                     whole body

                                     abdominal regions
                                     whole body
                                     whole body
                                     whole body
                                     whole body
                                     whole body
thoracic fatty
material

gills

hepatopancreas


muscle
                     13 ppm dry weight
                     8.? ppm dry weight
                     0.14 ppm dry weight
                     6.5 ppm dry weight
                     6.2 ppm


                     10.7 ppm

                     3.7 ppm
                     27.3.  60S mg/kg dry weight
                     1.2, 2.2 mg/kg dry weight
                     <30.9  mg/kg dry weight
                     <17.0  mg/kg dry weight
                     60.3 mg/kg dry weight
<0.1-4.0 ppm (weight)


0.7-4.0 mg/kg dry weight

0.45-2.15 mg/kg dry weight


0.2-0.85 mg/kg dry weight
                              Fradel  Dam,  lejo River,  Portugal
                     0.06-1.16 mg/kg dry weight    Japan
                              ash deposit
                              ash deposit

                              fly ash basin  drainage  system,
                              Savannah River Project
                              sewage  treatment
                              sewage  treatment
                              sewage  treatment
                              sewage  treatment
                              sewage  treatment
                                                                                        South  Louisiana
basin, Hungary
basin, Hungary
basin, Hungary
basin, Hungary
basin, Hungary
                                                                              Alice and Hastings Arms,
                                                                              British Columbia
                                                                              Alice and Hastings Arms,
                                                                              British Columbia

                                                                              Alice and Hastings Arms.
                                                                              British Columbia
                     frletas et al., 1988
                     Yamamoto et al.. 1985


                     Cherry and Guthrle. 1979


                     Cherry and Guthrle. 1979

                     Cherry and Guthrle. 1978
Ciegeny and Deval, 1985
Czegeny and Deval. 1985
Czegeny and Oeval, 1985
Czegeny and Oeval, 1985
Czegeny and Devat. 1985
                     Bernard and Roy, 1977


                     Thompson et al.. 1986

                     Thompson et al.. 1986


                     Thompson et al.. 1986
 o
 tn
 CD
 u>

-------
                                                                    IABIF  4-1  (cont.)
0
CD
Q.


1
r\i
1




o
O
Species
Insects, aquatic
Megarcys slgnata
Prunella
Hydropsyche
llnyqmula
'teronarcella bad la
Aquatic Insects
water boatmen
midge larvae
dragonfly nymphs
Aquatic Insects • •'
water boatmen
midge larvae
dragonfly nymphs
damsel fly nymphs
Asiatic clam
Corblcula flumlnla
Asiatic* lam
Clam
Elliptic dllatata
Cockle
Katalysla scalar Ina
Musset
Mytllus edulls

Oyster
Ostrea slnuata
Rock oyster
Saccostrea cuccullata
Scallop
Pec ten novae-ielandlae
Tissue
whole body
whole body
whole body
valve
viscera
whole soft tissue
soft tissues
whole soft tissue
kidney
gill
mantle
soft tissue
whole soft tissue
soft tissue
whole soft tissue
Molybdenum Concentration
0.09-1.65 ppm dry weight
<2.1 ppm dry weight
<1.6 ppm dry weight
0.30. 0.40 ppm
2.1. 16.3 ppm
0.73 iig/g wet weight
<2 mg/kg dry weight
<1.0 ppm dry weight
-38 ppm dry weight
-IS ppm dry weight
-7 ppm dry weight
-0.6 mg/kg dry weight
0.1-0.4 ppm dry weight
<1-3 mg/kg dry weight
0.1-2.3 ppm dry weight
Sampling Site
East River/Upper Gunnlson River.
Colorado
Kesterson Reservoir. California
Volta Wildlife Area. California
New River. Glen Lyn. Virginia
New River. Glen Lyn. Virginia
Tadenac Lake. Ontario
Princess Royal Harbour, Albany,
Australia
Taiman Bay. Nelson, New Zealand
Ml. Desert Island, Lamolne, Maine
Four sites In New Zealand
Tasman Bay. Nelson. New Zealand
Oampter Archipelago, Gldley Island,
Western Australia
Tasman Bay, Nelson. New Zealand
Reference
Colborn. 19B2b
Ohlendorf et al.. 1986
Ohlendorf et al.. 1986
Rodgers et al.. 1980
Rodgers et al.. 1980
Wren et al.. 1983
Talbot and Chang. 1987
Brooks and Rumsby. 196S
Sutherland and Major, 19B1
Kennedy, 1986
Brooks and Rumsby, 196S
Talbot and Chang. 1987
Brooks and Rumbsy, 1965
10
o

-------
TABtt^l
(cont.)
CO
Cf>
a.




i
ro
tn
i





07/26/8'
Species
Freshwater fish
Angullla
Salmo sp.
Levclscus sp.
fish
Chondrostema
Smallmoulh bass
Hlcropterus dolomleu -
Common carp
Cyprlnus carplo
Lake charr
Salvellnus namaycush
Bluntnose minnow
Plmepha-les notatus
Hosqultof Ish
Gambusla offlnls

Northern pike
tiox luclus
Dover sole
Hlcrostomus paclf Icus
Blueglll sunflsh
Lepomls macrochlrus
Lake trout
S. namaycush
Rainbow smelt
Osmerus mordox
Herring gull
Larus argentatus

Tissue
muscle
whole body
, fish muscle
t
i
whole body
fish muscle
fish muscle
muscle tissue
whole body
fish muscle
liver
whole body
muscle
fish muscle
muscle

Molybdenum Concentration
<0.18 ppm dry weight
0.46 ppm fresh weight
0.63 pg/g wet weight
<3.6 pg/g dry weight
0.41 pg/g wet weight
O.SS pg/g wet weight
0.4 ppm
0.36-0.67 ppm
O.S2 pg/g wet weight
0.081-0.13 pg/g wet weight
<2.8 pg/g dry weight
2.2-8.5 ppb fresh weight
O.SO pg/g wet weight
0.58 pg/g wet weight

Sampling Site
Turin region, Italy
Fradel Dam. Tejo River, Portugal
ladenac Lake, Ontario
Lower San Joaquln River. California
ladenac Lake, Ontario
ladenac Lake, Ontario
fly ash basin drainage system.
Savannag River Project
Grassland Water District.
Merced County, California
ladenac Lake, Ontario
south California coast
lower San Joaquln River,
California
Cayuga Lake. New York
Tadenac Lake, Ontario
ladenac Lake, Ontario

Reference
Parlsl et al.. 1986
Freltas et al.. 1988
Wren et al.. 1983
Salkl and Hay. 1988
Wren et al.. 1983
Wren et al.. 1983
Cherry and Guthrle. 1978
Ohlendorf et al., 1987
Wren et al.. 1983
Oe GoetJ et al., 1973
Salkl and Hay, 1988
Tong et al.. 1974
Wren, et al.. 1983
Wren et al., 1983


-------
                                                                          TABIE  4-1  (cont.)
0
£ Species
en
Q.
Common loon
Cavla Immer
American coot
tul lea amerlcana
Beaver
Castor canadensls
Raccoon
Procyn lotor
Otter
Lutra canadensls
llssue
' muscle
muscle
muscle
, muscle
muscle
Molybdenum Concentration Sampling Site
0.59 vg/g wet weight ladenac Lake. Ontario
0.58 vg/g vet weight ladenac Lake. Ontario
0.46 v9/g wet weight ladenac Lake. Ontario
0.56 v9/g wet weight ladenac Lake. Ontario
0.54 vg/g wet weight ladenac Lake. Ontario
Reference
Wren et al.. 1983
Wren et al.. 1983
Wren et al.. 1983
Wren et al.. 1983
Wren et al.. 1983
0*
1
in
•*x
o)
 CD

-------
4.4.   AQUATIC RISK ASSESSMENT
    The  lack  of  pertinent  data  regarding effects  of  exposure  of  aquatic
fauna  and  flora  to molybdenum  precluded the  development  of  a  freshwater
criterion by  the method  of  U.S. EPA/OWRS (1986)  (Figure 4-1).   Additional
data  required  for  the development  of a  freshwater  criterion  Include  the
results of acute  assays with  planktonlc  and  benthlc crustaceans, an  Insect,
a  nonarthropod  and  nonchordate  species  and  an  Insect  or   species  from  a
phylum  not   previously   represented.    The   development  of  a   freshwater
criterion also requires data  from chronic  toxIcHy tests  with  two  species of
fauna and one species  of  algae or vascular plant and at  least  one  bloconcen-
tratlon study.
    The lack of  pertinent data  regarding  the effects  of  exposure of  aquatic
fauna  and  flora  to molybdenum  precluded  the development  of  a  saltwater
criterion by  the method  of  U.S. EPA/OWRS (1986)  (Figure 4-2).  Additional
data  required  for  the development  of  a saltwater  criterion  Include  the
results of acute  assays  with a  second chordate species, a  nonarthropod  and
nonchordate  species,  a  mysld  or  panaeld   crustacean,  three ' additional
nonchordate species and one other  species of marine fauna.  The  development
of a saltwater criterion  also requires data  from chronic  toxlclty  tests wlth-
two species of fauna and  one  species of algae  or vascular plant and at  least
one bloconcentratlon study.
    Data currently  available  Indicate that molybdenum can be acutely  toxic
to  freshwater  vertebrates at  concentrations  >0.73  ppm.   Molybdenum can  be
acutely toxic to saltwater fauna  at  concentrations >147 mg/i.
0186cl                               -27-                             01/30/90

-------
TEST TYPE
Farm ly Gl*lAva
Chordate (Salmonid-f i»h> 0.73*
•c-
Chordate (Marmwater fifth) 60. O"
• 2
Chordat* (fifth or amphibian) 0. 9£*
Crustacean (planPtonic) NA
Crufttacean ( bent hi c) NA
Insect an NA
non-Art hrc-pc-dX-Chc-rdate NA
GMCV
NA
NA
NA
NA
NA
NP
NA
&CF-
NA
NA
NA
NA
NA
NA
NA
     New Insect ar.  c>>* phylum
                  ive
      NA
NA
NA
                                  xxxxxxxxxxxx
                                  xxxxxxxxxxxx
                     NA
             NA
          «uc»
          l*'- pl«r,t
xxxxxxxxxxxx
xxxxxxxxxxxx
NA
NA
•NA=N:t Av*il*tle  •c.'S-day  LC(»  ir< ppw fo»* ambry*-larval
trc-'jt,  Sc>lf'r-»si us aur-at us • 7-day  LC«*  in  pprn for »tnbryc--larval
riarrc-w.-inc'uthec tc-ao,  6*st rc-pht-vne care-1 1 rigrisa *
                                  FIGURE 4-1

     Organization Chart for Listing GMAVs, GMVCs and BCFs Required to Derive
      Numerical Water Quality Criteria by the Method of U.S. EPA/OHRS  (1986)
          to Protect Freshwater Aquatic Life  From Exposure to Molybdenum
  0186d
  -28-
            01/30/90

-------
Farm 1 y
Chordate
Chordate
*3
non-Art hropod /-Chord at e
#4
Crustacean (Mysid/Panaeid)
rion-Chordat e
#6
non-Chordate
#7
rion— Chordate
#6
other
algae
#10
Vascular plant

GMAV*
££9»
NA
147-
NA
NA
NA
NA
NA
XXXXXXXXXXXX
XXXXXXXXXXXX
XXXXXXXXXXXX
XXXXXXXXXXXX
TEST TYPE
GMCV-
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA

BCF«
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
•NA=Not Available »9£-hour  TL,  in mg/L for the mummichog,
FundM1 us heteroclit us •46-hour  EC*•  in mg/L  for larvae of  the
mussel, Wyti1 us edulis
                                FIGURE 4-2

    Organization Chart for  Listing GMAVs,  GMVCs and BCFs  Required to Derive
    Numerical Water Quality Criteria by the Method of U.S. EPA/OHRS  (1986)
         to  Protect Saltwater Aquatic Life From Exposure  to Molybdenum
 0186d
-29-
05/31/89

-------
4.5.    SUMMARY
    Data  currently available  Indicate  that  molybdenum can  be acutely toxic
to  freshwater vertebrates at  concentrations  >0.73  ppm (B1rge, 1978; B1rge et
al.,  1979).   Molybdenum can  be  acutely toxic to  saltwater  fauna at concen-
trations >147 mg/i (Morgan et al., 1986).
    BCF  values  for molybdenum In aquatic fauna did  not  exceed 100, although
values  In algae  could  be >2000  and <10,000  1n  aquatic  plants  (Brooks  and
Rumsby,  1965;  Suloway et al.,  1983;  Sakaguchl et al., 1981;  Kovacs et al.,
1984).   The  highest  concentrations  of  molybdenum  1n  aquatic macrophytes were
from  samples collected from  the Tejo  River,  Portugal (8.2  ppm  dry weight)
(Freltas  et  al.,  1988).   The  highest  levels of molybdenum In  tissues  of
Invertebrates were reported  for  Molna  rectlrostrls  (605 mg/kg  dry weight)
and ollgocheates  (60.3 mg/kg  dry weight) from a  sewage treatment  basin  1n
Hungary  (Czegeny  and Deval,  1985).   No  single sample of  carp  exceeded  3.6
yg/g  dry  weight   (Salkl  and  May.   1988).   Levels  In wildlife  were  <0.58
vg/g wet weight (Wren et al., 1983).
0186d                               -30-                             01/30/90

-------
                             5.   PHARMACOKINETICS
5.1.   ABSORPTION
    Engel et  al.  (1967)  conducted a  dietary study  with 36  pre-adolescent
girls aged 6-10 years to collect balance data  on  some trace  elements,  molyb-
denum.  The  subjects,  divided  Into three  groups  of 12 each,  received three
different controlled  diet  patterns.   Group 1 received  the  controlled  diet
during 14 consecutive  4-day  periods,  group  2  during five consecutive 6-day
periods and group  3  during  an  unspecified number of  6-day periods.   Between
94 and 189 ppb molybdenum was present  In the diets.   Molybdenum was  measured
1n urine  and  feces collected throughout  the experiment.   For  dally  Intakes
between  40  and 80  yg  of molybdenum,  net  retention  varied  between 3.4  and
32.6  yg. No  clear  relationship  could be established  between  amount  of
Intake  and  net  retention,   but  all  diets  resulted In  positive  balances,
Indicating that storage occurred  when  the  Intake  was -100  yg/day.
    Van Campen and Mitchell  (1965)  Injected Jji situ  llgated  segments  of  the
gastrointestinal   tract  of  female  Sprague-Dawley   rats with  radioactive
ammonium molybdate In saline.  Within 2 hours, 9.5%  of  the administered dose
(2.7  yM  Mo/rat)  was taken  up  1n  the  duodenum,  8.354 In  the  1leum, 6.8% 1n
the mldgut and 3.6% 1n  the  stomach.
    Bell  et  al.  (1964)  administered  a single oral  (gavage)  or  Intravenous
dose  of  radioactive  molybdenum  (as ammonium molybdate  In aqueous  solution)
to  20 castrated  male  pigs  of  mixed  breeding (39  kg  bw).   Based  on  data
provided by the Investigators,  the doses were  -0.06  mg/kg or  0.5 mg/kg.   Two
hours after dosing by  either route and with either  dose, 6%  of the  adminis-
tered dose was detected  In whole blood; this  declined to  0.07% at 48 hours.
0186d                               -31-                             07/26/89

-------
Urinary  excretion  accounted for  80-86% of  the  dose during  5 posttreatment
days, with  very  little additional excretion after  the  first  24-hour collec-
tion  period.   Fecal  excretion accounted  for  8.6-14.6% of  the dose over the
5-day  collection  period.   These  data  suggest  that  Mo  Is  rapidly  and
efficiently absorbed from the gastrointestinal tracts of swine.
    Falrhall et al.  (1945)  administered  oral  doses  (presumably by gavage) of
-30  mg  Ho/kg/day  from molybdenum trloxlde  for  10  days  to guinea  pigs and
measured  the  urinary  and  fecal  excretion  of molybdenum  before  and  during
exposure, as well  as for  8  days  after  exposure.   The Investigators concluded
that  molybdenum  was  rapidly  absorbed,  since  fecal  excretion  Increased
greatly after dosing started.
5.2.   DISTRIBUTION
    Without providing  documentation, Goyer  (1986)  stated  that, 1n humans, -9
mg  of  molybdenum  Is located primarily  In  the liver, kidneys,  adrenals and
omentum.
    Comar et  al.   (1949)  reported that  an  oral  dose  of  41 mg/kg of  radio-
labeled molybdenum trloxlde  In aqueous  solution  given to  14-month-old  steers
was widely  distributed after 12  days,  with high selective accumulations In
the  adrenals,  bone,  liver,  eye.  Intestinal  lymph  glands  and  kidney.   The
authors  also  reported   that  0.26, 0.51  and 0.42% of  the  Ingested  dose was
found  In  the liver  at 16,   41  and 64  hours  after  dosing, respectively.  A
similar  pattern  of  distribution  was   observed  after  a  single   Intravenous
Injection of 11 mg/kg.
    Falrhall et  al.  (1945)  administered  a'single 50 mg  oral  dose of  Mo as'*'
molybdenum  trloxlde  In gum  arable solution  to young adult male  guinea pigs
and measured  the  content of Mo  In  several  tissues  at 4, 16 and  48  hours
after treatment (Table 5-1).  Similar  levels  of  Mo  were  located 1n the major
                                     rf

0186d                               -32-                             07/26/89

-------
                                  TABLE 5-1

                The Distribution of Molybdenum Following Oral
            Administration of Molybdenum Trloxlde to Guinea P1gs*
Tissue
Kidneys
Spleen
Blood
B1le
Liver
Lungs
Muscle
Interval
After Dosage
4 Hours - 16 Hours
Molybdenum Content (mg Mo/10
'0.46
0.26
0.26
0.28
0.20
0.31
NR
0.20
0.12
0.05
0.20
0.08
0.10
0.02
48 Hours
g tissue)
0.07
0.18
0.50
0.30
0.03
0.09 . .
0.01
'Source: Falrhall et al., 1945

NR = Not reported
0186d                               -33-                             05/31/89

-------
tissues at 4 hours after  treatment,  but  levels  1n the kidneys exceeded those
1n  the  liver.   No  tissue appeared  to  preferentially  retain  Mo,  but  the
highest  tissue  levels at  the  end  of the  48-hour  test  period were  In  the
blood.  In other  oral  studies,  Falrhall  et al.  (1945)  reported levels of Mo
In bone between those for the liver and kidneys.
    In a  study  by Falrhall et al. (1945) molybdenum was  highly concentrated
In  lungs,  kidneys and  bone after repeated  (1  hour/day,  5 days/week  for  5
weeks) Inhalation exposures of  guinea pigs  to molybdenum  trloxlde  dust (155
mg Mo/m3) and molybdlc oxide fumes (52 or 186 mg Mo/m3).
    In a  study  by   Rosoff  and  Spencer  (1973),  Swiss-Webster mice  (3/sex/
group) received an  Intravenous  Injection of an unspecified  amount  of  molyb-
denum-99  (as ammonium molybdate  In  aqueous  solution) and were  sacrificed  1
or 24  hours after the  Injection.   Organs, tissues and blood were assayed for
radioactivity.    Liver,  kidney  and  pancreas  had  the highest  uptake  (18.1,
11.6  and  4.7X  of  the dose,  respectively,  after  1  .hour).  Uptake  In other
organs varied between 0.8  and 2.3 X  of  the  dose.   In the group sacrificed 24
hours  after  treatment, the  percentage  of  the  dose  found  In the  liver  and
testes was similar to that  found  In  those sacrificed 1  hour after Injection.
The greatest decline In  molybdenum  concentration was  seen In  blood.   When
the results  were expressed as  percentage of  the dose/organ,  the  liver  had
the highest concentration  of  molybdenum  (25.6 and 20.9% of  dose  at  1  and 24
hours, respectively).  Other organs had much smaller amounts.
    Nellands  et al.   (1948) gave  six  male  Sprague-Dawley  rats oral doses of  a
solution  containing  13.34  mg  of radlolabeled  molybdenum.    Radlolabel  was
measured  In several  tissues  2.5.  26.1 and 51.0 hours after  treatment.  On  a
per-gram-of-t1ssue basis,  the  highest  levels were  located In  the  stomach.
0186d                               -34-                             05/31/89

-------
blood and  kidneys  at  2.1  hours  after treatment  and  In the  kidneys,  Intes-
tines and  bones  at 51 hours  after  treatment.   In rats similarly  treated at
26.68 mg  Ho/kg,  the  highest  levels  25.8 hours  after  treatment were  In  the
stomach, Intestines and bones.
5.3.   METABOLISM
    Data  were  not  located regarding  the metabolism  of  molybdenum;  appar-
ently, elimination of molybdenum Involves excretion rather  than metabolism.
5.4.   EXCRETION
    In the 10-day  oral  study  using  guinea pigs  (see Section  5.1.),  Falrhall
et  al.  (1945)  concluded   that  elimination  from  the  body  was rapid,  since
fecal and  urinary  Mo  levels  returned to pre-exposure  levels  shortly  after
exposure ceased.
    In a  study by  Lener  and  B1br (1979), male  Ulstar  rats  with  cannulated
bile ducts were  anesthetized  with urethane and  given  an  Intravenous  Injec-
tion  of  radioactive  pentavalent or  hexavalent  molybdenum  In solution  at
doses of  0.08  or  4.6 mg Mo/kg.  The  biliary excretion  of  penta-  and hexava-
lent molybdenum peaked  1  hour after  the  Intravenous Injection  of  0.08 mg/kg
and  slowly  declined over  the next  3 hours-   A  similar result was  obtained
with  the  4.6  mg/kg  dose  of   hexavalent  molybdenum.    However, the  biliary
concentration  of  pentavalent   molybdenum after  the 4.6 mg/kg dose  reached
only  one-fourth  that of  the  hexavalent   form.   The whole-body excretion  of
molybdenum after  a  subcutaneous  dose of  4.6  mg  Mo/kg was  faster  for  the
hexavalent than for  the  pentavalent  form, but no  difference  between the  two
forms was  seen with  a  dose  of  0.08  mg  Mo/kg.   Also,  after  an  Intravenous
dose of 4.6 mg Mo/kg,  hexavalent molybdenum decreased  faster  In blood, liver
and jejunolleocecum than did the pentavalent  form.
0186d                               -35-                             07/26/89

-------
    In mice  given  a  single Intravenous dose of  radlolabeled  molybdenum (see
Section  5.2.),  35.6%  of  the dose was excreted In  the  urine  and only 2.6% 1n
the feces In 24 hours (Rosoff and Spencer, 1973).
    In   four  patients  receiving  single   50-100   yd   Intravenous  doses  of
radioactive  molybdenum,  16.6-27.2%  of  the dose was excreted  In the urine In
a 5-day  period, the highest  percentage  being excreted  on day 1 and declining
thereafter.  In contrast, excretion  In  the  feces  totaled 6.8  and 1.0% of the
dose  In  two  patients  tested  over  a  10-day period (Rosoff and Spencer, 1964).
Engel et al. (1967)  also reported that,  In'humans, the urinary excretion of
molybdenum  exceeded  that In  the feces by  a  factor of -2 after  oral  dally
Intakes  between 40 and 80 yg.
    In  swine,   the cumulative  urinary  excretion  of   molybdenum  peaked  at
-75-80%  of  an  oral dose 24  hours after dosing and Increased  only  to 80-86%
during a 5-day  period (Bell  et al., 1964)  (see  Section 5.1.).  In contrast*
fecal excretion reached  only  8.6-14.6% of the administered dose In the same
observation period.
    Consolazlo  et  al.  (1964) studied  the excretion  of  molybdenum In  the
sweat of throe  male   volunteers  exposed  to 37.8°C and  50% relative humidity
during four  4-day  periods.   The  average  dally  Intake   of  molybdenum  was  172
yg.   Molybdenum 1n   the  sweat   was  reported  only In  one  of  the  exposure
periods  and  amounted  to 61  yg.   In the  same  period,  the urinary  and  fecal
excretions  of  molybdenum  were  188  and  82  yg,   respectively.  The  authors
concluded that, under conditions  of  profuse sweating,'the  loss of  molybdenum
should not be disregarded.
5.5.   SUMMARY
    Excretion studies  using  pigs suggest  that  -80-86%  of an  orally admin-
istered  dose of Mo  was  fairly  rapidly absorbed  from  the  gastrointestinal
                                     i*

0186d                               -36-                             07/26/89

-------
tract  (Bell  et  a!.,  1964).  In  6-  to  10-year-old girls, a  positive  balance
                _x
was  observed  when  the diet  provided  40-80 yg  Ho/day  (Engel et  a!.,  1967).
Molybdenum appears to be rapidly absorbed  from  the gastrointestinal  tract of
guinea pigs.  Studies using  rats  suggest  that absorption of  molybdenum from
molybdenum trloxlde  Is more  rapid  than from molybdenite, because  the  former
Is more soluble In digestive juices (Falrhall et  a!.,  1945).   Molybdenum was
widely distributed throughout the body after oral dosing  of  steers (Comar et
a!.,  1949) and  guinea pigs  (Falrhall  et  al.,  1945).  Qualitatively  similar
results were obtained In mice after Intravenous Injections and  In rats after
oral  administration   of  radlolabeled  molybdenum  (Nellands  et  al.,   1948;
Rosoff  and  Spencer,   1973).   In  mice, rats  and  steers,  liver and  kidneys
accumulated a considerable  percentage  of  the administered dose.   In  humans,
molybdenum  Is  found  mainly  In  the liver,  kidneys,  fat  and  blood  (Goyer,
1986).
    Molybdenum  Is  apparently   eliminated  primarily  by  excretion,   as  no
evidence  was found   for  metabolism  of   Mo.    In  swine,  urinary  excretion
accounted  for  80-86% of  an oral  dose   and  fecal   excretion  accounted  for
8.6-14.6%  (Bell  et  al.,  1964).   In   humans  treated  Intravenously,  urinary
excretion  accounted   for  16.6-27.2%  of   the  dose and  fecal  excretion  for
1.0-6.8%.  Substantial amounts  of  Mo  may be lost  through profuse  sweating
(Consolazlo  et  al.,   1964).  Following Intravenous   treatment,  mice  excreted
35.6%  of  the  dose  In the urine and 2.6%  In  the feces  over a  24-hour  period
(Rosoff  and  Spencer, 1973).   Lener  and   B1br  (1979)  demonstrated  qualita-
tively that  biliary  excretion  Is  Involved In Mo elimination,  but  the  extent
of excretion by  this  route  was  not determined.
0186d                               -37-                             07/26/89

-------
                                  6.   EFFECTS
6.1.   SYSTEMIC TOXICITY
6.1.1.   Inhalation Exposure.
    6.1.1.1.   SUBCHRONIC — Falrhall  et  al.  (1945)  exposed  male  guinea
pigs  to  dusts  of molybdenite,  calcium molybdate and molybdenum  trloxlde at
estimated  concentrations  of  279,  155  and  200 mg  of  molybdenum/m3  air,
respectively,  for  1  hour/day,  5 days/week for  5  weeks.   Data  regarding
control  (unexposed) animals were not  given.   Mean  particle  size was  1.63
vm, but  size distribution data were  not reported.    Exposure  to  molybdenite
dust  had no  noticeable  effects  on  a group of  25  guinea  pigs   other "Than
Increased  respiratory  rate  during exposure.   One animal  died  after  three
exposures,  but  the cause  of death was  not Indicated.   Molybdenum trloxlde
was.a  respiratory Irritant 1n  51  exposed guinea  pigs.   In  addition,  loss of
appetite, weight  loss,  diarrhea, hair  loss and muscle  Incoordlnatlon  were
observed.  Twenty-six of  the 51 guinea pigs died during  the testing period.
Hlstologlcal  examination  of  animals  1n   this  group  revealed   slight  to
moderate  swelling of  hepatocytes with occasional necrosis  and fatty  Infil-
tration.  Traces  of fatty  deposits  were seen  In  the kidneys.   Most  of  the
animals  examined  showed  mild  to  moderate  amounts of alveolar  and bronchial
exudate.  Exposure  of 24  guinea pigs  to calcium molybdate dusts (neutralized
with  calcium hydroxide)  Induced  no  clinical  signs  of  toxlclty;  however,
Falrhall  et  al.   (1945)  mentioned   that   5/24  animals  died  during   the
experiments.
    Falrhall  et  al.  .(1945)  also  exposed  male  guinea  pigs  (number   not
                       V
specified)  to  fumes of molybdenum trloxlde.  Fumes  were produced  by  arcing
across  a  110-volt d.c.   circuit with  molybdenum  metal  electrodes.   The
animals  were  exposed  to  the  trapped  fumes 1  hour/day,  5  days/week  for  5


0186d                               -38-                             05/31/89

-------
weeks.  The  estimated concentrations  were  52 or  186 mg Mo/ma  of air.   No
clinical signs of toxlclty were noticed with  the  low  molybdenum  dose,  and no
deaths occurred  In  this  group.   An 8.3% mortality was observed  In  the high-
dose  group,  but  the authors do  not  mention  the  number  of  exposures  or  the
cause of death.
    6.1.1.2.    CHRONIC — Walravens  et al.   (1979)  studied  the  effect   of
molybdenum dust  on  a  group  of  25 male workers aged 19-59 (mean  30.8)  from a
molybdenite  roasting  plant.   A  control  group  of 24  unexposed  subjects  of
comparable age (sex not  specified)  was used.  Oust particles  had  a diameter
of  <10  ym  and   were composed  mainly  of  molybdenum  trloxlde  and   other
soluble oxides.   Duration  of employment In  the  factory  by the  experimental
subjects ranged  from 0.5-20  years.   Based on  different levels  of exposure In
the different areas of the factory,  the authors calculated  that  each  subject
was  exposed   to  an  8-hour  TWA  of  9.47  mg Ho/m3.   Biochemical  variables
monitored  Included  urinary  and  plasma molybdenum,  serum ceruloplasmln  and
uric  add, and  urinary uric add/creat1n1ne  ratios.   The mean  serum  levels
of  ceruloplasmln  and  uric   acid   were  significantly  greater   In exposed
subjects than  In control  Individuals.  Plasma molybdenum  levels  In  unexposed
subjects varied  from  undetectable  to  34 ng/ml,  whereas  In those  exposed to
                                                             w
molybdenum dust,  the  range  was  9-365 ng/mi.  The  urinary  levels  of  molyb-
denum  In  14  exposed  subjects  fell  between  120  and  11,000 yg/mn,  compared
with  20-230   pg/ms.  In  18 unexposed  Individuals.  It  could   not  be  deter-
mined  whether  molybdenum was absorbed through  the lungs  or  In  the gastro-
intestinal tract.   In addition,  the  Investigators  Indicated  that the  wide
range  of  plasma  molybdenum  levels may reflect  "that  the blood  samples  were
collected when some workers  were starting their 8-hour shift,  others were In
the middle of the work day,  and  some had Just completed the  shift."


0186d                               -39-                             07/26/89

-------
6.1.2.   Oral  Exposure.   In most oral  exposure  studies, the  basal  diet fed
to  animals,  which was  generally used  as  the control  diet,  contained trace
amounts  of  molybdenum.   These  trace  amounts  are  not  mentioned   In  the
descriptions of  the  studies,  since  they represent  a very small percentage of
the  total  molybdenum  administered;   therefore,  their   contribution  to  the
development of toxic effects Is considered negligible.
    6.1.2.1.   SUBCHRONIC — Falrhall  et  al.  (1945)   fed  rats  diets  (not
described) to  which  one of several Ho  compounds were added,  as presented In
Table  6-1.   The  Investigators  stated that molybdenite.  In which  the Mo Is
present  In a  valence of «4, was  poorly-soluble  In digestive  juices.  Tissue
concentration  studies  suggest  that  this  compound  was  poorly  absorbed.   The
other  Mo compounds  are  all hexavalent and  readily soluble  In gastrointes-
tinal  tract  contents.  Tissue  concentration  studies  suggest  that  they  were
more  readily  absorbed.   No adverse effects were observed  regarding clinical
appearance, food  consumption, body  weight  gain or  hlstologlcal appearance of
(unspecified)  organs and tissues  In  rats  fed diets  containing molybdenite.
Thus,  from this  study,  the dose  of 4310 mg Mo/kg/day can  be  Identified  as  a
NOAEL  for rats fed diets containing molybdenite.
    Diets  that provided estimated  doses  of 111,  203,  350.  1471 or  6757 mg
Mo/kg/day  (from  molybdenum trloxlde)  for  <137 days caused 50% mortality In
the  lowest  dose  group  1n  120  days.   All  animals In  the two  highest  dose
groups died  In the first 2 weeks of  the study.  In rats  fed  a diet contain-
ing calcium molybdate at  levels that provided doses  of  70, 181,  326,  573 or
       J .        „      ~      -     -         . I ,-,....' t    - •- ll'K  Q1"  '  * C T*,' '  , ".
2986 mg  Mo/kg/day for .£137 days,  50% mortality  occurred  In  the  lowest  dose
group  In 137  days,  whereas  all the rats In  the highest  dose group  died
within 17 days.   When  the diet contained ammonium  molybdate  at a level  that
                                                                           t
provided a dose  of 100  mg Mo/kg/day,  25%  of  the  rats died In  232  days,  but


0186d                               -40-                             07/26/89

-------
                                                      TABLE 6-1
oo
cr>
CL
   Ingestlon  of  Molybdenum by  Groups  of  Hale White Rats  Fed  Diets Containing Various Molybdenum Compounds3
o
in
oo
Compound >
Control . ;
Molybdenite


Molybdenum trloxlde
.



Calcium molybdate




Ammonium molybdate
,
'
Number of
Rats/Group
48
8
8
8
8
10
10
8
8
10
10
10
10
10
8
8
8
Exposure
(days)
137
44
44
44
120
137
137
14
8
137
128
137
57
17
232
13
9
Estimated
Mo Intake^ •
(mg/day)
0
10
100
500
10
25
50
100
500
9
21
43
86
430
10
100
500
Average
Body Ue1ghtc
(kg)
0.137
0.117
0.113
0.116
0.09
0.123
0.143
0.068
0.074
0.129
0.116
0.132
0.15
0.144
0.1
0.068
0.077
Estimated
Dosage of Mod
(mg/kg/day)
0
85
885
4310
111
203
350
1471
6757
70
181
326
573
2986
100
1470
6494
aAdopted from Falrhall et al. (1945)
 Data provided by Investigators
Calculated from Initial and terminal body weight data provided by Investigators
 Estimated dally Intake of Mo divided by average body weight

-------
all  died  before 2 weeks when  the  dose  was  1470 or 6494 mg/kg/day.  Toxldty
signs  attributable to  molybdenum 1n all  three  forms  were  diminished food
Intake,  weight loss,  llstlessness  and  rough  hair  coat.  Results  of  hlsto-
pathologlcal examination, 1f performed,  were not reported.
     Gavage  doses  of 25, 100  or 200 mg/day  of Mo from  calcium molybdate In
gum  arable  (53, 218 and 410 mg Mo/kg/d based on body weight  data) given to
groups of eight male guinea  pigs  for  95 days caused 12.5, 25 and 25% mortal-
ity,  respectively.   Similar administration  of 25 mg Mo/day  from molybdenum
trloxlde  (85  mg Ho/kg/day)  caused 75X mortality  1n  99  days.   Doses  of 100
and  200  mg Mo/day  from molybdenum trloxlde  (303 and 583 mg/kg/day)  caused
100X mortality 1n 27  and 9  days, respectively (Falrhall et  al.,  1945).  No
controls were  given the vehicle  alone,  and the nutritional  adequacy  of the
diet was not reported.
     Arrlngton  and  Davis  (1953)  fed  groups  of  two  to  five  weanling  Dutch
rabbits  of  both  sexes  commercial  diets containing  added sodium  molybdate
(purity  not reported)   at  0.014,  0.05,   0.1,  0.2 or  0.4X.   Dosages  of 6.9,
24.5,  49,  98  or 196 mg Mo/kg/day can  be  estimated  by applying  a  reference
food factor of  0.049 (U.S.  EPA, 1986b).  Diets containing 0,  0.014, 0.1, 0.2
or 0.4% Ho  were also fed to  groups  of  two  to four mature rabbits.  The exact
duration  of  the   treatment  Is  not  stated,  but  was presumably  <17  weeks
according to data presented  1n  one of the  tables.   The  animals were examined
dally  for signs of  toxlclty,  and body weight  gain was monitored weekly from
24 six-week-old  rabbits.  The  hematocrlt was  measured  periodically  and the
hemoglobin  concentration,  every  2 weeks.   The  frequency of the  analyses
Increased upon manifestation  of  toxic  signs.   Doses  <49 mg/kg/day  Induced
anorexia, weight loss,  alopecia and anemia  1n  young rabbits after  4 weeks  of
treatment.   Mature rabbits  at  this dosage developed these signs after  longer

0186d                               -42-                             07/26/89

-------
periods of treatment.  A total of 10 deaths occurred  1n  the  groups  given the
two highest  doses  of molybdenum within  30  and  54 days of treatment.   Seven
young  rabbits  given  doses  <49 mg/kg/day developed  deformities  In  the  front
legs progressing  to  the point  where  they  could  not  maintain their  weight.
Hemoglobin concentration  and the  number of  red  blood  cells  were  markedly
reduced  starting  at  week  3  In  rabbits  given  doses  of  49  mg/kg/day.   Two
young rabbits at 49 mg Mo/kg/day gradually  recovered  after Initially showing
signs of  toxldty, suggesting that  young rabbits  may be  more sensitive than
adults to  Mo toxldty.   Since no effects were  observed with doses  of  <24.5
mg  Ho/kg/day,  this  value  represents  a  NOEL.   Addition  of copper  to  the
experimental  diet relieved the signs of  toxldty Induced  by molybdenum.
    Robinson  et  al.  (1969)  studied the  effects  of  two diets  supplemented
with  sodium  molybdate  (purity  not reported)  on the  life  span  of  rabbit
erythrocytes.   Sodium  molybdate  was  added  to  basic  diets  at  0.4%.   By
adjusting  for  content  of  Ho and application of  a  reference food  factor,  a
dose of  91 mg  Mo/kg/day  can  be estimated.  The erythrocytes were  labeled U»
vivo  with 32-P  DFP  Injected  Intravenously.  Four  different  groups  were
formed.   In  group  1, eight control  and  12  test rabbits  previously  mantalned
on  a  commercial  pelleted  diet  were  Injected  with  DFP  the  day  molybdate
feeding  was  begun.   In  group 2  (eight  controls,  11  test  rabbits  previously
maintained on  the  pelleted diet) were fed  the  test  diet for 52 days  before
the  OFP   Injection.  Group  3 (eight controls,  11 test  rabbits)  was fed  an
oats-alfalfa  (nutritionally  deficient)  diet, and= the DFP  was  Injected  27
days  before  molybdate.-feeding  began.   Group  4   (seven  controls,  12  test
rabbits),  also  fed  the  oats-alfalfa  diet,  was  Injected  with DFP 7  days
before the test  feeding  started.   Total  Mo exposure  time  was not  clear, but
0186d                               -43-                             05/31/89

-------
the total experimental period was  apparently  60  days.   There were no statis-
tically  significant  differences   1n  red blood  cell  survival  time  between
treated  rabbUs  and  controls  In  groups  1  and  2  (pellet-fed  rabbits),  but
body weight gain was  reduced  In  test  animals.  The erythrocyte survival time
of  controls  In  group 3 (oat-alfalfa-fed)  did  not differ  from that  of  the
test  animals  from  group 3.   However,  1n group  4, a  significant  difference
was seen  In  erythrocyte  survival  time between control  and  test animals.   No
deaths attributable to molybdenum Ingestlon occurred  1n  pellet-fed rabbits.
Seven  of  eleven  and 11/12  rabbits died after 12-35 days  on  the test  diet 1n
groups 3  and  4,  respectively.   The mean survival  time of the molybdenum-fed
rabbits  In  group   4  was  24.2  days.   Although  the   authors   Indicate  that
hemoglobin concentration and packed cell volume  were measured throughout  the
experiment, no values are given.   The authors stated,  however, that a severe
anemia developed In test rabbits on the oats-alfalfa diet.
    An early  study by  Franke  and Hoxon  (1937)  provides data  regarding  the
effects of  oral  Ingestlon  of molybdenum  In rats.   In  this  study,  groups of
10 Wlstar rats of  both sexes were  fed  a wheat diet (nutritional adequacy  not
described)  containing 25  or 50   ppm  of molybdenum   as  ammonium  molybdate
(purity  not  reported)  for  100   days.   The  authors  calculated  that  the
low-dose diet  provided  1.75  and 1.87 mg  Ho/kg/day to male  and female rats,
respectively,  and  that  the  high-dose  diet provided  3.35  and  3.68   mg
Mo/kg/day to  males and  females,  respectively.   Two groups  of 10  rats each
were  fed  the  wheat diet only  and served  as  controls.   Body weight, food
consumption and  hemoglobin concentration were monitored regularly  throughout
the experiment.   Molybdenum,  at either  level,  caused  no deaths and  had  no
noticeable  effects on  hemoglobin concentration   In  male or   female  rats.
0186d                               -44-                             07/26/89

-------
Although the authors concluded that treatment had no  effect  on  body weights,
rats  In  the 50  ppm group had body weights  slightly but consistently  below
those  of  controls  at  <20 days  (females)  or  40  days  (males)  of  exposure.
Food  consumption  was   apparently  not   affected.    Accepting  the  author's
conclusion  that  body weight  was  not affected,  this  study defines  NOAELs  of
3.35 and 3.68 mg Ho/kg/day for male and  female  rats,  respectively.
    Lallch  et  al.   (1965)   studied  the  effect  of  dietary molybdenum  on
abnormal skeletal growth  In  weanling  male Sprague-Dawley rats  (39-45 g bw).
Sodium molybdate  (purity  not  reported)  was  added to a  basic diet  (1.6  ppm
Cu)  at  concentrations  of 1.0,  1.5 or  2.0  g/kg of  food.   By  adjusting  for
content of  Ho and applying a  reference  food  factor  of 0.05  (U.S.  EPA,  1980),
doses of 23,  35 or  47  mg Ho/kg/day can be estimated.  There  were  seven rats
1n  the  low-dose  group,  four  In  the  Intermediate  and  11  In  the  high-dose
group.  After  6 weeks   on the diet, the  rats  were  sacrificed  and  autopsies
performed.   Ten rats  fed a   molybdenum-free  diet  served as  controls.   All
three  dietary  levels   of molybdenum  greatly  decreased  weight  gain  (35%
decrease for  the low- and Intermediate- and 60X  decrease for  the  high-dose
diet) and transient diarrhea  was  common during  the  first  2  weeks  of feeding.
Other toxic  signs observed were mandlbular nodulatlons and  gross  deformities
of  the knee  Joint.   Test  rats  also  developed  malformations  of  the  long
bones.   The  three  long  bones  examined  (femur,  tibia  and  humerus)   were
shorter with  Increased shaft  diameters.   Malformations  of  the sternum  and
vertebral column  were  noticed only In  rats  of the high-dose group.   Hlsto-
loglcal  examination of  the   major organs  did not   reveal  any  significant
alterations.  Skin  and bone   of  rats  In  the  high-dose  group (93  mg/kg/day)
showed a great  Increase  In molybdenum content over control rats.   Combining
molybdenum  with  copper   1n   the   diet  prevented  the  development  of   bone
malformations, but not  the loss of weight.

0186d                               -45-                             07/26/89

-------
    Winston  et  al.  (1973)  conducted a toxlclty study using  rats mantalned  on

a  commercial diet to  determine  the effect of  molybdenum on the response  to

cold  stress.   Hale  and female Sprague-Dawley  rats  were given 0 or 10 ppm  of

molybdenum   (from  sodium  molybdate,  purity  not  reported)   in  the  drinking

water   from  birth.   Assuming  rats  weigh  0.35  kg  and  drink  0.049  s.   of

water/day  (U.S. EPA,  1986b),  these levels of  molybdenum provided estimated

doses  of  0  and 1.4 mg Ho/kg/day.   At  5-12 months old. the  rats were tested.

The  response to  cold  stress was  examined by  keeping  groups of  rats  for 4

days  In a  chamber  at  room temperature  or 3°C  and determining  the weight

changes.   A  group  of  rats  given molybdenum-free  water  was  divided  Into

subgroups, one  of which  was tested at  3°C and the other maintained at  ?5°C.

A  similar  subdivision was made  In the  group administered molybdenum.   In

each  of the  four subgroups, there  were  two to five females and 11-12 males.

All  rats  subjected  to the  low-temperature test  had depressed  body weight

gain;  however,  this depression  was significantly greater  (p<0.01) In  those

receiving molybdenum  than  In  those given  molybdenum-free  water.   Hales and

females showed  the same pattern of  response.

    Nellands  et  al.  (1948)  fed  a  group  of  four  21-day-old  male Sprague-

Dawley  rats  a  purified  diet (virtually  free  of Cu) containing  40 mgX (400
                     '      • r   ,            '      "
ppm)  molybdenum (from sodium  molybdate)  for  6 weeks.   A  control  group was

fed a  molybdenum-free  purified diet.   Rats fed the test  diet, which provided

20  mg  Ho/kg/day  (assuming a  food factor  of  0.05), gained weight signifi-

cantly  more  slowly  than  rats on the  control  diet.   Rats fed a diet contaln-
     r  - ,    -            ..;*,-.,        ,  .'-      '•-     •          •-•".'.  -
Ing  400 ppm  Mo supplemented with  5X whole  liver  substance  (rich  in  trace
                       * *    r
elements Including Cu)  outgalned control rats fed the purified diet.

    6.1.2.2.   CHRONIC  — Pertinent data  regarding  chronic  oral  exposure  to
                         •,,.    -         -     •><;' -                        .'•."•'
molybdenum compounds were  not located  In the available  literature cited   In
                                     i*
Appendix A.


0186d                               -46-                             07/26/89

-------
6.1.3.   Other  Relevant  Information.  Molybdenum  1s  a basic  component  of
the  prosthetic   group  of  flavoproteln  enzymes  such   as  xanthlne  oxldase,
nitrate reductase, aldehyde oxldase, nltrogenase and  xanthlne  dehydrogenase.
In  addition,  molybdenum  Is  essential  for  the  utilization  of  Inorganic
nitrogen  In the synthesis  of proteins,  nucleic  adds  and other  nitrogenous
cell constituents (Lener and  Blbr,  1984).   Xanthlne oxldase plays  a  crucial
role  In  the  end  stage of  purlne  catabollsm,  by  catalyzing  the  aerobic
dehydrogenatlon   of  hypoxanthlne  to  xanthlne  and of xanthlne  to uric  acid.
Therefore,  a  reduction  1n   the  molybdenum  content  In  body  tissues  may
decrease  the  activity  of xanthlne oxldase, which  may  be reflected as  hypo-
urlcemla, hypourkosurla and  elevated  urinary xanthlne.  This can  result  In
calculus  formation  In  the  kidney collecting  tubules  (Lener  and  B1br,  1984;
Solomons, 1984).
    The  Impact  of  Cu nutrition on  the toxlclty  of Mo  has  been  reviewed  by
Underwood (1977).  An antagonism  occurs  between  Cu and Mo such  that  animals
fed diets deficient  In  Cu  are likely  to experience unusually severe conse-
quence of Increased Mo Intake.  For  example,  Robinson et al.  (1969) reported
severe anemia and  mortality  In rabbits  fed  a nutritionally Inadequate  diet
that also provided  Mo  at 91  mg/kg/day for <60 days.   The  same dosage  of  Mo
In rabbits fed  a commercial (presumably  adequate) diet  only  reduced the rate
of body weight gain.
    Nellands et  al. (1948)  fed groups  of 21-day-old male Sprague-Dawley rats
purified  diets  virtually devoid  of Cu containing 0,  50,  100 or   500  mg% (0,.
500, 1000 or  5000  ppm)  Mo  from sodium molybdate for <4 weeks  to  Investigate
effects on body weight  gain.   Assuming a food factor for rats of 0.05  (U.S.
EPA, 1980), these dietary  concentrations corresponded  to doses of  0,  25,  50
and 250 mg/kg/day,  respectively.   Ra'ts on  the 5000 ppm diet lost weight and

0186d                               -47-                             07/26/89

-------
died  shortly  after  1  week  of  treatment.   Gross  pathological  examination
revealed   extreme  emaciation.   There  were  no  effects  on  hematologlcal
parameters.  A dose-related depres-  slon  of  body weight  gain was reported at
the lower  dosage levels.
    Oral  LDcnS  of  101,  125  and  333 mg Mo/kg  were  reported  In rats  for
calcium molybdate, molybdenum trloxlde and ammonium molybdate, respectively,
In a  dietary study  In which  rats were fed Ho for 40 days  (Falrhall  et a "I.,
1945).  Intragastrk Intubation of neonatal  rats  on  days  4-15 with a neutral
solution  of  ammonium molybdate that  provided  doses  of 200  mg Mo/kg/day had
no adverse effects  on body weight,  hemoglobin,  hematocrH  or hlstopathology
(Hunt and Navla, 1973).  However, the same doses given  In  acidic solutions
Induced fatty liver and death.
    In a  study by Rana  et  al.  (1980), 10  male  albino rats  fed a  diet that
provided  1.0 g/kg bw  of ammonium molybdate  (571  mg Ho/kg/day) for  20 days
lost  considerable weight,  from  103  g at  the start of  the experiment  to 60 g
after 20  days  of the test diet.  Concurrent controls  fed a  standard  labora-
tory  diet went from an  Initial body weight of 105-140 g  In  the same period
of time.   Information regarding food consumption was not given.   In  addi-
tion, molybdenum enhanced the rate  of Upld  accumulation In the  liver  and
kidneys,  compared with control rats.   The same group of  Investigators,  using
the same  protocol, reported  that  molybdenum decreased the activities  of  the
enzymes alkaline and acid phosphatase  and llpase,  but  did not alter glucose-
6-phosphatase and chollnesterase In  rat liver  (Rana  and Kumar,  1980a).   Rana
and  Kumar  (1980b)  also  reported  that  the  percentage  of  total  proteins
significantly  decreased  In   the  kidneys,  but not  1n  the   liver,  of  rats
treated as described  above.
0186d                               -48-                             07/26/89

-------
    Molybdenum caused thyroldal hypofunctlon In male New Zealand  rabbUs  fed
diets containing 0.3%  molybdate  Ions for 25 and  31  days,  as  Indicated by  a
50%  decrease  In  thyroldal  hormone  synthesis  and  secretion,  compared with
controls  (Wldjajakusuma   et  al.,  1973).   Also,  body  weights,   hemoglobin
concentrations  and   packed  cell  volumes  were  significantly  reduced.    By
adjusting for content of  Mo and  assuming a food factor for  rabbits  of 0.049
(U.S. EPA, 1986b),  a dose of 98 mg  Mo/kg/day  can  be  estimated.
    Bandyopadhyay  et  al.  (1981)   reported  that  oral   administration   of
ammonium molybdate  In  water  at doses of  500 mg/kg  bw (289 mg Ho/kg/day)  to
male Wlstar rats for 28 days Induced moderate to  severe  hlstologlcal changes
In the liver and kidneys and caused  marked growth retardation, compared with
basal diet-fed  controls.  A high-protein diet  could partially prevent these
changes.   Molybdenum  also  altered  the  activities  of  several   glycolytlc
enzymes  In  the  liver and kidneys as well  as  the serum levels of  prolactln,
cortlsol and lutelnlzlng  and follicle-stimulating  hormones.
    Rats  fed  a  basal  diet supplemented with  6  mg/kg  (6 ppm)  of  Mo from
ammonium tetrathlomolybdate (0.3 mg/kg/day,  assuming  a food factor  of 0.05)
for 21 days developed hlstologlcal alterations  In the  gastrointestinal tract
Including cell  fragmentation and necrosis  In  the caecum and colon,  compared
with controls  fed  a basal diet  alone  (Fell  et  al., 1979).  Also, mltochon-
drlal abnormalities  1n the duodenum and  jejunum were  noticed.   A  dietary
concentration of 6  ppm Mo (0.3 mg Mo/kg/day) for 21 days  also caused  severe
skeletal abnormalities  In rats (Spence et al., 1980).  Alterations were most
prominent  In  long-bone  growth  plates,  muscle  Insertions  and  beneath   the
periosteum.                        .  ,   ,     .
    Falrhall et  al.  (1945)  administered  molybdenum  trloxlde to guinea pigs
by  dally stomach Intubation  at  25, "50, 75, 100 or  200  mg/kg/day  for  <25


0186d                               -49-                             07/26/89

-------
days.   The  estimated doses adjusted  for content of  Mo  were 17,  33,  50, 67
and  133 mg  Mo/kg/day.  All animals  exposed to the two  higher  doses  died by
the  9th  day.  Hlstologlcal  examination  of  the tissues revealed fatty changes
In  the  liver  and  swollen hepatocytes and  epithelial  cells  In the convoluted
tubules  of  the kidney,  as  well  as  dose-related Increases  1n  the Incidence
and  Intensity  of  fatty  Inclusions  In the  cortical epithelium.   Mild  to
moderate  congestion  was  observed  1n  the lungs,  and  pulp  retlculum cells In
the  spleen  Increased.  No  changes  were noticed  In the  heart.   There  was no
mention of a control group.
6.2.   CARCINOGENICITY
6.2.1.   Inhalation.   Pertinent  data  regarding  the  Inhalation  carclnogen-
Iclty of  molybdenum compounds  were  not located  1n the  available literature
cited In Appendix A.
6.2.2.   Oral.   The  only  Information  regarding  oral   carclnogenlclty  of
molybdenum  can  be  found  In Luo  et  al. (1983),  described  1n  Section  6.2.3.
In  this  study,  no  tumors or pretumorous lesions were found In the esophagus
and  forestomach of  male Sprague-Dawley  rats  receiving 2.8 mg  Mo/kg/day for
<30 weeks.
6.2.3.   Other  Relevant  Information.   The  co-carcinogenic  properties  of
molybdenum were studied  by  Luo et al.  (1983).   In  this  study,  weanling male
Sprague-Dawley  rats   (10-15/group)   were   given   sodium  molybdate  In  the
drinking water at levels  of 0, 2  or  20 ppm Mo (0. 0.28 or  2.8 mg Mo/kg/day
assuming  rats  drink  0.049  I/day and  weigh  0.35  kg)  for 19  or  30  weeks.
                                                                 _,,,.,   i . r ~ •
Treated  groups  also  received   twice weekly  Intubations  of a  solution  of the
carcinogen NSEE  for  8 consecutive weeks beginning at  the 4th  week.   Three
                                                                           , :
additional groups were  treated with either NSCE or saline  Intragastrlcally,
or with  20  ppm  Mo  In the drinking water.   Addition of molybdenum,  at  either


0186d                               -50-                             07/26/89

-------
dose level, significantly Inhibited the formation of tumors  In  the  esophagus
and forestomach Induced by administration of NSEE.  Molybdenum  by  Hself  did
not Induce tumors  In either  organ.
    Bogdcn et  al.   (1986)  studied  the  co-carcinogenic  properties  of  molyb-
denum  1n male  Sprague-Dawley rats  administered the  esophageal  carcinogen
HBN.  Groups of rats  (nine/group)  received  sodium molybdate  In  the  drinking
water at  concentrations  that  provided Ho at 0,  15  or  45 ppm.   Before expo-
sure to  Mo,  the rats  were pretreated with 2.5 rag/kg of  MBN  Intragastrlcally
In 10% ethanol twice/week  for 5  weeks.  A third group received  only MBN  for
5 weeks.  After a subsequent  12-week  period of exposure  to Mo,  the  rats were
killed and  their  esophagi prepared  for  gross  and hlstologlcal  examination.
No  significant  differences were  noticed among  the  three  treatment  groups
regarding the  number  of  rats  bearing precancerous lesions,  gross  papHlomas
or carcinomas or  the number  of esophageal  lesions/rat.
    Stoner et  al.  (1976)  examined  the carcinogenic properties  of  Intraperl-
toneal  Injections  of  molybdenum  trloxlde In  the  Strain A  mice lung  tumor
assay.   Groups of  20 mice  (10/sex/group)  received  Injections  of molybdenum
trloxlde In 0.85% saline three times/week for a  total  of 19  Injections..  The
cumulative dose received by each mouse In each of the three  test groups  was
633, 1823 or 3167 mg Mo/kg.   Two additional groups either  remained  untreated
or received  the  solvent  alone.  Positive controls  received  a  single  Intra-
perHoneal Injection  of  20 mg  urethane/mouse.   The average  number of  lung
tumors/mouse In the highest dose group was 1.13, compared with  0.42 and 0.28
In solvent  controls and untreated mice,  respectively.  This difference  was
significant  (p<0.05).   In  addition,   the  number  of mice bearing tumors  was
higher in the high  group (10/15) than  In  the control  groups  (7/19),  although
the difference was  not  statistically significant (p>0.08; Fisher Exact Test
performed at  SRC).   The  number  of  mice  with  lung  tumors  and the  average

0186d                               -51-                             07/26/89

-------
number of  lung  tumors/mouse  In the low and  Intermediate dose  groups  was  not
significantly different than  In controls.  The authors  concluded  that molyb-
denum was  "weakly positive" 1n this assay.   In view  of  the small  Increase In
the number of lung  tumors/mouse and the  Insignificant Increase  1n  the number
of  mice  bearing  tumors,  the   evidence  for  cardnogen1c1ty  In  this  test  1s
Inconclusive.
    We1  et al.  (1985) administered molybdenum  (unspecified form)  to  female
Sprague-Dawley rats maintained on a low  (0.026 ppm)  Ho  diet  at  a  level  of 10
ppm In the drinking water  for 125 or 198 days.  This level  of  molybdenum In
the water  corresponds to  a  dose of  1.4 mg Ho/kg/day,  assuming  rats  weigh
0.35 kg  and  consume 0.049 I  of water/day  (U.S.  EPA, 1986b).  The  rats also
received a single Intravenous  Injection of the carcinogen  NMD.  The positive
control  group received only NMU,  whereas a negative control group  was  given
molybdenum-free demlneraHzed  water and  no NMU.   After  125 days,  the  Inci-
dence of mammary  tumors In  the  positive controls  and  NMU-molybdenum  group
did not  differ  significantly.   However, after 198  days,  positive  controls
had  a  tumor Incidence  of  90.5%,  compared with   50%  1n  those  receiving
NMU-molybdenum.
6.3.   MUTAGENICITY
    Several  molybdenum  compounds   have   been  tested   for  mutagenldty   In
bacteria  (Table 6-2).  Negative  or  weakly positive mutagenlc responses were
seen In  Bacillus subtills as Judged by a DNA repair  assay  (Kanematsu  et al.,
1980).    When tested  In  Escherlchla  coll.  sodium molybdate Induced  lambda
prophages  (Rossman  et al., 1984)  and enhanced  the mutagenldty  of  ultra-
violet light (Rossman  and Molina,  1986).   In  the  only  available  report
regarding  mutagenldty  of  molybdenum  In mammalian  cells, molybdate Ions
caused forward  mutations  1n  Chinese  hamster  lung  cells  (Zellkoff  et al..
1986).

0186d                                -52-                             07/26/89

-------
o
CO
o.
TABLf 6-2


Mutagenlclty Testing of Molybdenum
Assay Indicator Organism Purity
(X)
i
Microbiological Assays
Rec assay (DNA repair) Bacillus subtllts NR
H17, H«5
Rec assay (DNA repair) B. subtllls NR
H17. M«5
Ul
*j° xProphage Induction Escherlchla coll technical
WP2S (x) grade
ONA repair -- C. coll ' technical
1 WP2 (trpE) grade
F
Mammalian cells
forward mutation * Chinese hamster NR
lung cells (V79)
Application Concentration
or Dose

plate 0.005-0.5 M
Incorporation (0.05 ml)
plate . 0.7 M
Incorporation (0.05 ml)
plate 0.05 N
Incorporation
plate 0-30.000 nM
Incorporation

cell culture NR
Response Comment

Compounds tested
were MoS?, MoOi and
H2M00«.
-/» Compound tested was
(NH4)( Moy024.
» Compound tested was
Na?Mo04.
t NajHoO^ enhanced
the mutagentclty of
UV light.

• (HoOi)'* was tested;
relatively nontoxlc
doses were used.
Reference

Kanematsu
et al.. 1980
Kanematsu
et al.. 1980
Rossman
et al.. 1984
Rossman and
Molina. 1986

Zellkoff
et al.. 1986
         NR * Not reported; -/» * weakly mutagenlc
o
Ul
CD
VD

-------
 6.4.    DEVELOPMENTAL TOXICITY
    The only report available  regarding  developmental  effects of molybdenum
 1s  that of  Perm (1972).   In  that  study,  Intravenous  Injections  of sodium
 molybdate  \n doses  <100 mg Mo/kg  to  pregnant  hamsters  on day 8 of gestation
 were neither embryoddal nor developmentally toxic.
 6.5.    OTHER REPRODUCTIVE EFFECTS
    In  a  3-generat1on  reproductive  study  (Schroeder  and  Kitchener,  1971),
 Charles  River  CD mice (five/sex) mantalned on a  diet  containing 1.95 ppm Cu
 and  0.045  ppm Ho  were administered molybdenum  In the drinking water  at <6
 months  of  age  at  a  concentration of  10 ppm  (from  an  unspecified  soluble
 salt),  which  provided  a dose  of  1.9  mg  Ho/kg/day,  assuming  mice  consume
 0.0057   i  of  water/day and  weigh  0.03  kg  (U.S.  EPA,  1986b).   Randomly
 selected  pairs  (unspecified  number)  from  the  first  (F,.),  second  (F,B),
 or  third Utter (F,-) were allowed  to breed  at  will  to produce  the second
 generation  (F.).   The  same  procedure was  followed  to produce  the  third
 generation  (F3).   Control  animals  received plain delonlzed  water.   Molyb-
 denum caused  15  early deaths out  of  238  offspring 1n the  F.  generation  but
 none  In controls (p<0.001);  It caused five dead  Utters In  the  F_  genera-
 tion  but  none  In  controls  (not  statistically  significant).   In  the  F,
 generation,  there were  4 maternal  deaths  (none  In controls;  p<0.05),  4 dead
 Utters  (none  In   controls;  p<0.05),  34  young  deaths  (1  1n  controls;
 p<0.0001),  11  runts (none  In  controls;  p<0.0001), and  3 failures to  breed
 (none   In  controls;  not  statistically  significant).    The  F_  generation
                      "          J  r  -    —                     W
 totaled  123 mice, compared with  230  for the  control group.   Ihe total  number
                      \       .
 of  Utters/generation,  as  well  as  the  average Utter size/generation, were
 not affected by Ingestlon of molybdenum.
0186d                               -54-                             01/30/90

-------
    Intravenous  Injection  of molybdenum  (0.1  ml of  a 100  mH solution  of
  ( .  _         _ >   "     .j. . ,,.j j - c  *,  .    -1., .*  4>-   t-f   ._...-        -  .....
sodium molybdate, -30 mg Ho/kg) Into pregnant mice on  day  3 of pregnancy did
not  Interfere  with   Implantation  or subsequent  development of  the  fetuses.
When mice  were  Injected on day 8 of  gestation, molybdenum Induced  signifi-
cant decreases  In  the weight of  the  fetuses and  In  the degree of  skeletal
ossification; the number of  resorptlons  was  not  affected (Wide, 1984).
    In  a  study  by  Jeter  and Davis  (1954), groups of  8-16  Long-Evans  rats
(4-8/sex) were fed a basal diet supplemented with  sodium molybdate at  20,  80
or 140 ppm Ho  for ~90 days.  The  control  (basal) diet  was  analyzed,  found  to
contain Ho at <1 ppm and  supplemented with  copper  sulfate  to contain Cu at 5
or 20 ppm.   In addition, a group  of four  male  and four  female rats was fed a
diet containing 80 ppm Ho and 20  ppm Cu.   Assuming a  food  factor for rats  of
0.05, the 20, 80 and 140  ppm Ho diets  correspond to  dosages of 1,  4 and 7  mg
Ho/kg/day, respectively.  Reduced rate  of  body  weight  gain was reported  In
all Mo-treated  groups of  males  and In  females  treated  with Ho at 80  or 140
ppm  \n  diets  containing  5  ppm  Cu.    No  effect  on  body  weight  gain  was
observed  In  rats treated with 80 ppm  Ho on  the 20 ppm Cu-conta1n1ng d1»t,
and  no  effect  on   blood  hemoglobin   concentration   was   reported  In  any
Ho-treated groups.   AchromotMchla  and alopecia  were  observed  In  some  rats -
                         •    •*
1n the  80  and  140  ppm Ho groups and occasionally  1n the 20 ppm Ho groups  on
diets  containing 5  ppm  Cu.   When  the  rats  were  allowed  to breed,  male
Infertility  was  observed  In  80 and 140 ppm Ho  groups on  diets  containing 5
ppm Cu.   Hales  that  received  molybdenum at 80 and 140  ppm produced  only one -
litter  (out  of  four  matlngs),  as  compared with  four  Utters (out of  four
mat Ings) produced by males not receiving  molybdenum.  The  20 ppm Ho 5  ppm Cu
and  80  ppm  Ho  20  ppm Cu  diets  did not  affect fertility.   Control animals
produced  eight  Utters  out  of eight'matlngs.   Examination of  the testes  of


0186d                               -55-                             07/26/89

-------
the  males  from  the  80 and 140  ppm Mo  (5  ppm Cu) diets producing  only one
IHter  showed  various degrees  of seminiferous  tubule  degeneration.   Testes
from  control  rats  were normal.   Molybdenum did not affect  female fertility
or  gestation,   but  did  Interfere  with  normal  lactation,   as   Indicated  by
reduced weaning weight of offspring of dams exposed to >20 ppm Mo, 5 ppm Cu.
6.6.   SUMMARY
    Reported  oral  LD^nS  for  Mo  exposed  to  rats  In  the diet  for 40  days
were  101 mg/kg  for  calcium molybdate, 125  mg/kg  for  molybdenum trloxlde and
333  mg/kg  for  ammonium  molybdate  (Falrhall  et al.,  1945).  LD5Q  data for
other  species   were  not  available.   Short-term oral  studies  with  various
species Indicate that  molybdenum  depresses body weight gain  and  affects the
gastrointestinal tract,  the  liver  and  kidneys.   The  doses  associated  with
these  effects   vary  with different  molybdenum  compounds.   In   rats,  sodium
molybdate  caused  death In  <2 weeks at  doses  of  250  mg Mo/kg  (Nellands  et
al.,  1948), whereas  571  mg Mo/kg/day  from  ammonium molybdate was not  lethal
(Rana et al., 1980).   Ammonium  tetrathlomolybdate  Is  apparently considerably
more  toxic  than other molybdenum compounds,   since dietary  doses of  0.3  mg
Mo/kg for 21 days had  gastrointestinal and skeletal effects  In  rats (Fell  et
al., 1979; Spence et al., 1980).  Inhalation of  dusts  of  molybdenum trloxlde
and  calcium molybdate  killed  guinea  pigs  1n  <5 weeks  at levels of 200 and
155  mg  Mo/m3,   respectively;  however,   these  experiments   were  not  well
designed and the results  not clearly reported  (Falrhall  et al.,  1945).
    Molybdenum  added   to  the  diet  of  male rats  as   the trloxlde, calcium
                                                              ft    ' _ i    • *   >•
molybdate,  or as ammonium  molybdate  In  doses  between  85 and 6757 mg  Mo/kg
for 8-232 days caused weight loss  and mortality (Falrhall  et  al.,  1945).
    In  rabbits,  dietary  doses  of >91 mg  Mo/kg as sodium  molybdate  In  the
                                >  ' ,         • i
diet caused anemia  and,  eventually, death  In  -40  days,  but  doses of  <25  mg
                        »            «*

0186d                               -56-                              07/26/89

-------
Ho/kg had no no-tlceable adverse effects  (Arrlngton and  Davis,  1953;  Robinson
et a!.,  1969).   In rats,  doses  of -20  mg  Ho/kg/day from  sodium  molybdenum
for  42  days  1n  the  diet  or  drinking  water  significantly  decreased  body
weight gain (Lallch et al., 1965;  Nellands  et al.,  1948).
    In  rats,  sodium  molybdate  added  to  the drinking  water  at levels  that
provided doses of  0.28-2.8  6 mg  Ho/kg/day decreased the  Incidence of  tumors
Induced by known carcinogens (Luo et al., 1983; He1  et  al., 1985).   However,
IntraperUoneal  Injections  of  molybdenum trloxlde In mice  for -a total  dose
of 3167 mg Mo/kg over a 30-day period  Increased the  Incidence  of lung  tumors
(not  statistically  significant)  and  significantly  Increased  the  number  of
lung  tumors/mouse  (Stoner  et  al.,  1976).   The  overall  evidence  Indicates
that  some  molybdenum  compounds   are   weak  mutagens   In  bacterial   assays
(Kanematsu et  al., 1980;  Rosmann  et al.,  1984).   In  the  only assay  using
mammalian  cells,   molybdate anlons  caused  a  positive  mutagenlc  response
(Zellkoff  et  al.,  1986).   Sodium  molybdate was  not  developmentally  toxic
when Injected Intravenously to  pregnant hamsters (Perm,  1972).
    In a 3-generat1on study by Schroeder and Kitchener  (1971),  a dose  of 1.9
mg Mo/kg In drinking water was  associated with  early death   1n  offspring,
Increased number of dead litters,  maternal  mortality  and the birth  of runts.
    In rats, 20 ppm Mo  In  the  diet  (1  mg/kg/day)  was associated with reduced
body weight gain In male rats  and  reduced  lactation  Index In  female  rats;  80
ppm  (4  mg/kg/day)  was  associated with  male Infertility  (Jeter and  Davis,
1954).
0186d                               -57-                             01/30/90

-------
                     7.   EXISTING GUIDELINES  AND  STANDARDS
7.1.   HUMAN
    ACGIH  (1988)  recommended a  TLV-TWA of  5  mg Mo/m3  and  10 mg  Mo/m3  for
soluble  and  Insoluble molybdenum compounds, respectively.   This  recommenda-
tion  1s  based  largely  on  the  conclusions  of  Falrhall et  al.   (1945)  and
Mogllvskaya  (1950)  that Industrial  exposure  results  In   a  low  order  of
toxlclty (ACGIH, 1986).  OSHA  (1989)  established  a  PEL for  soluble compounds
of  molybdenum  1n  air of 5  mg/m3 TWA.   The OSHA PEL  1n  air for  Insoluble
compounds,   based  on  physical   Irritation  of  Mo03  (ACGIH,   1986),  1s 10  mg
Mo/m3  for  total dust,  and   5  mg Mo/m3 for  the  resplrable fraction,  based
on  limited Industrial experience with  these  compounds, to protect  against
eye, nose and skin Irritation and chronic respiratory effects (OSHA, 1989).
7.2.   AQUATIC
    Guidelines  and  standards   for   the  protection  of  aquatic   life  from
exposure to molybdenum were  not  located In the available literature cited In
Appendix A.
0186d                               -58-                             05/31/89

-------
                             8.  RISK ASSESSMENT
8.1.   CARCINOGENICITY
8.1.1.   Inhalation.   Pertinent  data regarding  the  Inhalation carclnogen-
1cUy of molybdenum  compounds  were not  located  In the available  literature
cited In Appendix A.
8.1.2.   Oral.   As  part of  the study  by Luo  et  al.  (1983)  In  which  the
Investigators  examined   the  co-carcinogenic  properties  of  molybdenum  and
NSEE, one group  of female Sprague-Dawley  rats was  given 20  ppm of  molybdenum
(from sodium  molybdate)  In  the drinking  water  for <30 weeks.  This  concen-
tration  of  molybdenum,  equivalent  to  a  dose  of  2.8 mg  Mo/kg/day, did  not
Induce tumors  In  the  esophagus  or  forestomach, the only  two  organs  examined
at the end of the dosing period.
8.1.3.   Other Routes.  Stoner  et al. (1976) gave  groups  of male and  female
Strain A mice  Intraperltoneal Injections  of molybdenum trloxlde, for  a total
dose of 633,  1823 or  3167 mg Mo/kg.  Mice were  Injected throe times/week  for
a  total  of  19  Injections  1n   a  30-week  period.   In  the  group  given  the
highest  dose,  the  number  of   lung tumors/mouse  was  significantly  higher
(p<0.05) than  In those  receiving the vehicle  alone or those  untreated.   An
Insignificant  Increase  was  reported In   the  number   of  mice  bearing  lung
tumors.   Ihe  Incidence  In   the low and  Intermediate  dose  groups  did  not
differ  significantly  from that  In controls.   In  the  study  by Luo  et  al.
(1983),  molybdenum  Inhibited  the   formation  of esophageal  and forestomach
tumors Induced by N-n1trososarcos1ne.  Molybdenum did not alter  the  carclno--
genie potency of methylbenzylnltrosamine (Bogden et al., 1986).
8.1.4.   Weight of Evidence.  No data were available regarding the  carclno-
genlclty of  molybdenum  compounds  In humans.   The  limited  negative  carclno-
genldty  results from  the  study  using  rats  by  Luo et  al.  (1983),  the


0186d                               -59-                             07/26/89

-------
Inconclusive results of  the  Strain A mouse lung  tumor assay  (Stoner  et  al.,
1976} and  the  co-cardnogen1cHy studies  (Bogden  et  al., 1986; Luo  et  al.,
1983) constitute Inadequate evidence  to  evaluate  the  carcinogenic  potency of
sodium molybdate.   According  to U.S. EPA  (1986a)  guidelines, molybdenum can
be placed 1n EPA Group D: not classifiable as  to cardnogenldty to humans.
8.1.5.   Quantitative Risk Estimates.   The lack of  suitable  positive Inha-
lation and  oral carcinogenic data  precludes  the derivation of  carcinogenic
potency factors for molybdenum.
8.2.   SYSTEMIC TOXICITY
8.2.1.   Inhalation Exposure.   Inhalation studies conducted  by Falrhall  et
al.  (1945),  In which guinea pigs  were  exposed  to dusts  or fumes  of  several
molybdenum  compounds  1   hour/day,  5  days/week  for 5  weeks,  are  considered
Inadequate as  the basis  for deriving  a  chronic  or  subchronlc  Inhalation  RfD.
The  study's  exposure  schedule can be better described as  Intermittent acute
exposures, and  adjustments  for  continuous exposure may result  In  misleading
figures.    Furthermore,   molybdenum  dusts  caused  deaths  at   <4.  weeks  of
exposure, which  Is  considered  acute.  Relevant  human  data were not  located
1n the available literature.
8.2.2.   Oral Exposure.
    8.2.2.1.   LESS   THAN    LIFETIME    EXPOSURES    (SUBCHRONIC)  —  Several
subchronlc oral  studies  were performed  with  different molybdenum  compounds
In animals.   Falrhall  et al.  (1945) reported  high  mortality  In rats given
molybdenum trloxlde. calcium molybdate  or ammonium molybdate  In the  diet  at
doses >111,  70 and 100  mg  Mo/kg/day,  respectively,  for  120-232 days (Rec.   '
#5,  6 and  7).  Similar results  were   reported  for  guinea  pigs   receiving
calcium molybdate  (Rec.  #8)  or  molybdenum trloxlde  (Rec.  #9)  by  gavage  at
0186d                               -60-                            07/26/89

-------
doses >53 and  303  mg Ho/kg/day,  respectively, for 95 days  (Falrhall  et  al.,
1945).  In  general,  the studies of  FaUhall  et  al.  (1945) were  not  clearly
reported.
    In rabbits, anemia  and  mortality occurred with doses of  91  mg  Mo/kg/day
(Rec. #12}  for <60 days  (Robinson  et al., 1969), or  49 mg  Mo/kg/day  {Rec.
#11) for 120 days  (Arrlngton and Davis,  1953).   Nevertheless,  a  dose  of  24.5
mg Ho/kg/day was Identified  as  a NOAEL  for rabbits from Arrlngton  and  Davis
(1953) (Rec. #10).
    From the study by Franke and Moxon  (1937), In  which  rats  were fed a  diet
supplemented with  molybdenum for  100 days,  NOAELs  of  3.35  (Rec.  #13)  and
3.68 mg Ho/kg/day  (Rec.  #14)  were  Identified for males  and  females,  respec-
tively.    Body  weight  gain, food  consumption and  hemoglobin  concentration
were monitored.
    Two   reproductive  studies  were   located  1n  the  literature,  and   both
reported adverse reproductive effects at rather  low doses, compared to  other
endpolnts  studied  (Jeter and  Davis, 1954; Schroeder  and  Mltchener, 1971).
In  the  study  by Jeter  and  Davis (1954), male rats  fed  a diet  supplemented
with sodium molybdate  to  provide doses  of 4  (Rec. #2) or 7 mg  Mo/kg/day for
-90  days  produced  fewer Utters  than  those given  a   lower  dose of  1  mg
Mo/kg/day  (Rec. #1)  or  control  rats  (no statistical  analysis was  provided).
Males  that   received  molybdenum produced  only  one  litter  (out of   four
matlngs),  compared with four Utters  (out of  four  ma tings) produced by  males
not receiving  molybdenum.''  The  low-dose and  control  groups  had  100% mating
success.  Hlstologlcal  examination of  the  testes of  the affected males  from
the  4 and  7  mg  Mo/kg/day  groups   showed  various degrees  of  seminiferous
tubule degeneration.   Growth  retardation was significant  (5% level)  In  all
treated  groups  of  males  and  In females  of  the  2 highest  dosage  levels  on


0186d                               -61-                            07/26/89

-------
diets  containing  5  ppm  Cu.   Hemoglobin  levels,  measured  throughout  the
experimental  period,  were  not  affected.  Molybdenum  did not  affect  female
fertility or  gestation but  Interfered  with normal  lactation,  as Indicated by
reduced weaning  weights  of  offspring In all treated groups  {5  ppm Cu).   The
dosage of 1  mg Mo/kg/day 1s considered a LOAEL  for weight gain In males  and
Impaired lactation  In females.
    In a 3-generatlon study,  molybdenum given  In the  drinking  water  to  mice
for <6  months at  a  level  to  provide  a dose of  1.9  mg Mo/kg/day  (Rec.  #3)
caused  significant (p<0.001)  early mortality  In the offspring  of  the  F..
generatloa fSchroeder and MHchener, 1971).  In  addition,  1n  the test  groups
of  the  F-   generation,   there  were  4  maternal  deaths  (p<0.05),  4  dead
          o
Utters (p<0.05),  34  young deaths  (p<0.0001) and 11   runts  (p<0.0001).   For
this study,  the dose of 1.9 mg Mo/kg/day represents a  LOAEL.
    The LOAEL of  1 mg Mo/kg/day  (Rec.  #1) In  the  rat  study  by  Jeter  and
Davis (1954)  and  the  LOAEL  of 1.9 mg Ho/kg/day  In the mouse  study (Rec.  #3)
by  Schroeder  and  Mltchener  (1971)  are similar.  Either  could   serve as  the
basis for risk assessment.   Schroeder  and MHchener (1971)  evaluated  repro-
ductive performance over  three generations but In only five  pairs  of mice In
each generation.   Jeter and Davis  (1954) only  evaluated reproduction  1n  one
generation  but used  slightly  larger group  sizes and  evaluated other  end-
points  of   toxlclty,  as  well.   Most  Importantly,  Jeter  and  Davis   (1954)
provided diets containing 5 ppm Cu, which  Is  the NRC  (1978) recommendation
for  this  species.   Schroeder   and  Mltchener  (1971)  on  the   other  hand,
provided a  diet  containing  only 1.95  ppm  Cu,  somewhat below the  NRC  (1978)
recommendation of 4.5 ppm for this  species.       .  - ,.
    Because  of the  Impact of Cu  nutrition on the  toxlclty  of  Mo (see Section
6.1.3.)  and  the  uncertainties  associated with  possibly suboptlmal  Cu  levels
                        ->             i*

0186d                                -62-                             07/26/89

-------
In Schroeder  and  MHchener  (1971),  the  LOAEL of 1  mg Mo/kg/day  from  Jeter
and  Davis  (1954)   Is  chosen as  the basis  for  risk assessment.   Therefore,
applying an uncertainty  factor  of  1000 (10 each for  Inter- and  Intraspecles
extrapolation  and  10  to  reflect  the use of a LOAEL  Instead of NOAEL)  to  the
dose  of  1  mg,  a   subchronlc  oral  RfD of  1  yg Ho/kg/day  Is  derived.  This
subchronlc   RfD  Is  somewhat  below  the   recommended  dietary  allowance  for
molybdenum  of  150-500  yg/day  (NAS,  1980)   and  supports  the  notion that
long-term Intake of these levels of molybdenum are  not only safe,  but  essen-
tial.  The  RfO  of  1  vg Mo/kg/day,  derived from data  obtained  from  sodium
molybdate,  should  be  protective for  soluble  salts  and compounds  containing
hexavalent  Ho,  provided  that toxlclty of  the  nonmolybdenum  moiety does  not
become  a  factor  1n  the toxldty  of the  molybdenum compound.   Acute  and
subchronlc  data In  rats  by  Falrhall et al. (1945)  suggest that  the  toxlclty
of calcium molybdenum trloxlde  and  ammonium molybdate Is similar.  The RfD,
however, does  not  apply  to  Mo obtained from ammonium tetrathlomolybdate.
    Confidence  In  the data  base  Is low,  largely  because  chronic data were
not available and because the data  do  not  clearly define a target  organ or  a
critical effect  In humans   or  laboratory animals.   None  of  the  longer-term
studies provided  an  adequate  hlstopathologlcal  evaluation.   Confidence  In
the  key  study   Is  medium,  because  several   endpolnts  of   toxlclty  were
evaluated In  rats  maintained on a  diet that was  adequate  In Cu  nutrition.
Confidence  In the  RfD Is medium.   The RfD should  be  sufficiently conserva-
tive, because 1t 1s below the NAS (1980)  recommended dally allowance  for Ho.
    8.2.2.2.    CHRONIC^EXPOSURE --Pertinent data regarding  the  toxlclty of
chronic oral  exposure to  Ho were  not located  In  the available  literature
cited  In Appendix  A.  In  the absence of  chronic  data, an  RfD for  chronic
oral  exposure  can  be derived  from' the  subchronlc data.   Ordinarily,  an
0186d                               -63-                             07/26/89

-------
uncertainty  factor  of 10  would  be applied  to  the  subchronlc RfD  or  to the
subchronlc  benchmark dose that  was  the  basis  for  the subchronlc  RfD,  to
expand  from  subchronlc to  chronic exposure.   This  manipulation Is not neces-
sary  for  Ho,  however, because  Ho Is a nutritionally essential trace element,
and  the RfD  for subchronlc exposure  Is  somewhat  below the recommended dally
allowance.   Therefore,  the  subchronlc  oral  RfD  of  1  yg  Ho/kg/day  1s
considered  sufficiently  protective  for  chronic   oral   exposure,  as  well.
Confidence In  the  data  base Is  low,  and  confidence  1n the  key study and RfD
Is medium, as discussed above.
0186d                               -64-                             07/26/89

-------
                          9.  REPORTABLE QUANTITIES
9.1.   BASED ON SYSTEMIC TOXICITY
    The  toxlclty  of  molybdenum  compounds was  discussed  In  Chapter  6  and
dose-response data considered for CS derivation are summarized 1n Table  9-1.
Since no  chronic  data were available,  subchronlc  data  were considered.   In
Table  9-1,   the  dosage  of  molybdenum  compounds  Is  expressed  1n  terms  of
molybdenum element In mg/kg/day, and  the  equivalent  human dose 1s  expressed
1n mg of  molybdenum/kg/day.  Table  9-1  also  shows that the different  molyb-
denum  compounds  used  Induced   similar  adverse  effects   at   similar   doses
expressed as molybdenum element.
    Effects  attributed  to  subchronlc  Inhalation  and  oral  exposure  to
molybdenum  are mortality  and  reduced  survival   (RV =10),  weight  loss  or
depressed  body weight  gain  (RV =4),  anemia  (RV -5) and  skeletal  deformi-
ties  In  ttie  young  (RV =9)   (ArMngton and  Davles,  1953;  Lallch  et  al.,
1965; Nellands  et  al.,  1948; Robinson  et  al.,  1969).  However, the  Impair-
ment of  reproductive  performance 1n mice  and  rats (see Table 9-1)  provided
what proved  to  be the  most sensitive  endpolnt,  based  on  estimated  human
equivalent. doses  calculated for   these  effects  (Jeter   and  Davis,   1954;
Schroeder and MHchener, 1971).
    Composite  scores and their corresponding RQs are calculated In  Table 9-2
for  the effects  Identified  1n   Table  9-1.   Data  selected  for  Inclusion  1n
Table 9-2 Include  the lowest human  equivalent dose associated with  mortality
as well as lower human  equivalent doses associated with less  severe effects.
Accordingly, mortality  In the guinea pig Inhalation study by  Falrhall  et al.
(1945)   and  mortality  In offspring  of  mice  In  a 3-generat1on drinking water
study In  rats  (Schroeder and MHchener, 1971) were selected for  Inclusion In
Table 9-2.   Because the Falrhall et al. (1945) Inhalation study has  several

0186d                               -65-                             05/31/89

-------
                                                                              TABU 9-1
0
CO
Q-
Route
Inhalation
Inhalation
Inhalation
i
Cf
i
Inhalation
Oral
Oral
Oral
Oral
(gavage)
Oral
(gavage)
o
v! Oral


Species/
Strain
human
guinea
plg/NR
guinea
plg/NR
mice/
B6C3F1
rat/NR
rat/NR
rat/NR
guinea
plg/NR
guinea
plg/NR
rabbit/
Dutch


Sex/Number
H/25
M/51
M/24
both sexes/
20 total
M/B
M/10
M/B
M/B
M/B
both sexes/
7 total


Average
Body
Weight
70b
0.84°
0.84°
0.03°
0.09d
0.129d
O.ld
0.46d
0.29d
1.1-


Compound/Purity/
Vehicle
Mo oxIdes/NR/dust
Mo03/NR/dust
CaMo04/NR/dust
Mo03/NR/dust
Mo03/NR/food
CaHo04/NR/food
(NH4)?Mo04/
NR/food
CaMo04/NR/ 10X
gum arable
Mo03/NR/10X gum
arable
Na 3X004 -2H20/NR/
diet


Exposure
occupational.
9.47 mg Mo/m*
200 mg mo/m*.
1 hour/day,
5 days/week
for 5 weeks
155 mg Mo/m>.
1 hour/day,
S days/week
for 5 weeks
67 mg Ho/m».
6 hours/day.
S days/week
for 13 weeks
111 mg/kg/day
for 120 days
70 mg/kg/day
for 137 days
100 mg/kg/day
for 232 days
53 mg/kg/day
for 95 days
85 mg/kg/day
for 99 days
0.1JC Mo In diet
for 13 weeks


Transformed
Animal Dose
(mg/kg/day)
NA
2.83C
15. 5<
IIId
70d
100d
53
85
49*


Equivalent
Human Dose9
(mg/kg/day)
0.64C
0.65
0.5
0.12
12.1
8.6
11.3
9.9
13.7
12.3


Response
Altered serum
ceruloplasmln.
uric acid and
urinary uric acid/
creatlnlne ratios
Respiratory Irri-
tation, weight
loss, diarrhea,
liver and kidney
changes, mortality
Mortality
No effects observed
Mortality
Mortality
Mortality
Mortality
Mortality
Anemia; weight
loss; alopecia;


Reference
Ualravens
et al.. 1979
Falrhall
et al.. 1945
Falrhall
et al.. 1945
NTP. 1983
Falrhall
et al.. 1945
Falrhall
et al., 1945
Falrhall
et al.. 1945
Falrhall
et al.. 1945
Falrhall
et al.. 1945
Arrlngton and
Davis. 1953
CD
ID
front leg abnor-
malities

-------
                                                                            TABlf
(cont.)
o
03
o.
Route
Oral
Oral
Oral
Oral
Oral
i
T* Oral
Oral
Species/
Strain
rabbit/
Dutch
rabbit/
NR
rat/
Sprague-
Oawley
rat/
Sprague-
Dawley
rat/
Sprague-
Daw'ley
mice/CD
rat/long-
Evans
Sex/Number
both sexes/
B total
NR/12
M/7 |
both sexes/
14 total
H/4
both sexes/
5 pairs
both sexes/ .
4 pairs
Average
Body
Weight
3.8°
O.ld
0.35°
0.1d
0.03°
0.35°
Compound/Purity/
Vehicle
Na?Mo04-2H20/NR/
diet
NapMo04/NR/d1et
Na?Mo04/NR/d1et
Na2Mo04/NR/
drinking water
Na2Mo04>2H20/NR/
diet
unspecified
soluble salt/NR/
drinking water
Na2Ho04*2H20/NR
) '
Transformed
Exposure Animal Dose
(mg/kg/day)
0.2X Ho In diet 9B«
for 17 weeks
0.4X Na?Ho04 91e
In diet for 42
days
0.1X Na2Mo04 23e
In diet for 6
weeks
10 ppm Ho In 1.4'
water for 5-12
months
400 ppm Ho In 20*
diet for 6
weeks
10 ppm Ho In 1.9'
water for 6
months
20 ppm Ho In le
food for -90
days
Equivalent
Human Dose8
(mg/kg/day)
24.5
34.5
2.6
0.24
2.3
0.14
0.17
Response
Mortality
Anemia; mortality
Eecreased weight
gain; skeletal
deformities
Reduced adapta-
bility to cold
temperature
Decreased weight
gain
Early death of
offspring In Fj
generation
Decreased weight
gain; Impaired
lactation (reduced
weaning weight)
Reference
Arrlngton and
Davis. 1953
Robinson
et al.. 1969
lallch et al..
1965
Winston et al..
1973
Nellands
et at.. 1948
Schroeder and
HUchener, 1971
Jeter and
Davis. 1954
      'Calculated by multiplying the animal  dose  expressed as mg/kg/day molybdenum by the cube root of  the  ratio  of  the animal body weight  to  the  reference body
       weight for a 70 kg human

      ••Reference body weight  from U.S.  EPA  (1980,  1986b)

      'Calculated by expanding to continuous  exposure,  multiplying  by  the  reference  Inhalation rate and dividing by the reference body weight  for the species

      dEst1mated from data provided by  the  Investigators

0    'Based on reference food factors  from U.S. EPA (I960,  19B6b)
-~j
J^J    'Calculated by assuming a  dally water consumption of  0.049  t  for  rats  and  0.0057  i  for mice  (U.S. EPA,  19B6b)
C7»
x,
CD
IO

-------
o


CO
 CD
 I
                                                                            TABLE 9-2


                                                             Compos tie  Scores  for Molybdenum Compounds
Route

Inhalation
.
Oral/water

Oral/diet


Species Compound Animal Dose
(mg/kg/day)

guinea pig CaMoO^ 2.2

mice ' unspecified 1.9
soluble salt
rat Na2Mo04.2H20 ,


Chronic
Human HEO* RV,j Effect RVe CS
(rng/day)

35 3.2 Mortality 10 32

9.8 4 Mortality In offspring 10 40

11.9 3.9 Impaired lactation In 8 31.2
females (reduced wean-
Ing weight of offspring)
RQ Reference
t
100 Falrhall
et al., 1945
100 Schroeder and
Mltchener. 1971
100 Jeter and
Davis. 1954

          'Calculated by multiplying  the human equivalent dose by TO kg to present the MEO In terms of mg/day for a 70 kg human
 o
 in
 CD
 U)

-------
deficiencies, the results must be Interpreted with caution.  The  guinea  pigs
were exposed to the test chemical 1 hour/day, 5 days/week  for  5 weeks.   This
exposure  schedule  models  Intermittent  acute exposure  rather than  a  truly
subchronic  exposure  protocol.   Furthermore,  the  Investigators  provided  no
Information regarding the number  of  exposures  that  caused death.
    In  the  derivation  of  the  CSs  for  these  effects,  an uncertainty  factor
was not applied to expand  from subchronic to  chronic exposure.  As discussed
In  Section  8.2.2.2.,  H  does  not  appear  to be  necessary  to  expand  from
subchronic to chronic exposure because Mo 1s  a nutritionally essential  trace
element.
    From  the  three studies  presented In Table  9-2. -the  higher CS  of  40.
which  corresponds  to  an  RQ  of 100,  1s  chosen  to  represent  the  hazard
associated with chronic exposure  to  molybdenum compounds  (Table 9-3).
9.2.   BASED ON CARCINOGENICITY
    Limited cardnogenlcHy data, summarized  In Section 6.2., consist  of  the
study  by  Luo  et  al.  (1983)  In  which  the   Investigators  examined   the
co-carcinogenic properties of molybdenum and  N-n1trososarcos1ne.  As part of
the experimental  series,  one group of  Sprague-Dawley  rats  was given  20  ppm
of  molybdenum  (2.8 mg  Mo/kg/day)  In  the drinking water for  <30 weeks.  In
this group,  no  tumors  were  found 1n  the  esophagus or  forestomach, the  only
organs examined.  Moreover, molybdenum  Inhibited the formation of esophageal
and  forestomach  tumors  Induced  by  NSEE.    Molybdenum  did  not  alter   the
carcinogenic potency of  MBO  (Bogden et al.,  1986),  but repeated  Intraperl-
toneal  Injections  of  3167 mg Mo/kg  In mice Increased  the number  of  lung
tumors/mouse In  the  Strain A mouse lung  tumor  assay (Stoner et al.,  1976).
Data  regarding  cardnogenlcHy  In  humans  were  lacking, and molybdenum  was
classified  In  EPA  Group D:  not  classifiable as  to  human  cardnogenlcHy.


0186d                               -69-                             07/26/89

-------
                                  TABLE 9-3
                                  Molybdenum
           Minimum Effective  Dose  (MED) and Reportable Quantity  (RQ)


Route:                  oral/drinking water
Species/Sex:            rats/both
Dose*:                  11.9 mg/day
Duration:               90 days
Effect:                 decreased weight  gain;  Impaired  lactation 1n females
                        (reduced weaning  weight)
RVd:                    3.9
RVe:                    8
                                  /
CS:                     31.2
RQ:                     100
Reference:              Jeter and Davis,  1954
*Equ1valent human dose
0186d                               -70-                             05/31/89

-------
Hazard ranking  Js  not possible  for  EPA Group D  chemicals,  hence a  cancer-
based RQ cannot be  derived.
0186d                               -71-                             05/31/89

-------
                                10.   REFERENCES

Abbott,  O.J.   1977.   The toxUHy of  ammonium  molybdate to  marine  Inverte-
brates.  Mar. Pollut. Bull.  8(9): 204-205.

ACGIH  (American  Conference  of  Governmental  Industral  Hyg1en1sts).   1986.
Documentation of  the Threshold  Limit Values and  Biological  Exposure  Indices,
5th ed.  Cincinnati, OH.  p.  415.

ACGIH  (American  Conference  of  Governmental  Industral  Hyglenlsts).   1988.
Threshold  Limit  Values  and  Biological Exposure  Indices  for 1988-1989,  5th
ed.  Cincinnati. OH.  p. 28-29.

Al-Amoud1, O.A. and  M.E.  El-Naggar.   1987.  Distribution of  heavy metals  In
a species of Caulerpa from Shauba, Saudi Arabia.   Mlcroblos.   52(211):  81-86.

Arrlngton, L.R. and  G.K. Davis.  1953.   Molybdenum  toxlclty In  the  rabbH.
J. Nutr.  51: 295-304.

Bandyopadhyay, S.K., K.  Chatterjee,  R.K.  T1war1, et al.  1981.   Biochemical
studies  on  molybdenum  toxlclty  In  rats:  Effects of  high  protein  feeding.
Int. J. V1tam. Nutr.  Res.  51(4): 401-409.

Barr,  R.Q.   1981.   Molybdenum and   molybdenum alloy.    I_n:   Klrk-Othmer
Encyclopedia  of  Chemical Technology,  Vol. 15,   3rd  ed., M.  Grayson and  D.
Eckroth, Ed.  John Wiley and  Sons, Inc., New York. p.  670-682.
0186d                               -72-                             07/26/89

-------
Barry,, H.F.   198,1.   Molybdenum compounds.   In:  Klrk-Othmer Encyclopedia  of
Chemical  Technology, Vol. 13,  3rd  ed.,  H. Grayson and  D.  Eckroth,  Ed.   John
Wiley and Sons, Inc., New York.  p.  683-697.

Bell, M.C.,  E.G.  Dlggs,  R.S.  Lowrey  and  P.L.  Wright.  1964.   Comparison  of
Ho"  metabolism  In  swine and  cattle as  affected  by stable molybdenum.   J.
Nutr.  84: 367-372.

Bernard,   O.L.  and  K.W.   Roy.   1977.   Heavy  metals In  Louisiana  crayfish
Procambarus clarkll  determined  by x-ray  fluorescence analysis.   In.:  Fresh-
water Crayfish, Vol. 3, O.V.  Llndqulst,  Ed.   p.  357-361.

Blrge, W.3.   1978.  Aquatic  toxicology of  trace elements  of  coal and  fly
ash.  Doe Symp. Ser.  48:  219-240.

Blrge, W.J.,  J.A.  Black  and  A.G.  Westerman.   1979.   Evaluation  of  aquatic
pollutants  using  fish and  amphibian  eggs   as   bloassay  organisms.   Anlm.
Monlt. Environ. Pollut.  p.  108-118.

Bogden, J.D., H.R. Chung, F.W. Kemp,  K. Holding,  K.S.  Bruenlng  and Y.  Naveh.
1986.  Effect  of selenium and molybdenum on  methylbenzylnltrosamlne-lnduced
esophageal lesions  and tissue trace metals  In  the rat.  J.  Nutr.   116(12):
2432-2442.                           .              .            --

Bohn,  H.L.,  B.L. McNeal and  G.A.  O'Connor.   1985.  Soil Chemistry,  2nd  ed.
John Wiley and Sons, New York.  p.  308.
0186d                               -73-                             07/26/89

-------
Brooks,  R.R.  and M.G. Rumsby.   1965.   The blogeochemlstry  of  trace element
uptake by some New Zealand bivalves.  Llmnol. Oceanogr.  10(4): 521-527.

Bysshe,  S.E.   1988.   Uptake  by  biota.   IJK Environmental Inorganic Chemistry
Properties,   Processes  and   Estimation   Methods,   I.   Bodek,   et  a!.,  Ed.
Pergamon Press, New York.  p. 4.3-10.

Chappell, W.R., R.R.  Heglen,  R.  Houre-Eraso,  C.C.  Solomons  and T.A. Tsongas.
1979.  Human  Health Effects  of  Molybdenum 1n  Drinking  Water.  Health Effects
Research Laboratory, Cincinnati, OH._ p.  116.

Cherry,  D.S.  and R.K. Guthrle.   1978.   Mode  of elemental  dissipation from
ash basin effluent.  Hater A1r Soil Pollut.  9(4):  403-412.

Cherry,  D.S.  and  R.K.  Guthrle.   1979.   The uptake  of  chemical  elements from
coal  ash and settling  basin  effluent  by  primary producers:  2.  Relation
between  concentrations In ash deposits and tissues  of  grasses  growing on the
ash.  Scl. Total Environ.  13(1): 27-32.

Colborn, T.   1982a.   Aquatic Insects as  measures  of trace  element presence
In  water:  Cadmium  and  molybdenum.   AS1M Spec.  Tech.  Publ.  766.   Aquat.
Toxlcol. Hazard Assess.  61(2):  316-325.

Colborn, T.    1982b.  Measurement of  low levels  of  molybdenum In the environ-
ment  by using  aquatic'  Insects.   Bull.  Environ.   Contam.  Toxlcol.   29(4):
422-428.
0186d                               -74-                             07/26/89

-------
Colmano,  G.    1973.   Molybdenum  toxldty:  Abnormal  cellular  division  of
teratogenlc appearance In Euqlena gradHs.  Bull. Environ.  Contam.  Toxlcol.
9(6): 361-364.

Comar,  C.L.,  L.  Singer  and  G.K.  Davis.   1949.   Molybdenum metabolism  and
Interrelationships  with  copper  and  phosphorus.   3.  B1ol.  Chem.   180:  913-922.

Consolazlo,  C.F.,  R.A.  Nelson,  L.O.  Matoush,  R.C. Hughes  and  P.  Urone.
1964.   The  trace  mineral losses 1n  sweat.  U.S.  Army Med.  Res. Nutr.  Lab.
Report No.~284.  15 p.

Cowglll, U.M.  1974.  The hydrogeochemlstry of  Llnsley Pond, North  Branford,
Connecticut.    II.   The   chemical  composition  of  the aquatic  macrophytes.
Arch. Hydroblol.  Suppl.   45(1): 1-119.

Crockett,  P.W.,  B. Klllan,  K.S.  Crump and  R.B.  Howe.   1985.   Descriptive
methods  for  using  data  from dissimilar experiments  to  locate a  no-adverse-
toxlc-effects region In the dose-duration plane.   Prepared by  K.S.  Crump  and
Co.,  Inc.,   under  Contract   No.  68-01-6807  for Environmental  Criteria  and
Assessment Office,  U.S.  EPA,  Cincinnati, OH.

Czegeny,  I.  and  I. Daval.   1985.   Accumulation of  heavy metals In  aquatic
organisms  of  sewage  water   treatment  plants.   In:   Symposia  Blologlca.
Hungarlca, 3. Salankl/'Ed..  Vol.  29.   0{0): 105-110.

Davids,  B.E.   1980.  Applied Soil  Trace  Elements.   John  Wiley and  Sons,  New
York.  p. 176-192.


0186d                               -75-                              07/26/89

-------
 De  GoelJ,  3.M.,  V.P.  Gulnn,   D.R.  Young and  A.J. Hearns.   1973.   Neutron
 activation  analysis  trace  element  studies  of dover  sole liver  and marine
 sediments.   1%:  Int.  Atomic  Energy Agency  Proceedings  Series.  Comparative
 Studies  of  Food  and Environmental Contaminations, Otan1em1, Finland, August,
 1973.  623  p.

 Dorfman,  D.  1977.   Tolerance  of Fundulus  heteroclltus  to different metals
 In salt waters.  Bull. NO Acad. Scl.  22(2): 21-23.

 Dreesen,  D.R.  and  E.J.  Cokal.   1984r   Plant uptake assay to  determine b1o-
 avallablllty  of  Inorganic   contaminants.    Water  Air  Soil Pollut.   22(1):
 85-94.

 Ourkln,  P.  and W.  Heylan.   1988.   User's  guide  for  D2PLOT:   A  program for
 dose/duration  graphs.   Prepared  by  Chemical  Hazard  Assessment  Division,
 Syracuse  Research   Corp. under  Contract  No.  68-C8-0004  for  Environmental
 Criteria and Assessment Office, U.S. EPA. Cincinnati. OH.
                                  /
 Ellis.  B.G.,  B.D.  Knezek   and  L.U.   Jacobs.   1983.   Leaching  of  micro-
 nutrients.   lt±:  Soil  Science  Society  of  America.   Chemical  Mobility  and
 Reactivity  In Soil Systems.  SSSA Special  Publ. No. 11.   American Society of
 Agronomy and Soil  Science Society of America, HAdlson,  WI.

 Engel, R.W.,  N.O.  Price and  R.F. Miller.   1967.   Copper, maganese,  cobolt
 and molybdenum balance 1n pre-adolescent girls.  J. Nutr.  92:  197-204.
0186d                               -76-                             02/05/90

-------
Evans, E.G., G.F. Evans, O.B. Ray et al.   1984.   A1r  quality data for  metals
1977-1979  from  the National  Air  Surveillance Networks.   EPA-600/S4-83-053.
Off.  Res.  Devel.  Environ.  Honlt.  Systems  Lab.,  Research Triangle Park,  NC.
p. 3.

Falrhall,  L.T.,  R.C.  Dunn, N.E.  Sharpless and  E.A.  Prltchard.   1945.   The
toxUHy of molybdenum.   Pub.  Health Bull.  No.  293.  36  p.

Fell,  B.F.,  0.  Dlnsdale and  T.T.  El-Gallad.  1979.   Gut  pathology of  rats
dosed with tetrathlomolybdate.  3.  Comp.  Pathol.   89(4):  495-514.

Ferm,  V.H.   1972.   The  teratogenlc effects  of metals on mammalian  embryos.
Adv. Teratol.  5: 51-75.

Franke,  K.W.  and   A.L.  Moxon.   1937.   The  toxlclty  of  orally   Ingested
arsenic, selenium,  tellurium,  vanadium and  molybdenum.   J. Pharmacol.  Exp.
Ther.  61:  89-102.

Freltas, M.C., M.C. Vaz  Carrelro,  M.F.  Rels and  E. Mar\1nho.  1988.   Deter-
mination of  the  level   of  some  heavy metals   In  an aquatic  ecosystem  by
Instrumental  neutron  activation  analysis.   Environ.  Technol  Lett.  9(9):
969-976.

Goetz, L.   1983.   Radlochemlcal techniques applied  to laboratory studies  of
water  leaching  of  heavy metals  from  coal  fly  ash.  Water  Scl.   Technol.
15(11): 25-47.
0186d                               -77-                             02/05/90

-------
 Goyer,  R.A..  1986.   Toxic effects  of metals.   In:  Casarett  and Douglas,
 Toxicology,  3rd ed.  p. 582, 615-616.

 HJelmar,  0.   1983.   Marine  disposal  of fly ash from coal-fired power plants.
 Water Scl. Techno!.  15(11): 109-131.

 Hunt, C.E. and  3.M.  Navla.   1973.   Effects of Sr, Mo, L1 and B on developing
 teeth and other  tissues  of  neonatal  rats.   Trace Substances In Environmental
 Health VI.   p. 159-168.

 Jeter,  M.A.  and G.K.  Davis.   1954.   The  effect of dietary  molybdenum upon
 growth,   hemoglobin,  reproduction  and lactation  of  rats.   J.  Nutr.   54:
 215-220.

 Kanematsu,  N.,  M.  Hara  and  T.  Kada.   1980.   Rec  assay and  mutagenlclty
 studies on metal compounds.  Mutat. Res.  77(2): 109-116.

 Kennedy,  P.C.   1986.   The  use of  mollusks for monitoring  trace  elements  1n
 the  marine  environment  In  New  Zealand  1.   The  contribution  of  Ingested
 sediments  to  the  trace element concentrations In New  Zealand  mollusks.   New
 Zealand 3. Mar.  Freshwater Res.  20(4): 627-640.

 Kovacs,  M.,  1.  Nyary and L.  Toth.   1984.   The microelement content of  some
 submerged and floatlng..aquatic plants.  Acta Bot.  Hung.  30(1-2):  173-185.
                      «..»                                                   . •

 Lallch,  J.J., K. Groupner  and  J.  Jolln.  1965.  The Influence of copper  and
molybdate salts  on the production of  bony  deformities  In rats.   Lab.  Invest.
                        >             r*
14(8):  1482-1493.

0186d                               -78-                            02/05/90

-------
Lantzy,  R.J.  and F.T.  Mackenzie.   1979.  Atmospheric  trace metals:  Global
cycles  and  assessments  of man's  Impact.   Geochlm.  Cosmochlm.  Acta.   43:
511-525.

Lener, J. and  B.  Blbr.   1979.   Biliary excretion and tissue  distribution of
penta- and hexavalent molybdenum 1n rats.  Toxlcol. Appl.  Pharmacol.   51(2):
259-263.

Lener,  J.  and B.  Blbr.    1984.   Effects  of  molybdenum on  the  organism  (a
review).  J.  Hyg. Epidemic!. Mlcroblol.  Immunol.   28(4):  405-419.

Lindsay, W.I.  1979.   Chemical Equilibria  In Soils.    John  Wiley and  Sons,
New York.  p.  365-372.

Luo, X.H., H.3.  We1  and  S.P.  Yang.  1983.  Inhibitory  effects of  molybdenum
on esophageal  and forestomach  cardnogenesls  1n rats.   0.  Natl. Cancer  Inst.
71(1): 75-80.

Mantel,  N.  and   M.A.  Schnelderman.   1975.   Estimating  "safe"   levels,  a
hazardous undertaking.   Cancer  Res.   35:  1379-1386.

M1ller-Ihl1,   N.J.  and  W.R.   Wolf.   1986.   Characterization  of  a   diet
reference material for  17 elements!   Anal.  Chem.   58:  3225-3230.

Mogllvskaya,  O.Y.  1950.   No  title given.  Gig.  SanH.  12: 18.  (Cited  1n
ACGIH, 1986)
0186d                               -79-                             02/05/90

-------
 Morgan,   J.D.,  D.G.  Mitchell  and  P.M.  Chapman.   1986.   Individual  and
 combined  toxldty  of  manganese  and  molybdenum  to  mussel,  Mytllus  edulls.
 larvae.   Bull. Environ. Contam. Toxlcol.  37: 303-307.

 NAS  (National  Academy  of  Sciences).   1980.   Recommended  Dally  Allowances,
 9th  ed.   Food  and  Nutrition  Board,  National  Academy  of  Sciences,  Washington,
 DC.   (Cited 1n Solomons, 1984}

 Nellands,  3.B.,  F.M.  Strong and C.A.  Elvehjen.  1948.   Molybdenum  In  the
 nutrition of the rat.  J. B1ol. Chem.  172: 431-439.

 NRC  (National  Research Council).   1978.   Nutrient requirements  of  domestic
 animals.   Nutrient  Requirements  of  Laboratory  Animals,  3rd ed.   National
 Academy of Science,'Washington, DC.   p. 17, 41,  45.

 NMagu,  J.O.  and   J.M.  Pacyna.   1988.   Quantitative  assessment of worldwide
 contamination  of   air,  water  and  soils  by trace  metals.   Nature.   333:
 134-139.

 NTP  (National  Toxicology  Program).   1983.   Subchronlc  Inhalation  toxldty
 studies of molybdenum trloxlde.  Unpublished.  Research Triangle Park,  NC.

 Ohlendorf,  H.M.,    D.J.  Hoffman,   M.K.  Salkl   and   T.W.  Aldrlch.    1986.
 Embryonic mortality  and  abnormalities  of aquatic birds:  Apparent Impacts of
 selenium from Irrigation dralnwater.   Sd.  Total  Environ.   52(1-2): 49-63.
0186d                               -80-                            02/05/90

-------
Ohlendorf,  H.M.,   R.L.   Hothem,  T.W.  Aldrlch  and  A.J.  Krynltsky.   1987.
Selenium contamination of the grasslands, a major  California  waterfowl  area.
Sc1. Total Environ.  66:  169-183.

Olmez,  I.,  A.E.   Sheffield,  G.E.   Gordon  et  al.   1988.   Compositions  of
particles  from selected  sources  In  Philadelphia for  receptor  modeling appli-
cations.  J. Air  Pollut.  Control  Assoc.   38:  1392-1402.

OSHA  (Occupational  Safety and Health  Administration).   1989.   Occupational
Standards.    Permissible  Exposure   Limits.    29CFR   1910.1000.    Federal
Register.  54(12):  1596,  1945.

Parlsl, E., G. Fornerls  and V. Glaccone.  1986.  Freshwater  fish as  biologi-
cal  Indicators of  heavy metal pollution.   Ind.  Aliment.  (Plnerolo,  Italy).
25(3): 214-218.

Rana,  S.V.S.  and  A.  Kumar.   1980a.  Enzymologlcal  studies  on  the  liver  of
rats fed with molybdenum and  copper.  Toxlcol.  Lett.   6:  163-166.

Rana,  S.V.S.  and A.  Kumar.   1980b.   Proteins,  I1p1ds,  and carbohydrates  In
the  liver  and kidney of rats after molybdenum and copper treatment.   Bull.
Environ. Contam.  Toxlcol.  25(1): 146-152.
                                                                     '    , i"
Rana,  S.V.S.,  A.  Kumar,  N.G. Bhardwaj  and  A. Kumar.   1980.   Llplds In  the
liver  and  kidney  of  rats  fed various  heavy metals.   Acta.  Anat.   108(3):
402-412.
0186d                               -81-                             02/05/90

-------
 Rawlence,  D.3.  and  3.S.  WhUton.  1976.   An element  survey  of  the aquatic
 macrophytes,  water and plankton  from the  Walkato River, North  Island, New
                                                         •
 Zealand.  Mauri Ora.  4: 121-131.

 Robinson,  G.A.,  V.E.  ValU,  B.J.  McSherry and  A.M.  Peplno.   1969.   The
 survival  of  DF32 P-labelled erythrocytes In  molybdate-fed  rabbits.   Can. J.
 Physio!. Pharmacol.  47(4): 343-347.

 Rodgers,  J.H.,  Jr., D.S.  Cherry, R.L.  Graney,  K.L.  Dlckson  and  J. Cairns,
 Jr.   1980.   Comparison  of heavy  metal  Interactions In  acute  and  artificial
 stream   bloassy   techniques   for   the  Asiatic   clam   (Corblcula   flumlnea).
 Aquatic Toxlcol.  ZSTM STP. 707.  p. 266-280.

 Rosoff,  B.  and H.  Spencer.   1964.   Fate  of molybdenum-99  In man.   Nature.
 202: 410-411.

 Rosoff,  B.  and  H. Spencer.   1973.    The   distribution  and  excretion  of
 molybdenum-99 1n mice.   Health Physics.  25(2):  173-175.

 Rossman,  T.G.  and  M.  Molina.    1986.   The  genetic  toxicology  of  metal
 compounds:  II.  Enhancement  of  ultraviolet  light-Induced   mutagenesls  In
 Escherlchla coll WP2.  Environ. Mutagen.   8(2):  263-271.

 Rossman, T.G.,  M.  Molina  and  L.W.  Meyer.   1984.  The  genetic toxicology of
metal compounds:  I.  Induction of  lambda prophage  1n  E_. coll  WP2S  (Lambda).
Environ. Mutag.   6(1):  59-69.
0186d                               -82-                             02/05/90

-------
Salkl, U.K.  and. T.W. May.   1988.   Trace  element  residues 1n bluegllls  and
common  carp  from  the  lower  San  Joaquln River,  California  (USA)  and  Us
tributaries.   Scl.  Total Environ.   74(0):  199-218.

Sakaguchl, 7., A.  NakaJIma  and  T.  Horlkoshl.  1981.  Studies  on  the  accumu-
lation of  heavy  metal  elements  In  biological systems.  XVIII.  Accumulation
of  molybdenum  by  green mlcroalgae.   Eur. 0.  Appl.  M1crob1ol.  Blotechnol.
12(2): 84-89.

Schroeder, H.A. and M.  HUchener.  1971.   Toxic effects of  trace  elements on
the reproduction  of mice and rats.   Arch.  Environ.  Health.   23: 102-106.

Solomons,  N.W.  1984.   The  other  trace  minerals  manganese,   molybdenum,
vanadium, nickel  silicon and  arsenic.   In: Current Topics  1n  Nutrition  and
Disease.   Absorption  and  Malabsorptlon of Mineral  Nutrients,  Vol. 12,  N.W.
Solomons and  I.H. Rosenberg, Ed.   Alan  R.  L1ss,  Inc.,  New  York.  314 p.

Spence, J.A., N.F.  Suttle,  G. Wenham, T.  El-Gallad  and  I.  Bremner.  1980. A
sequential study  of the skeletal abnormalities which  develop In  rats  given a
small  dietary  supplement  of  ammonium  tetrathlomolybdate.   3.  Comp.  Pathol.
90(1): 139-153.

SRI  (Stanford  Research  Institute).    1988.    1987  Directory  of  Chemical
Producers: United  States of  America.    SRI   International,  Menlo Park,  CA.
p. 460, 789-790,  950.
0186d                               -83-                             02/05/90

-------
 Stoner,  G.D.,  H.B.  Shlmkln,  M.C.  Troxell,  T.L.  Thompson  and L.S.  Terry.
 1976.  Test  for  cardnogenlclty  of  metallic compounds  by the pulmonary tumor
 response 1n  strain A mice.  Cancer Res.  36(5): 1744-1747.

 Suloway,  J.J.,  W.R.  Roy,  l.H.  Skelly,  D.R.  Dlckerson  and R.H.  Schuller.
 1983.   Chemical  and  lexicological  properties  of  coal  fly  ash.   Report
 IL/SGS/EGN-105.  NTIS PB84-116110.  77 p.

 Sutherland,  J. and  C.W.  Major.  1981.   Internal  heavy  metal  changes as  a
 consequence  of  exposure  of Hytllus  edulls.  the  blue  mussel,  to  elevated-
 external  copper(II)   levels.   Comp.  Blochem.  Physlol.  C.  Comp.  Pharmacol.
 68(1): 63-68.

 Talbot, V. and H.J.  Chang.   1987.   Rapid multielement  analysis  of  oyster  and
 cockle  tissue  using x-ray  fluorescene  spectrometry, with  application  to
 reconnaissance  marine pollution  Investigations.   Sc1.  Total  Environ.   66:
 213-223.

 Thompson,  J.A.J.,  M.D.  Nasslchuk,  D.U.  Paton.  B.J.   Rein and  H.A  Farrell.
 1986.  Examination of tissue metal  burdens  and metal-binding protein  In  the
 golden king  carb (LUhodes  aequlsplna Benedict) from  AUc  Arm and  Hastings
 Arm, British  Columbia,  Canada.  Can. Tech.  Rep. F1sh  Aquat. Sc1.   0(1440):
 1-44.

Tong, S.C., W.D. Youngs,  W.H.  Gutenmann  and 0.3. L1sk.   1974.  Trace  metals
 In  Lake  Cayuga lake  trout  (Salvenllnus  namaycush)  In  relation  to age.  J.
 Fish Res.  Board Can.   31(2):  238-239.


0186d                               -84-                             02/05/90

-------
Underwood, E.J.  1977.  4V Molybdenum toxldty.  ITK Trace  Elements  In  Human
and Animal Nutrition, 4th ed.   Academic  Press,  New  York,  NY.  p.  120-131.

USDI  (U.S.  Department of  Interior).   1988.   Molybdenum.   Reprint  From  the
1987  Bureau  of Mines Minerals  Yearbook.   U.S.  Department  of the  Interior,
Bureau of Mines, Washington,  DC.

U.S.  EPA.   1973.   National  Emissions  Inventory  of  Sources  and  Emissions  of
Molybdenum.  GCA Technology  D1v.,  GCA  Corp.,  Bedford, Mass.   36 p.

U.S.  EPA.   1980.   Guidelines  and  Methodology  Used  In   the  Preparation  of
Health  Effect  Assessment  Chapters  of   the  Consent  Decree  Water  Criteria
Documents.  Federal Register.   45(231):  79347-79357.

U.S.  EPA.  1984.   Methodology  and  Guidelines for Ranking Chemicals  Based  on
Chronic Toxldty Data.   Prepared  by the  Office  of Health  and Environmental
Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH  for
the Office of Emergency  and  Remedial Response,  Washington, DC.

U.S.  EPA.   1986a.   Guidelines for  Carcinogenic  Risk  Assessment.   Federal
Register.  51(185): 33992-34003.

U.S.  EPA.   1986b.   Reference  Values  for  Risk Assessment.   Prepared by  the
Office  of  Health  and"Environmental  Assessment, Environmental  Criteria  and
Assessment Office,  Cincinnati,  OH for  the Office of Solid Waste, Washington,
DC.
0186d                               -85-                             02/05/90

-------
U.S.  EPA/OWRS (Office  of Water  Regulations  and Standards).   1986.   Guide-
lines  for  Deriving  Numerical  National  Water  Quality Criteria for the Protec-
tion   of  Aquatic  Organisms  and  Their   Uses.   U.S.  EPA,  Washington,  DC.
p. 22-58, 98.  NTIS PB85-227049/XAB.

Van  Campen,  D.R.   and  E.A.  Mitchell.   1965.   Absorption  of  Cr64,  Zn«s,
Mo"  and  Fes»  from  Ugated  segments of  rat   gastrointestinal  tract.   J.
Nutr.  86: 120-124.

Walravens,  P.A.,  R.  Moure-Eraso,  C.C.   Solomons,  W.R.  Chappell  and  G.
Bentley.   1979.   Biochemical  abnormalities 1n workers exposed  to  molybdenum
dust.  Arch. Environ. Health.  34(5): 302-308.

Weast,  R.C.,  Ed.   1985.   CRC  Handbook  of Chemistry  and Physics, 66th  ed.
CRC Press, Inc.,  Boca Raton, FL.  p. B-72, B-116-117, B-144,  D-194.

Mel.  H.J.,  X.M.   Luo  and  S.P.  Yang.   1985.   Effects  of  molybdenum  and
tungsten  on  mammary  cardnogenesls   In  SD  rats.   J.  Natl.  Cancer  Inst.
74(2): 469-473.

Wide,  M.   1984.  Effect  of  short-term exposure  to  five  Industrial  metals  on
the  embryonic  and  fetal  development  of  the mouse.   Environ.  Res.   33(1):
47-53.
  i,                        *               .                             *
Hldjajakusuma, M.C., P.K. Basrur and G.A.  Robinson.  1973.   Thyroid  function
In molybdenotlc rabbits.   J.  Endocrlnol.   57(3):  419-424.
0186d                               -86-                            02/05/90

-------
Wlersema, 3.M.,  L.  Wright,  B. Rogers,  R.  Barta,  L. Haeuser and  3.H.  Price.
1984.  Human  exposure  to potentially toxic  elements  through ambient  air  1n
Texas.   .In.:   Proc.  77th  APCA Annual  Meeting, Austin,  TX,  January,  1984.
p. 15.

Winston,  P.W.,  L.  Hoffman  and W.  Smith.   1973.    Increased  weight loss  In
molybdenum-treated  rats  1n  the  cold.   Trace  Sub.  Environ.  Health.   7:
241-244.

W1tz,  S.,  J.A.  Wood  and M.W.  Wadley.   1986.  Toxic  metal and  hydrocarbon
concentrations  1n  automobile  Interiors  during freeway  transit.   J.TK  Proc.
192nd National Meeting ACS Dlv. Environ. Chem.  26:  302-305.

Wren, C.O., H.R.  Maccrlommon  and  B.R.  Loescher.  1983.  Examination of bio-
accumulation  and blomagnlflcatlon of  metals  In a  Precambrlan Shield  lake.
Water Air Soil Pollut.   19(3): 277-291.

Yamamoto, T.,  Y. Otsuka, K.  Aoyama,  H. Tabata and K. Okamoto.   1985.   The
distribution  of  chemical  elements In selected marine  organisms:  Comparative
blogeochemlcal data.   In: Proc.  Symp.  Mar. Estauarlne Geochem, Chelsea,  MI,
1984.  p. 315-327.

Zellkoff, J.T.,  N.  Atkins and T.G.  Rossman.-. 1986.  Mutagenldty  of  soluble
metal  salts   using  the  V-79   hypoxanthlne-guanlne  phosphorlbosyltransferase
mutation assay.  Environ. Mutagen.  8(6):  95.        -                  ,•=.:.
0186d                               -87-                             02/05/90

-------
                                  APPENDIX A

                              LITERATURE SEARCHED



    This  HEED  1s  based  on  data  Identified  by  computerized  literature

searches of the following:

              CHEMLINE
              TSCATS
              CASR online (U.S. EPA Chemical Activities  Status  Report)
              TOXLINE
              TOXLIT
              TOXLIT 65
              RTECS
              OHM TADS
              STORET
              SRC Environmental Fate Data  Bases
              SANSS
              AQUIRE
              TSCAPP
              NTIS
              Federal Register
              CAS ONLINE (Chemistry and Aquatic)
              HSDB
              SCISEARCH
              Federal Research In Progress


These,  searches  were  conducted  In  Hay,   1988,  and  the following  secondary

sources were reviewed:
                                  /

    ACGIH  (American  Conference of  Governmental  Industrial  Hyglenlsts).
    1986.   Documentation  of the  Threshold  Limit Values and  Biological
    Exposure Indices, 5th ed.  Cincinnati, OH.

    ACGIH  (American  Conference of  Governmental  Industrial  Hyglenlsts).
    1987.   TLVs:  Threshold  Limit Values  for Chemical Substances  In  the
    Work  Environment  adopted   by   ACGIH   with   Intended   Changes   for
    1987-1988.  Cincinnati,  OH.  114 p.

  -  Clayton,  G.D.  and  F.E.  Clayton,  Ed.   1981.   Patty's  Industrial
    Hygiene and  Toxlco.logy,  3rd rev.  ed., Vol.  2A.    John  Wiley  and
    Sons, NY.   2878 p. ,

    Clayton,  G.D.  and  F.E.  Clayton,  Ed.   1981.   Patty's  Industrial
    Hygiene and  Toxicology,  3rd rev.  ed., Vol.  2B.    Oohn  WHey  and
    Sons, NY.   p. 2879-3816.
0186d                               -88-                             05/31/89

-------
    Clayton,  G.D.  and  F.E.  Clayton,  Ed.   1982.   Patty's   Industrial
    Hygiene  and  Toxicology,  3rd  rev.  ed.,  Vol.  2C.   John  Wiley and
    Sons,  NY.   p.  3817-5112.

    Grayson,  M. and  D.  Eckroth,  Ed.   1978-1984.  Klrk-Othmer  Encyclo-
    pedia  of  Chemical  Technology,  3rd ed.  John Wiley and Sons,  NY.   23
    Volumes.

    Hamilton,  A.  and H.L.  Hardy.  1974.  Industrial Toxicology,  3rd ed.
    Publishing  Sciences  Group, Inc.,  Littleton, MA.  575 p.

    IARC   (International  Agency for  Research  on Cancer).   IARC  Mono-
    graphs on  the  Evaluation  of Carcinogenic  Risk  of  Chemicals   to
    Humans.   IARC,  WHO,  Lyons, France.

    Jaber, H.M.,  W.R.  Mabey,  A.T.  L1eu, T.W.  Chou and  H.L.  Johnson.
    1984.    Data  acquisition  for  environmental  transport  and  fate
    screening for compounds  of  Interest  to  the  Office  of Solid Waste.
    EPA 600/6-84-010.   NTIS  PB84-243906.   SRI   International,   Menlo
    Park,  CA.

    NTP (National Toxicology  Program).   1987.   Toxicology Research and
    Testing   Program.    Chemicals   on  Standard  Protocol.    Management
    Status.

    Ouellette,  R.P.  and  J.A.  King.   1977.   Chemical  Week Pesticide
    Register.   McGraw-Hill  Book  Co.,  NY.

    Sax,  I.N.  1984.  Dangerous Properties of  Industrial  Materials, 6th
    ed. Van  Nostrand  Relnhold Co., NY.

    SRI (Stanford  Research  Institute).   1987.   Directory  of  Chemical
    Producers.   Menlo  Park,  CA.

    U.S.   EPA.   1986.   Report  on  Status  Report  In  the  Special Review
    Program,   Registration   Standards   Program  and   the   Data  Call   In
    Programs.   Registration  Standards  and  the Data Call  1n Programs.
    Office of Pesticide  Programs,  Washington, DC.

    USITC   (U.S.   International  Trade  Commission).    1986.   Synthetic
    Organic  Chemicals.  U.S. Production  and Sales, 1985,  USITC  Publ.
    1892,  Washington,  DC.

    Verschueren,  K.   1983.   Handbook of  Environmental  Data  on  Organic
    Chemicals,  2nd ed.   Van Nostrand  Relnhold Co.,  NY.

    Wlndholz,  M.t  Ed.  "'1983.  The Merck  Index, 10th ed.   Merck  and Co.,
    'Inc.,  Rahway,  NO.

    Worthing,  C.R.  and  S.B.  Walker, Ed.   1983.   The Pesticide  Manual.
    British  Crop Protection Council.  695 p.
0186d                               -89-                             05/31/89

-------
    In  addition,  approximately 30  compendia  of aquatic  toxldty data  were

reviewed, Including the following:


    Battelle's  Columbus  Laboratories.   1971.   Water  Quality  Criteria
    Data  Book.   Volume  3.  Effects   of  Chemicals   on   Aquatic   Life.
    Selected  Data  from the Literature  through  1968.   Prepared for  the
    U.S. EPA under Contract No. 68-01-0007.  Washington,  DC.

    Johnson,  W.W.  and H.T. Flnley.   1980.  Handbook  of Acute  Toxldty
    of  Chemicals  to  Fish and  Aquatic  Invertebrates.   Summaries   of
    Toxldty  Tests  Conducted  at  Columbia  National  Fisheries  Research
    Laboratory.   1965-1978.   U.S.  Dept.  Interior,  F1sh  and  Wildlife
    Serv. Res. Publ. 137,  Washington,  DC.

    McKee. J.E. and  H.W.  Wolf.  1963.  Water  Quality Criteria, 2nd  ed.
    Prepared  for  the  Resources   Agency  of   California,  SJate   Water
    Quality Control Board.  Publ.  No.  3-A.

    Plmental, D.  1971.   Ecological Effects of  Pesticides  on  Non-Target
    Spedes.  Prepared for the U.S.  EPA, Washington. DC.   PB-269605.

    Schneider, B.A.   1979.  Toxicology  Handbook.  Mammalian and Aquatic
    Data.  Book 1: Toxicology  Data.   Office of  Pesticide  Programs, U.S.
    EPA, Washington, DC.  EPA 540/9-79-003.  NTIS PB 80-196876.
0186d                               -90-                             05/31/89

-------
APPENDIX B
o
CO
O.


r



05/31 /8<


Species
Inhalation Exposure
Subchronlc ; ID
Chronic ID
Carclnogenlclty ID
Oral Exposure
Subchronlc rat
Chronic rat
Carclnogenlclty ID
REPORTABLE QUANTITIES
Based on chronic toxlclty:
Based on Carclnogenlclty:
in - Incnfftrtont Hat*- NA .
Summary

Exposure
ID
ID
ID
1.0 mg/kg/day
1n the diet
for -90 days
1.0 mg/kg/day
In the diet
for -90 days
ID

100 pounds
ID
nnt annllrahlp
Table for Molybdenum

Effect
ID
ID
ID
Decreased weight gain;
Impaired lactation
(reduced weaning weight)
Decreased weight gain;
Impaired lactation
(reduced weaning weight)
ID








RfD or qj* Reference
ID NA
ID NA
ID NA
1x10"* mg/kg/day Jeter
Davis
1x10"" mg/kg/day Jeter
Davis
ID NA

Jeter
Davis
NA




and
, 1954
and
, 1954
. 	
and
, 1954



-------
                                  APPENDIX C
           DOSE/DURATION RESPONSE GRAPHS FOR EXPOSURE TO MOLYBDENUM
C.I.   DISCUSSION
    Dose/duration-response  graph(s)  for   Inhalation and  oral  exposure  to
molybdenum  generated  by  the  method of  Crockett  et  al.  (1985)  using  the
computer  software  by  Durkln  and Meylan  (1988)  developed  under contract  to
ECAO-C1nc1nnat1  are presented  1n  Figures  C-l  through  C-4.   Data  used  to
generate  these  graphs  are  presented 1n  Section  C.2.   In the  generation  of
these figures,  all  responses are  classified  as  adverse (PEL,  AEL  or  LOAEL)
or  nonadverse  (NOEL or NOAEL)  for  plotting.   For  Inhalation  exposure,  the
ordlnate  expresses  concentration  In either  of two ways.   In  Figure  C-l,  the
experimental  concentration  expressed  as  mg/m3  was multiplied by  the  time
parameters of  the  exposure protocol  (e.g.,  hours/day  and days/week)  and  Is
presented  as   expanded   experimental   concentration  [expanded  exp.   cone.
(mg/m3)].   In  Figure  C-2,  the  expanded  experimental  concentration  was
multiplied by  the  cube root of the  ratio of  the  animalchuman body weight  to
adjust   for   species  differences  1n  basal  metabolic   rate   (Mantel   and
Schnelderman, 1975)  to estimate an equivalent human or  scaled  concentration
[scaled cone. (mg/m3)].
    For  oral  exposure,  the  ordlnate  expresses   dosage  as human  equivalent
dose.  The animal  dosage  In mg/kg/day  Is multiplied by  the  cube  root  of  the
ratio of  the  animal:human body  weight  to adjust for species  differences  In
basal metabolic  rate  (Mantel and Schnelderman,   1975).  The  result Is  then
               _                 •               C~   ("*
multiplied by  70 kg,  the reference human body weight,   to express  the human
equivalent dose as mg/day for a 70 kg human.
0186d                               -92-                             05/31/89

-------
       iwe
                         I II

                         1
  Z
  S
        199 •-
                       --M4
                                                                  j
                                                                  J
                                                                  -I
            .81
 1 r>ihalM*)or>
                           NUMN EOUIU BUMATION (f>>««tien
                                         MT« KtTNOV
                                                                           0.1
   Key:
N . NOAEL
F » PEL
   Solid line - Adverse Effects  Boundary
   Dashed line « No Adverse  Effects Boundary
                                   FIGURE C-l
     Dose/Duration - Response  Graph  for Inhalation Exposure  to Molybdenum:
                              Censored 'Data Method
0186d
                           -93-
07/26/89

-------
        1M
 r.
 \
 I
 6
 V
                        III
12
; 5
                       -M4
        16 4
          0.01
                                                  0.1
                          NUMN taUlU BUMTION 

                                CXNSOR£» MT« NCTNO»
  Key:   N . NOAEL
         F . FEL

  Solid line - Adverse  Effects Boundary
  Dashed line - No Adverse Effects Boundary
                                   FIGURE C-2

     Dose/Duration - Response Graph  for  Inhalation Exposure to Molybdenum:
                              Censored Data Method
0186d
             -94-
07/26/89

-------
        188888
\
f
    V
    I
    9
    a
    h.
    z
    a
          ieee T
      188 '-
           18 -r
             8.881


    (Oral Exposuw)
                                                    •4M
                                             *22
                                   •*.
                                                              "
                                                               -
                                                           LI
                                              »a»-
                                                         4-
                                                                  n
                               8.81                  8.1
                          HUNAN EQUIU BUXATION (fy>«ctien lif»«>«n)
                                   ENVELOP NTTMOP
    Key:
        A  «  AEL
        L  -  LOAEL
        N  «  NOAEu
    Solid  line « Adverse Effects  Boundary
    Dashed  line « No Adverse  Effects Boundary
                                   FIGURE  C-3

        Dose/Duration  -  Response Graph for Oral  Exposure to Molybdenum:
                                 Envelope Method
0186d
                                 -95-
05/31/89

-------
1HMMH

» imee -
•
T
\
?
t
V
u 18*9-
, M
«
B
»
31 BO *
* vc
»
K
z
1 «•

I •
1 ' . 1 I .... | , .1 	 | , .,.,,,,;
Insufficient Data fop Ctntor Lin* :
.
! A22

i 1 Fl&3 F21 F12 *"4 ' "
ij, i»ttl » n
: '^^^^ " u. g '*

' \ •
-*.«' eu
; \ :
: \ 3

X «
r ' \ u " -
= \a« =

               .091
    (Oral  Exposui"*)
                         0.81                  t.l
                    HUNAN X9UIU »UR«TION 

                         CDttOXEV MI* NXTHO»
   Key:
A « AEL
L - LOAEL
N . NOAEu
   Solid line  -  Adverse Effects Boundary
   Dashed  line - No Adverse Effects  Boundary
                                   FIGURE  C-4

        Dose/Duration  -  Response Graph for Oral  Exposure to Molybdenum:
                              Censored  Data  Method
0186d
                           -96-
05/31/89

-------
    The boundary  for  adverse effects  (solid  line)  Is  drawn by  Identifying
the lowest adverse effect  dose  or  concentration at  the shortest  duration  of
exposure at which an  adverse  effect  occurred.   From this point,  an  Infinite
line  Is extended  upward,  parallel  to  the  dose  axis.  The starting  point  Is
then  connected  to the  lowest adverse  effect  dose  or  concentration at  the
next  longer duration  of  exposure that  has  an adverse effect dose or concen-
tration equal to  or  lower  than  the previous one.  This process  1s continued
to the lowest adverse effect  dose  or concentration.  From this  point, a line
1s  extended  to the  right, parallel  to the duration  axis.   The region  of
adverse effects lies  above the adverse  effects boundary.
    Using  the  envelope  method,  the boundary for  no adverse effects (dashed
line) 1s drawn by Identifying the  highest  no adverse effects dose or concen-
tration.   From this point,  a  line  parallel to  the duration axis  Is  extended
to the dose  or  concentration  axis.  The starting point Is  then  connected  to
the next lower or  equal  no adverse effect dose or concentration  at  a longer
duration of exposure.  When  this process  can no longer be  continued, a line
1s dropped parallel to  the dose or concentration axis to the  duration ax'is.
The no  adverse effects  region  lies  below  the  no adverse effects boundary.
At  either  end  of  the  graph  between  the adverse  effects and   no  adverse
effects boundaries are  regions of  ambiguity.   The  area  (1f any)  resulting
from  Intersection of  the adverse  effects  and no adverse effects boundaries
1s defined as the  region of contradiction.
    In the censored data method, all no adverse  effect points  located in the
region of  contradiction  are  dropped  from  consideration and  the  no adverse
effect boundary 1s redrawn so that 1t  does  not  Intersect  the adverse effects
boundary and no region of  contradiction Is  generated. This  method results  1n
the most conservative definition of the no  adverse effects region.

0186d                               -97-                             05/31/89

-------
    Figures C-l and C-2  reflect  the  paucity  of the data regarding Inhalation
exposure  to molybdenum.   The  data,  composed of  only  five  records,  were
extracted  from Falrhall  et al.  (1945).  This  study  suffers  from  serious
deficiencies In design and  In  the  manner in  which  the results  are described.
The data  point N,  (NOAEL),  derived  from  exposure to molybdenite,  seems  to
conflict   with  lower   experimental   concentrations   of   other  molybdenum
compounds   that   Induce   lethality  (F.,  F.  and  F,.}.    It   may  be  that
molybdenite has a lower  deposition rate  than  other molybdenum  compounds or a
lower  absorption  rate;   however, there are no  data to support  this  assump-
tion.   The  data  point  N.,   the   concentration   that   caused   no  adverse
effects, represents Inhalation  of  fumes  of molybdenum trloxlde  at a  concen-
tration  level   considerably  lower  than  the  other  points   1n   the  graph.
Another  significant  feature  of  these  graphs   1s   the  large  region  of
ambiguity, which reflects the limited size of the data base.
    Figures  C-3  and  C-4 show  the  dose/duration-effect  graphs  generated  by
the  envelop and  censored  data methods  for  oral exposure   to  molybdenum,
respectively.  The  boundary for adverse effects  1s defined by  an AEL (A27)
from Falrhall  et  al.  (1945) from a  gavage study 1n guinea  pigs, a FEL (F28)
from the same  experimental  series  (Falrhall  et al., 1945) and  two reports  of
AELs  In  rats  (A26  superimposed  onto  A25)  from short-term studies  (Fell  et
al.,  1979;  Spence  et  al.,  1980).    In  the  two   latter   studies,  ammonium
tetrathlomolybdate  was   used;  therefore,  It  appears   that  this   compound  1s
considerably more  toxic  than  other  molybdenum compounds.  Another  signifi-
cant  feature   1s  the  data  point  N.   from  Falrhall et al.  (1945), In  which
molybdenite was  administered to guinea  pigs.   The fact  that  the dose used
was  without effects  agrees  with  the  lack  of  toxlclty  of  molybdenite  by
Inhalation.  The fact   that  reproductive  effects (L,)  are  manifested  at

0186d                               -98-                              05/31/89

-------
doses  much  Tower   than   those  causing  other  systemic  effects  1s  highly

significant, and this finding was  used as the basis  of the oral RfD.

C.2.   DATA USED TO GENERATE DOSE/DURATION-RESPONSE  GRAPHS

C.2.1.   Inhalation Exposure

Chemical Name:    Molybdenum
CAS Number:       439-98-7
Document Title:   Health and Environmental  Effects Document on Molybdenum
Document Number:
Document Date:
Document Type:    HEED
RECORD #1
Comment:
Citation:
Species:
Sex:
Effect:
Route:
Guinea pigs
Male
NOEL
Inhalation
Dose:                  279.000
Duration Exposure:     5.0 weeks
Duration Observation:  5.0 weeks
Number Exposed:     25
Number Responses:   25
Type of Effect:
Site of Effect:     SENSR
Severity Effect:

Animals were exposed  to  molybdenite dust 1 hour/day,  5 days/
week for 5 weeks.  The only  reported  effect  1s an Increase In
respiratory rate.

Falrhall et al., 1945
RECORD #2: Species: Guinea
Sex: Male
Effect: FEL
Route: Inhalat
Number Exposed:
Number Responses:
Type of Effect:
SHe of Effect:
Severity Effect:
pigs


Ion
26
51
DEATH
LIVER'
10
Dose: . 200.000
Duration Exposure: 5.0 weeks
Duration Observation: 5.0 weeks

26
' 51
DEATH
KIDNY
10
Comment:
Citation:
Animals  were exposed  to molybdenum  trloxlde  1  hour/day,  5.
days/week  for   5  weeks.  Weight  loss  and diarrhea  occurred.
Necrosis  and fatty  changes  In   the  liver  and  kidneys  were
observed.

Falrhall et al., 1945 "
0186d
                     -99-
                                           05/31/89

-------
RECORD #3:
Comment:
Citation:
Species:
Sex:
Effect:
Route:
Guinea pigs
Hale
PEL
Inhalation
Dose:                  155.000
Duration Exposure:      5.0 weeks
Duration Observation:   5.0 weeks
Number Exposed:      5
Number Responses:   24
Type of Effect:      DEATH
SHe of Effect:      NR
Severity Effect:    10

Calcium molybdate dust neutralized with calcium hydroxide was
used.  No  signs   of  clinical  toxldty were  observed,  but  the
authors report that 5/24 animals  died during exposure.

Falrhall et al., 1945
RECORD #4:



Species:
Sex:
Effect:
Route:
Guinea pigs
Male
NOEL
Inhalation
Dose:
Duration
Duration


Exposure:
Observation:

52.000
5.0 weeks
5.0 weeks

Comment:
Citation:
Number Exposed:
Number Responses:
Type of Effect:
SHe of Effect:
Severity Effect:

Animals were exposed  to  fumes  of  molybdenum trloxlde 1  hour/
day,  5  days/week  for 5  weeks.   No  signs of  toxldty were
noticed.

Falrhall et al., 1945
RECORD #5:



Species:
Sex:
Effect:
Route:
Guinea pigs
Hale
PEL
Inhalation
Dose:
Duration
Duration


Exposure:
Observation:

186.000
5.0 weeks
5.0 weeks

Comment:
Citation:
Number Exposed:      NR
Number Responses:    NR
Type of Effect:      DEATH
SHe of Effect:      NR
Severity Effect:     10

Animals were exposed  to  fumes  of  molybdenum trloxlde 1  hour/
day, 5 days/week  for  5  weeks.   The only Information given  1s
that 8.3X mortality occurred.

Falrhall et al.,  1945 "
0186d
                     -100-
                                           05/31/89

-------
RECORD #18:
Comment:


CUatlon:
Species:
Sex:
Effect:
Route:
Rats
Hale
PEL
Food
Dose:                   101.000
Duration Exposure:      40.0  days
Duration Observation:   40.0  days
               Number  Exposed:     10
               Number  Responses:   5
               Type  of Effect:     DEATH
               SHe  of Effect:     NR
               Severity Effect:    10
Comment:
CUatlon:
RECORD #19:
The dose corresponds
additional Information
Falrhall et al., 1945
Species: Rats
Sex: Male
Effect: PEL
Route: Food
to an 1050 for calcium
was provided.
molybdate. No
Dose: 125.000
Duration Exposure: 40.0 days
Duration Observation: 40.0 days
               Number  Exposed:      10
               Number  Responses:    5
               Type  of Effect:      DEATH
               SHe  of Effect:      NR
               Severity Effect:     10
Comment:
Citation:
RECORD #20:
The dose corresponds to an 1059 for molybdenum trloxlde.
No additional Information was provided.
Falrhall et al.. 1945
Species:
Sex:
Effect:
Route:
Rats
Male
PEL
Food
Dose: 333.000
Duration Exposure: 40.0 days
Duration Observation: 40.0 days
Number Exposed:     10
Number Responses:   5
Type of Effeci:     DEATH
SHe of Effect:     NR
Severity Effect:    10

The dose  corresponds  to an 1059  for  ammonium molybdate,
additional Information was provided.

Fairhall et al., 1945
                                                No
0186d
                     -107-
                                           05/31/89

-------
               Sex:
               Effect:
               Route:
           rtdiS
           «R
           i-EL
           Gavage
uose:                  200.000
Duration Exposure:      13.0 days
Duration Observation:   13.0 days
               Number Exposed:     NR
               Number Responses:   NR
               Type of Effect:     DEATH
               Site of Effect:     LIVER
               Severity Effect:    10

Comment:       Neonatal rats received sodium molybdate In an acidic solution.
               Fatty liver and  death occurred.  If administered  In a  neutral
               solution no adverse effects were reported.

Citation:      Hunt and Navla, 1973
RECORD #22:








Species: Rats
Sex: Hale
Effect: AEL
Route: Food
Number Exposed:
Number Responses:
Type of Effect:
SHe of Effect:
Severity Effect:




10
10
OTHER
LIVER
5
Dose:
Duration Exposure:
Duration Observation:

10
10
HGTDC
BODY

571.000
20.0 days
20.0 days






Comment:       Ammonium molybdate  was  given to albtao  rats,
               developed In liver and kidneys.

Citation:      Rana et al., 1980
                                                Fatty changes
RECORD #23:



Species:
Sex:
Effect:
Route:
Rabbits
Hale
AEL
Food
Dose:
Duration
Duration


Exposure:
Observation:

98.000
25.0 days
25.0 days

Comment:
Citation:
Number Exposed:     7
Number Responses:   7
Type of Effect:     FUND
SHe of Effect:     ENDOC
Severity Effect:    8

New Zealand rabbits were administered sodium molybdate  In  the
diet.    Holybdenum  caused   thyroldal   hypofunctlon.    Body
weight, hemoglobin and packed cell  volume were  reduced.

Uldjajakusuma et al., 1973
0186d
                     -108-
                         05/31/89

-------
RECORD #24:
Comment:
Citation:
Species:
Sex:
Effect:
Route:
Rats
Hale
AEL
Water
               Number Exposed:      5
               Number Responses:    5
               Type of Effect:      HISTO
               Site of Effect:      LIVER
               Severity Effect:    5
  Dose:                  289.000
  Duration Exposure:     28.0 days
„ Duration Observation:  28.0 days
                             5
                             5
                             WGTNS
                             BODY
Ammonium molybdate  was administered  to Mlstar  rats.   Fatty
changes  In  liver and  kidney were  noticed.  Molybdenum  also
caused marked growth retardation.

Bandyopadhyay et a!., 1981
RECORD #25:


"~~
Species:
Sex:
Effect:
Route:
Rats
Hale
AEL
Food
Dose:
Duration
Duration


Exposure:
Observation:

0.300
21.0 days
21.0 days

Comment:


Citation:
Number Exposed:     36
Number Responses:   36
Type of Effect:     DEGEN
Site of Effect:     COLON
Severity Effect:    6

Ammonium tetrathlomolybdate was used.  Cell  fragmentation and
necrosis In the caecum and colon were observed.

Fell et al., 1979
RECORD #26:



Species:
Sex:
Effect:
Route:
Rats
Hale
AEL
Food
Dose:
Duration
Duration


Exposure:
Observation:

0.300
21.0 days
21.0 days

Comment:
Citation:
Number Exposed:     24
Number Responses:   24
Type of Effect:     ANATM
SHe of Effect:     MSKEL
Severity Effect:    7

Ammonium   tetrathlomolybdate   was   used.    Severe   skeletal
abnormalities  were  observed 1n  long bones growth  plates  and
muscle Insertions.

Spence et al., 1980
0186d
                     -109-
                                           05/31/89   '

-------
RECORD #27;
Comment:
Citation:
Species:
Sex:
Effect:
Route:
Guinea pigs
Hale
AEL
Gavage
Dose:
Duration Exposure:
Duration Observation:
17.000
25.0 days
25.0 days
NR
NR
HISTO
LIVER
5
NR
. NR
HISTO
KIDNY
5
               Number Exposed:
               Number Responses:
               Type of Effect:
               Site of Effect:
               Severity Effect:
Molybdenum trloxlde was administered to an unspecified  number
of  guinea  pigs.   Severity  of   the  effects  Increased  with
Increasing dosages.

Falrhall et al., 1945
RECORD #28: Species: Guinea
Sex: Male
Effect: PEL
Route: Gavage
Number Exposed:
Number Responses:
Type of Effect:
Site of Effect:
Severity Effect:
pigs



NR
NR
DEATH
BODY
10
Dose: 67.000
Duration Exposure: 9.0 days
Duration Observation: 9.0 days
-



•

Comment:       Molybdenum  trloxlde was  administered  to  an  unspecified number
               of  guinea  pigs.  All  died  by the 9th day.   Fatty changes in
               the liver and kidney were observed.

Citation:      Falrhall et al., 1945
RECORD #29:



Species:
Sex:
Effect:
Route:
Rats
Male
NOCEL
Water
Dose:
Duration
Duration


Exposure:
Observation:

2.800
30.0 weeks
30.0 weeks

               Number Exposed:     20
               Number Responses:
               Type of  Effect:
               Site of  Effect:
               Severity  Effect:

 Comment:       Sprague-Dawley  rats were  administered  sodium molybdate In the
               drinking  water.   No evidence of tumors or pretumorous lesions
               was   observed  In  esophagus   or   forestomach,   only  organs
               examined.

 Citation:      Luo et al.,  1983
 NR  «  Not  reported
                                     -110-
                                                      05/31/89

-------